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General introduction and aims 
1. Periodontal diseases 
Periodontal diseases are inflammatory diseases that originate from the oral microbiota and 
that affect the tooth-supporting tissues (1, 2). More specifically, oral micro-organisms form 
biofilms at the gingival-tooth interface which can result in an inflammatory reaction of the soft 
tissues. These biofilms are often referred to as dental plaque. The most common periodontal 
diseases originating from dental plaque are gingivitis and periodontitis (3). Gingivitis is a 
reversible inflammatory pathology in which the inflammation is restricted to the gingiva around 
the teeth. It is characterized by redness, swelling, bleeding either upon probing or even 
spontaneously and an increase in gingival exudate. If left untreated, gingivitis can progress to 
periodontitis although this is not always the case (4, 5). Different forms of periodontitis were 
defined in 1999 by the American Academy of Periodontology (AAP) (6, 7). “Chronic 
periodontitis”, the most common form of periodontitis, originates from inflammation within the 
supporting tissues of the teeth and results in attachment and bone loss around the affected 
teeth (Figure 1). Clinically it is characterized by pocket formation and/or recession of the 
gingiva.  It is most prevalent in adults, but can occur at any age. Progression of attachment 
loss usually occurs slowly, but periods of rapid progression can occur. “Aggressive 
periodontitis” on the other hand occurs in patients who are otherwise clinically healthy. 
Common features include rapid attachment loss and bone destruction and familial aggregation. 
This form of periodontitis is typically seen at younger ages. “Periodontitis as a manifestation of 
systemic diseases” also often begins at a young age. Systemic conditions such as heart 
disease, respiratory disease, and diabetes are associated with this form of periodontitis. The 
rarest form of periodontitis is “necrotizing periodontitis”. It is a painful infection of the gums 
characterized by necrosis of gingival tissues, periodontal ligament and alveolar bone. These 
lesions are most commonly observed in individuals with systemic conditions such as HIV 
infection, malnutrition and immunosuppression or in smokers with high stress levels and 
inadequate oral hygiene.  
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Figure 1. Health versus periodontal disease. Extracted from: 
(http://www.absolutedentalcare.com.au/services/gum-disease-treatment-periodontal-disease-brisbane-
dentist/). 
 
Although gingivitis is reversible after removing the dental plaque biofilm and improving oral 
hygiene, periodontitis is not. The attachment loss which occurs in periodontitis will not 
regenerate spontaneously. Moreover, if left untreated, periodontitis can lead to tooth loss. 
Periodontitis is also related to an increasing list of systemic diseases such as diabetes mellitus 
(8), respiratory diseases (9), stroke (10), coronary heart disease (11), rheumatoid arthritis (12) 
and many others (13, 14). Although the relationship between periodontal diseases and 
cardiovascular diseases has not completely proven, some evidences claimed a possible 
association between both pathologies (15, 16). For instance, periodontal pathogens caused 
atherosclerosis in experimental animals and has been found in atherosclerotic lesions in 
humans (16, 17). Higher concentrations of LDL cholesterol (Low-density lipoprotein) and 
triglycerides and lower concentrations of HDL cholesterol (High-density lipoprotein) have been 
observed in individuals with periodontitis before periodontal treatment. Additionally, periodontal 
pathogens induced also elevated concentrations of C-reactive protein (CRP). CRP is a blood 
marker which indicates inflammation of the coronary arteries, which can mean a higher risk for 
heart attack. By contrast, periodontal treatment decreased the CRP levels (17). These data 
suggest that the host systemic and immune response, which is triggered during periodontal 
diseases in response to periodontal pathogens, can increase the levels of CRP and other 
inflammatory mediators and subsequently increasing the risk to develop cardiovascular 
diseases (16, 17). In this line, some meta-analysis reviews also indicated a likely association 
between periodontitis and preterm birth and/or low birth weight (18, 19). However, the 
mechanisms by which these pathologies are associated are still unclear. Further well-
conducted and randomized studies are necessary to avoid the heterogeneity of the current 
data. Although the association between periodontal diseases and cardiovascular or preterm 
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birth and/or low birth could be proven, it does not mean causation, and it is possible that other 
underlying host factors (i.e. genetically predisposition…) caused all these pathologies at the 
same time. It is, however, unclear for all the above mentioned diseases to which extent 
periodontal pathogens are cause or consequence of the disease since all these diseases are 
influenced by systemic inflammation. Although gingivitis and periodontitis can cause systemic 
inflammation, they are also influenced themselves by systemic inflammation.   
 
1.1. Prevalence of periodontitis 
Periodontal diseases are extremely common. Multiple epidemiological studies report that the 
prevalence of periodontal diseases depends on factors such as age, gender, race and ethnicity 
(20-22). The Global Burden of Disease study, executed by the World Health Organization, 
estimated that periodontitis is the 6th most prevalent health condition worldwide (23). 
Nevertheless, it remains difficult to make conclusive statements about the global periodontitis 
prevalence because of an overall dearth of studies reporting comparable estimates. Only a 
few epidemiological studies are from Asia and none are available from Africa; two continents 
that contain much of the global population (24). Additionally, studies use different sample 
strategies, different assessment tools and different case definitions for periodontitis which all 
influence the prevalence of periodontitis. In this regard, Costa and coworkers (2009) showed 
that on the same population the applied case definition for periodontitis could change the 
prevalence of periodontitis from 65% to 13% (25). In general, according to epidemiological 
studies, periodontal diseases affect up to 90% of the world population (1). Whereas gingivitis 
affects 50–90% of the adults worldwide (26), around 50% of the adult population is affected by 
some form of periodontitis and approximately 10%  suffers from its severe form (27, 28). Data 
from 2009 and 2010 showed that 64.7 million of American adults had periodontitis (29). 
Another study reported that from 2009 to 2012, the prevalence of periodontitis in a 
North-American adult population was 46%, of which 8.9% suffered from severe periodontitis 
(30). Similar data have been shown for a European population (31). 
The Global Burden of Disease study also showed that the prevalence of severe periodontitis 
gradually increases with age. However, a steep increase was noticed between the ages of 20 
to 40 years old. After the age of 40 the increase in severe periodontitis is low and rather 
constant (23). Whereas the prevalence of periodontitis in the age group between 30-34 years 
old is about 24%, this gradually increases to 70% for people in the age group of 65 and above 
(32).  
Aggressive forms of periodontitis, found in children and adolescents, are much less common. 
Epidemiological studies done in Europe estimate the prevalence of periodontitis in children to 
be around 0.1% (33). 
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The prevalence of periodontitis is also influenced by the ethnic and racial background as shown 
in a North-American population. In general, periodontitis is more prevalent in Hispanics than 
in non-Hispanic blacks, or than in Asian Americans or non-Hispanic whites with prevalence 
rates of 63.5%, 59.1%, 50% and 40% respectively (30). Additionally, gender and economic 
factors can also influence the prevalence of periodontal diseases. For instance, North-
American males suffered from periodontitis in higher numbers than females. Additionally, a 
high socioeconomic status reduces the risk to suffer from periodontitis twofold (30).  
 
1.2. Etiology of periodontitis 
The oral cavity is a complex polymicrobial ecosystem that harbors a vast number of bacterial 
species (34). Most of these bacterial species live within biofilm structures that reside on hard 
and soft tissues which are covered with saliva and/or gingival crevicular fluid (35). Within the 
oral cavity these bacterial biofilm communities are commonly called dental plaque. There is no 
doubt that the presence of a dental plaque biofilm is a “condition sine qua non” for the 
development of periodontal diseases such as gingivitis and periodontitis although 
environmental, systemic and genetic factors also play an important role. Over the years, 
different hypotheses were proposed which aimed to capture the role of dental plaque and oral 
biofilms in the development of periodontal diseases. 
 
1.2.1. Plaque hypotheses 
The knowledge about the initiation and development of oral pathologies has continuously 
evolved along the last decades, due to the optimization and invention of new microbiological 
techniques. In 19th century, the first theory called non-specific plaque hypothesis (NSPH) 
claimed that the only presence of the dental plaque could induce periodontal diseases (36). It 
considers that the amount of total bacteria is a more decisive factor than the capacity of certain 
specific bacteria to induce oral diseases (2). It also postulated that the prevention should be 
based on the maintenance of a high standard oral hygiene by means of a mechanical removal 
of the dental plaque (36). However, NSPH does not take into consideration the different grades 
of susceptibility among individuals, when the level of plaque is similar. However, the concurrent 
study Löe and colleagues (1986) confronted this hypothesis based on the data from a Sri 
Lankan population without any dental hygiene habits. 11% of Sri Lankan population never 
developed periodontal diseases beyond gingivitis. 
In 1976, Walter Loeshe introduced a new theory called specific plaque hypothesis (SPH), 
because of the improvement on the identification and detection techniques of oral micro-
organisms (36). SPH theory pointed that a considerable amount of plaque is not an essential 
requirement to develop severe destructive periodontitis, only the presence of specific 
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pathogenic oral species. Therefore, the preventive treatment should be focused on the 
eradication of these pathogens and not of all oral species. SPH also suggested a possible 
classification of high-risk patients depending on specific pathogens in their oral cavity. 
Nowadays, none of the known pathogens has been specifically related to gingivitis or 
periodontitis (36). However, only a unique study reported that the presence of JP2 clone of A. 
actinomycetemcomitans indicated high-risk of aggressive periodontitis in Moroccan 
adolescents (37). This study is the only case where a single specific pathogen was directly 
linked to a periodontal disease.  
During the posterior decade after SPH theory, more micro-organisms (spirochetes, 
streptococci, protozoa and actinomyces) were identified as potential periodontal pathogens. 
Lately, Gram-negative bacteria from different genera (Capnocytophaga, Eikenella, 
Actinobacillus and black-pigmented Bacteroides) were also considered as periopathogens 
(36). A further study carried out by Socransky et al., grouped these bacteria in complexes 
according to their relationship with periodontal diseases (38). Unfortunately, SPH theory could 
not explain the presence of pathogenic bacteria in patients, which never developed periodontal 
diseases.  
Due to this new knowledge about the etiology of periodontal diseases, this theory was updated 
resulting named updated non-specific plaque hypothesis (UNSPH). This theory postulates 
that oral diseases can be caused only by the growth of a few specific bacteria. Specifically, 
Theilade stated that “increased virulence of plaque (leading to disease) is due to a plaque 
ecology unfavourable to the host and favourable for overgrowth by some of the indigenous 
bacteria having a pathogenic potential” (39). The main contribution of the NSPH is to 
distinguish a change in bacterial composition during the transition from health to disease. 
However, UNSPH still considers that the dental plaque has the most important potential 
pathogenic effect compared with individual species. Although, dental plaque can contribute to 
the development of periodontal disease, the virulent and pathogenic factors of some oral 
pathogens could accelerate this process. These differences in pathogenicity of dental plaque 
might explain the severe progression of periodontal diseases in certain patients (36). 
Additionally, USPH also does not address which factors are behind of the outgrowth of these 
specific pathogens.  
In 1994, Philip Marsh formulated the ecological plaque hypothesis (EPH) (Figure 2), which 
suggested a balance between microbial composition and the ecological factors, such as pH, 
redox potential, nutrients or cofactors present (40, 41). A disruption of this balance by 
ecological stress results in an outgrowth of some periodontopathogens linked to periodontal 
diseases (36, 40). Currently, EPH is globally accepted. In addition, Marsh confirmed the 
reverse effect in which oral micro-organisms could also modify their environment (36). For 
instance, a decrease in redox potential allows the growth of strict anaerobic within oral biofilms, 
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due to the consumption of oxygen by facultative anaerobic early colonizers to produce H2O2 
and carbon dioxide as by-products (41). Therefore, the bacterial growth depends on the 
environment, which is influenced by the bacterial metabolism itself. This results in mutual 
dependencies in health, but also in a series of events that drive the biofilm development 
towards disease (36). However, together with the previous plaque hypotheses, the impact of 
the genetic component of the host, which is determining the composition of dental plaque and 
susceptibility to disease, is still absent in the EPH (42). 
 
Figure 2. Scheme of the ecological plaque hypothesis (EPH) in relation to gingivitis and 
periodontitis. Dental plaque accumulation induces host inflammatory response, which results 
in environmental changes that cause an ecological shift. These new ecological conditions 
enriched in new host proteins favors selectively proteolytic and anaerobic Gram-negatives 
pathogenic bacteria. Figure extracted from (43). 
 
Lately, the keystone-pathogen hypothesis (KPH) was enunciated. It proposed that certain 
low-abundance microbial pathogens modulate the host immune system and cause 
inflammatory disease. Inflammation caused by these low-abundance microbial pathogens, 
results in an increase in the amount of bacteria, thereby contributing to a change in biofilm 
composition resulting in inflammatory disease affecting the host (44). Studies showed that 
P. gingivalis could subvert and manipulate the native immune system of the host (45), 
increasing the growth of itself and of the whole bacterial community (45). Although the 
abundancy of some pathogens can influence inflammation, keystone-pathogens already 
trigger inflammation when present in low numbers (non-pathogenic concentrations) (44). 
During disease development, keystone-pathogens are detectable in a higher numbers 
(pathogenic concentrations) (38). 
 
The host immune system performed a critical role in the KPH (Figure 3). At periodontal health, 
periodontal tissues create a barrier of neutrophils localized between oral biofilms and the 
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epithelium. To form this neutrophil wall, specific inflammatory mediators such as intercellular 
adhesion molecule (ICAM), E-selectin and interleukin 8 (IL-8) are required (46). Additionally, 
oral epithelium can also express multiple Toll-like receptors (TLRs) to mediate the response 
to oral micro-organisms (47, 48). In health, the interaction between TLRs and microbial biofilms 
leads to the expression of several types of cytokines (49, 50). In addition, examinations of the 
periodontal health tissue showed low abundance of immune cells such as macrophages, 
Langerhans cells, tissue dendritic cells, and migratory neutrophils in gingival crevicular fluid 
and the epithelial cell layer. This reveals that in absence of bacterial challenge, a basal amount 
of cytokines are expressed based on the host genetic programming (51). However, changes 
in the amount of plaque and in its composition could modify the cytokine expression (49-51). 
The host defense mechanisms described above are proposed to be most likely deregulated 
by three KPH mechanisms of P. gingivalis: (i) manipulation of the TLR response, (ii) subversion 
of IL-8, and (iii) interruption of the complement system (52). 
 
 
Figure 3. Keystone-pathogen theory exemplified by the dysbiotic effect of P. gingivalis that 
induces periodontitis. Dysbiotic effect of P. gingivalis that induces periodontitis. 1 and 2) P. 
gingivalis subverts and manipulates the host immune response through the complement 
system. 3 and 4) This results in the outgrowth of dental plaque that causes complement-
dependent inflammation. Periodontal tissue breakdown is enhanced by further bacterial 
growth, which induces the release of gingival crevicular fluid enriched in host proteins and 
hemin. The new environmental conditions favor the growth of proteolytic and asaccharolytic 
bacteria, which leads to a microbial shift. 6 and 7) The inflammatory bone resorption creates 
new bacterial niches for the dysbiotic microbiota. The combination of all bacterial and host 
inflammatory alterations drives towards periodontal disease. Moreover, these chronologic 
steps form part of a vicious and self-feeding cycle Figure extracted from (44).   
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1.2.2. The relation between plaque hypotheses and periodontal diseases 
The etiology of periodontal diseases is complex. This complexity is enhanced by the interplay 
between micro-organisms and the host immune system leading to inflammation (36). 
Therefore, their etiology can currently not be explained by a single hypothesis.  
However, other oral pathologies can be largely explained by the EPH hypothesis, for instance 
tooth decay, in which the host diet is a major influencing factor. When acid production is 
increased by the consumption of fermentable sugar the pH drops off, stimulating the growth of 
acidogenic (acid-producing) and aciduric (acid-tolerant) bacteria, especially cariogenic 
bacteria such as S. mutans, S. sobrinus and Lactobacillus spp. This results in demineralization 
of the enamel, leading to caries. Additionally, EPH can also partially explain this pathology, 
since S. mutans and S. sobrinus are specifically associated to caries. However, the presence 
of both species is not a warranty to develop caries. Furthermore, the fermentation of sugars is 
not an exclusive property of these two bacteria, since the demineralization can also be caused 
by other species. 
In the line of the UNSP hypothesis, the development of total dental plaque for 3 weeks can 
induce gingivitis, when no dental care treatment is applied (12, 56). Subsequently, the 
interaction of bacterial compounds (LPS, DNA, flagella …) can activate the TLRs receptors 
and trigger inflammation, leading to gingivitis. 
The development of periodontitis is dependent on a complex matrix of interactions between 
the oral microbiota and the host immune system. When changes in abundance and/or 
composition (keystone-pathogen) in dental plaque occur, the production of a vast number of 
inflammatory mediators (i.e. cytokines) leads to tooth loss. However, differences in host 
susceptibility between individuals can determine the development or not of periodontal 
diseases. Several factors including the genetic component between healthy and periodontitis 
patients, the socio-economic level, the diet habits and various environmental factors can play 
an important role in the grade of susceptibility between individuals. For instance, differences 
in secretion of heat-shock proteins and Toll-like receptors after bacterial stimulation have been 
found among different ethnic groups. This suggests that genetics, host habits and environment 
are crucial factors during oral health and diseases. 
Taking all hypotheses together, none of them could explain completely the initiation and the 
progression of periodontal diseases. Therefore, new experimental models and studies on the 
complex interplay between the oral microbiota and the host immune system are needed in 
order to improve or complete the current plaque hypotheses.  
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1.2.3. Factors determining the susceptibility towards periodontitis 
There is little doubt that in health, dental plaque biofilms are primarily composed of 
non-pathogenic bacterial communities, i.e. without the capacity to induce periodontal diseases, 
which are in immunological balance with host tissues. This condition is called homeostasis but 
does not imply that there are no pathogenic bacteria present within these communities (53). 
However, environmental, systemic or genetic factors can change the susceptibility of the host 
towards the bacterial biofilm or the pathogenicity of the bacterial biofilm. Changes in these 
factors can shift non-pathogenic microbial communities to pathogenic biofilms by a process 
called dysbiosis (54). Dysbiosis of the human microbiota may play a crucial role in a variety of 
complex diseases such as type II diabetes, rheumatoid arthritis, allergy, inflammatory bowel 
disease and periodontitis (55). It is generally believed that the transition from the healthy 
homeostatic state to dysbiosis is driven by key microbial players in the community, which are 
bacterial species that can initiate and drive the progression of periodontal diseases (see 
Tables). These species can influence the host immune system and worsen the habitat 
conditions for the commensals which dominate the healthy symbiotic community although it 
cannot be excluded that the opposite is true. It might very well be that changes in the 
commensal microbiota or in the host immune system drive changes in the overall microbial 
community which is perceived as dysbiosis. Although dysbiosis is not very well defined 
clinically, it is often referred to when one notices an outgrowth of specific pathogenic bacteria 
which are called pathobionts. Pathobionts are natural members of the human microbiota that 
under certain perturbations in the host and/or microbiota can cause pathology (56, 57). 
Although the process of dysbiosis is captured in the UNSPH, EPH and/or KPH, the 
mechanisms behind dysbiosis remain obscure. All these theories contributed to our 
understanding of the dysbiotic process, however the initial triggering factors in the 
development of dysbiosis are still unknown. The factors that are currently believed to determine 
the susceptibility towards periodontitis are host-environmental factors, presence of pathobionts 
and absence of commensal albeit beneficial bacteria. 
. 
1.2.4. Host-environmental risk factors 
Host-environmental risk factors comprise personal behavior or lifestyle, an environmental 
exposure or an inborn or inherent characteristic that is known to be associated with disease 
related conditions, based upon epidemiological evidence.  
a. Age 
Although the prevalence and severity of periodontitis increases with age (58), the 
relationship is complex. It is not because a person ages, that periodontitis will occur 
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inevitably. The relationship more likely represents the cumulative effect of prolonged 
exposure to true risk factors than the increase in age as such. On the other hand, age-
associated molecular changes in key phagocytic cells involved in both protective and 
destructive immune responses have been shown to affect their ability to carry out 
efficient antimicrobial functions and to result in a dysregulation of the inflammatory 
response (59). Since periodontitis is a microbiologically induced inflammatory disorder, 
these alterations in innate immunity likely contribute to the more pronounced 
periodontal pathology in elderly individuals.  
b. Gender 
Men have shown worse periodontal conditions than women in multiple studies from 
different populations (60-63). This has been in general attributed to the documented 
better oral hygiene practices of women (64, 65) although there is evidence for sexual 
dimorphism in elements of both the innate and the acquired immunity. The latter leads 
to a more pronounced pro-inflammatory response in men (66). 
c. Genetic factors 
The development of periodontitis has an important genetic component which is related 
to the host immune system (67). Adult twin studies indicate that more than 50% of the 
susceptibility towards periodontitis is attributed to genetic factors (68). Genetic 
disorders can result altered host immune response, which in turn cause an increase in 
susceptibility to develop periodontitis (69). As result of these genetic disorders, the host 
response is inappropriate and/or insufficient against the pathogenic challenge (70). For 
instance, severe congenital neutropenia (SCN) or infantile genetic agranulocytosis 
(IGA) are primary immune deficiencies caused by the absence of neutrophils, which 
predisposes to a rapid and severe periodontal destruction caused by bacterial and 
fungal infections (71, 72). Other examples of such genetic disorders are 
hyperglobulinemia (73), Down syndrome (74, 75), Papillon-Lefèvre syndrome (76, 77), 
Marfan syndrome and Ehler-Danlos syndrome (78, 79). On the other hand, gene 
polymorphisms in otherwise healthy persons also play a role in the individual’s 
susceptibility. A recent systematic review of meta-analyses focusing on polymorphisms 
in inflammatory mediators and its relation with risk of periodontitis development showed 
that polymorphisms in the IL-1A, IL-1B, IL-6, IL-10, MMP-3, and MMP-9 genes were 
significantly associated with the risk of developing periodontitis (80). 
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d. Oral hygiene 
A good oral hygiene (OH) is an essential procedure to maintain a healthy oral status 
(81). The accumulation of dental plaque and calculus is usually caused by improper 
tooth brushing techniques, failure to carry out interdental cleaning and irregular dental 
visits. This accumulation predictably results in gingival inflammation (82). Persistent 
gingivitis is a key risk predictor for the breakdown of periodontal attachment. Although 
poor OH is a well-accepted and important risk factor for periodontitis, the magnitude of 
the association between OH and periodontitis has just recently been established (83). 
The results suggest an inverted correlation between OH and periodontitis, with fair and 
poor OH significantly increasing the risk of having periodontitis by two- and fivefold, 
respectively, compared with good OH. In contrast, regular tooth brushing and dentist 
visits could reduce periodontitis by 34% and 32%, respectively. 
e. Smoking 
Smoking is a major risk factor in the development of periodontal diseases. Smokers 
are characterized by an increased periodontal attachment loss, deeper periodontal 
pockets and more gingival recession when compared to individuals who were former 
smokers or who have never smoked (84). A proportional effect between the level of 
smoking and attachment loss has been reported (85). Likewise, scaling and root 
planing is more effective in non-smokers than in smokers (86). The biological 
plausibility of an association between smoking and periodontitis relates to the broad 
effects of tobacco-related substances on cellular structure and function (87). Recent 
studies also show that smoking contributes to the formation of a dysbiotic biofilm. It 
affects bacterial acquisition and colonization (49), bacterial aggregation (88), and 
results in higher levels of key periodontopathogens (89). 
f. Diabetes mellitus 
A recent meta-analysis confirmed a strong association between type 2 diabetes 
mellitus and periodontitis but the evidence for diabetes type 1 is weaker (90). Primarily 
patients with a long history of diabetes or with a poor metabolic control are specifically 
affected (91). For the latter, a positive correlation between a poor metabolic control and 
more risk of periodontitis has been shown (92). Moreover, the outcome of periodontal 
treatment in well-controlled diabetic patients is similar to that of non-diabetic patients 
(93), while patients with a poorly controlled DM display an inferior treatment outcome 
(94). Several biologically plausible mechanisms by which diabetes mellitus may 
contribute to periodontitis have been identified (95). Interestingly there is a 2-way 
relationship between diabetes mellitus and periodontitis. Patients with periodontal 
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disease exhibit a higher incidence of diabetic complications and a poorer metabolic 
control (95). 
g. Obesity 
A number of studies indicate a positive relationship between body mass index (BMI) 
and periodontitis (96). It is even so that a positive association between weight gain and 
new cases of periodontitis was found. However, these results originated from limited 
evidence (97). There is however a controversy about the influence of obesity on the 
periodontal treatment outcome in patients with chronic periodontitis. The biological 
plausibility of a potential link between obesity and periodontitis is explained by a hyper-
inflammatory state and an aberrant lipid metabolism, as well as the pathway of insulin 
resistance (98, 99). 
h. Viral infections 
Some viral infections are considered risk factors which predispose infected patients to 
develop periodontal diseases (100). Most of the viral infections depress the host 
immune system, thereby increasing the host susceptibility to bacterial infections. 
Several investigations related HIV and herpesviruses to periodontal infections. For 
instance, high prevalence of oral mucosal lesions and necrotizing gingival lesions were 
common and significant in HIV patients (101). However, contradictory findings have 
been published. In addition, herpesvirus infections damage the periodontal tissues, 
triggering the release of proinflammatory cytokines which can activate the osteoclasts 
and matrix metalloproteinases by reducing the antibacterial immune mechanisms, 
thereby increasing the growth of periodontal pathogens (102). A study on adults with 
gingivitis or periodontitis found statistically significant associations between periodontal 
Epstein–Barr virus type 1 or cytomegalovirus and the periodontal pathogens 
P. gingivalis, T. forsythia, P. intermedia, P. nigrescens and T. denticola (103). Other 
studies showed that concentrations of cytomegalovirus (CMV) and Epstein-Barr virus 
are higher in periodontal tissue samples of patients suffering from severe chronic 
periodontitis (104). A recent meta-analysis suggest that two members of the 
herpesvirus family, EBV and HCMV, are significantly associated with chronic 
periodontitis (105). 
i. Stress and psychosocial factors 
Chronic stress and mental pathologies, like depression, can play an important role 
modifying the personal behavior and the immune response in periodontal pathologies. 
Chronic stress and depression are considered as risk factors in periodontitis causing 
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changes in health-related behaviors, such as oral hygiene, smoking and diet (106). 
Several clinical studies described a link between on the one hand depression and 
chronic stress, and on the other severe periodontitis in adolescents and adults. These 
alterations of behavior can also cause dysfunctions in the neuro-immunologic system, 
as it has already been described that high amounts of cortisol in serum is related to a 
high clinical attachment loss (107). However, additional basic and epidemiological 
research is needed to fully elucidate a possible relationship between psychological 
factors and periodontal disease. 
 
1.3. Pathobionts 
As consequence of the global study of oral microbiota, the term “pathogen” has been redefined 
toward to a new term named “pathobiont”. Pathobiont is defined as an any oral species with 
capacity to induce periodontal diseases under certain specific environmental and/or metabolic 
conditions (108) (Table 1). This is because of their capacity to produce certain virulence factor 
such as proteinases, toxins… (Table 2).  Scientific evidences demonstrated that specific 
pathobionts or group of pathobionts play an important role in the development of the different 
forms of periodontal diseases (109).  
 
Table 1. Beneficial and pathogenic oral species significantly associated with oral health 
and periodontitis. 
 
 
 
 
Beneficial bacteria (Oral Health) Pathobionts (Periodontitis) 
Streptococcus spp. Porphyromonas spp. 
               -S. sanguinis                       -P. gingivalis 
               -S. gordonii Prevotella spp. 
               -S. cristatus                       -P. intermedia 
               -S. salivarius Fusobacterium spp. 
               -S. mitis                      -F. nucleatum 
               -S. parasanguinis Aggregatibacter ssp. 
               -S. oralis                      -A. actinomycetemcomitans  
Actinomyces spp. Filifactor spp. 
               -A. naeslundii                     -F. alocis 
               -A. viscosus Treponema spp. 
Acinetobacter spp.         -T. denticola  
Moraxella spp. Tannerella spp. 
Rothia spp.                     -T. forsythia 
Gemella spp. Selenomonas spp. 
Veillonella spp. Peptostreptococcus spp. 
Haemophilus spp. Desulfobulbus spp. 
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An early classification in bacterial complexes was established by Socransky and colleagues 
(1998) based on the prevalence and association of certain pathobionts with periodontal 
diseases (38). Among these complexes, “red complex” formed by Treponema denticola, 
Porphyromonas gingivalis, and Tannarella forsythia was especially related to adverse clinical 
parameters of periodontitis (pocket depth and bleeding on probing) (110). Further studies 
described the diversity and complexity of oral microbiota, however nowadays only 
Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia 
are considered as a real periodontal pathogens (111) (Table 1). 
Recently, the technical development of the molecular methodology especially in the next 
generation sequencing techniques allowed to understand better the complexity, the distribution 
and the complex interplay between oral species within the oral microbiota. These new 
techniques permitted the microbiological analysis and characterization of the specific oral 
microbiota linked to the different phases of periodontal diseases, and/or allowed the study of 
the non-culture part of the oral microbiota (34, 112-115). Collectively, sequencing data from 
the last decades indicated a microbial shift in the microbial communities in the transition from 
health to periodontal disease, identifying bacterial microbiota associated to periodontal health, 
gingivitis and periodontitis (116-118) (Table 1). Moreover these studies also suggested a core 
of bacterial species always present in any clinical condition, because of their versatility to adapt 
themselves to metabolic and environmental changes (116, 117). Although, traditional 
pathogens (Porphyromonas spp., Tannarella spp., Treponema spp., and Prevotella spp.) were 
also linked to periodontal diseases, a new cluster of micro-organisms composed by Filifactor 
alocis, Fretibacterium sp., Desulfobulbus sp. appeared significantly abundant in periodontitis 
sites (115, 116). Additionally, Perez-Chaparro and colleagues (119) found the association of 
17 novel periodontal pathogens including F. alocis, Selenomonas sputigena, Desulfobulbus 
sp. HOT 041, Fretibacterium sp. HOT 360, Bacteroidales sp. HOT 274, and TM7 [G-5] sp. 
HOT 356 to the etiology of periodontal diseases (119). This indicates that unknown and/or 
uncultured taxa seem to play an important role in the initiation and progression of periodontal 
diseases, therefore further investigations to determine their influence during periodontal 
diseases are needed.  
 
1.4. Beneficial bacteria 
Although the knowledge about the pathogenic molecular mechanisms behind periodontal 
pathologies has been deeply investigated, little is known about the molecular commensalism 
and its role in the maintenance of periodontal health (120). Commensal oral microbiota are 
host-compatible bacterial communities, which occupy and colonize intraoral sites without 
inducing periodontal pathologies (121). Recently, sequencing studies related some 
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commensal species from genera such as Streptococcus, Actinomyces, Haemophilus, 
Granuticatella, Gemella, and Veillonella to periodontal health (115, 116) (Table 1). The 
contribution of some commensal species to host homeostasis is either demonstrated by their 
abundance in periodontal health sites or by their loss during periodontal diseases (122-124). 
For instance, some commensal taxa are strongly related to periodontal healthy sites (125). 
Additionally, a clinical study showed that none of the 30 children with severe periodontal 
pathology contained S. sanguinis in their oral bacterial composition, while S. sanguinis was 
found in all healthy patients (126). Although the research on commensal bacteria is now being 
developed, several studies have already reflected that some of these health-associated 
bacteria, called beneficial bacteria, can also passively and/or actively contribute to maintain a 
healthy ecosystem by using the following competitive mechanisms: 1) by avoiding pathobionts 
colonization, 2) by actively reducing the adhesion of pathobionts, 3) by inhibition the 
pathobionts growth, 4) by the neutralization and degradation of the pathogenic virulence 
factors, and 5) by reducing the host inflammatory potential induced by pathobionts. For 
instance, commensal bacteria could antagonize the growth of A. actinomycetemcomitans, P. 
gingivalis, P. intermedia, and F. nucleatum (127). The colonization of epithelial cells by A. 
actinomycetemcomitans was decreased by S. sanguinis, S. mitis and S. salivarius (128). 
Commensal bacteria can also produce a wide range of antimicrobial substances such as 
organic acids, fatty acids, hydrogen peroxide and bacteriocins to limit the growth of periodontal 
pathogens and create a health-compatible host biofilm (129). For instance, S. sanguinis can 
inhibit A. actinomycetemcomitans by H2O2 production (130). In addition, S. gordonii can 
interfere the mutacin production of S. mutans by secreting an extracellular (challisin-like) 
protease to degrade the peptide CSP (competence-stimulating peptide), which regulates the 
mutacin gene expression (131). Moreover, the production of H2O2 can reduce the 
hemagglutinating and Arg-gingipain activities of P. gingivalis (132). Host immune response 
can be modulated by the commensal species, for instance S. cristatus attenuated the 
expression of IL-8 by oral epithelial cells in response to F. nucleatum. Only supernatants of S. 
sanguinis, S. mitis and S. salivarius could also reduce the A. actinomycetemcomitans-induced 
IL-8 production by epithelial cells (133). Due to the value of these beneficial properties of some 
commensal bacteria, together with their high colonization capacity, their absence of virulence 
factors expression and their modulation of the host immune response, a possible commensal 
probiotic therapy could be applied. Furthermore, the restoration and/or reinforce of these 
commensal microbiota could also be used as an alternative approach for improving oral health 
(120, 134).  
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1.5. Periodontal pathogenesis 
Dysbiosis in oral biofilms is characterized by a microbial shift, which increases the number of 
pathobionts and can lead to the development of periodontal diseases in a susceptible host 
(135). Dysbiotic biofilms are enriched in PAMPs (pathogen-associated molecular patterns) 
such as lipopolysaccharides (LPS), antigens or other virulence factors, which can activate and 
stimulate the host immune response by interacting with pattern recognition receptors (PRRs) 
(136). The recognition of PAMPs induces an activation and recruitment of host immune cells 
that subsequently release cytokines and chemokines (Figure 4). However, some pathobionts 
have developed specific molecular mechanisms to subvert the inflammatory response, to 
evade the immune killing-response and to deregulate the host response. Periodontal 
pathobionts can influence the host immune response mainly by subverting chemotaxis and the 
complement system (136). Neutrophils are leukocytes that are recruited to the periodontal 
pockets in order to maintain periodontal tissues homeostasis. However, disordered activity of 
neutrophils can produce a hyperactive response because of their excessive numbers, thereby 
damaging the periodontal tissues by the release of inflammatory toxic substances or proteolytic 
enzymes. The chronic recruitment of neutrophils is a consequence of the microbial challenge 
caused by the dysbiotic biofilm (137). For instance, interleukin-8 (IL-8) can be degraded by P. 
gingivalis proteases which contribute to the persistence of the infection due to the long-term 
presence of high amounts of neutrophils in periodontal pockets. Additionally, pathobionts can 
also subvert the complement system, a cascade of receptors and proteins involved in the 
microbial opsonization and phagocytosis. Some pathobionts like P. gingivalis can protect itself 
from opsonophagocytosis through the degradation of the C3 component complex (138). Due 
to these pathogenic properties, dysbiotic biofilms can be defined as bacterial communities, 
resistant to immune elimination, with an optimal environment for the growth of pathobionts. 
The host immune manipulation and subversion exerted by dysbiotic biofilms creates a chronic 
pro-inflammatory state by the secretion of matrix metalloproteinases (MMPs), lytic enzymes 
and prostanoids in host tissues, all together contributing to the destruction of the periodontium 
leading to the bone loss. 
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Figure 4. Biological mechanisms involved in the pathogenesis of periodontitis. Extracted from (2).  
 
2. Dysbiosis  
2.1. Initiation of dysbiosis 
The oral microbiota and the host tissues are in a constant equilibrium called homeostasis, 
which regulates the host inflammatory response and protects the host against external 
aggressions (45). Moreover, a microbial balance between different bacterial populations in the 
dental biofilm is present in healthy subjects. These bacterial populations can be grossly divided 
in pathogens, commensal and beneficial bacteria, based on their relation to periodontal health 
or disease (139). Pathogenic bacteria or pathobionts are oral bacteria which are able to cause 
disease under certain specific conditions. Commensal and beneficial bacteria are also 
populations of the indigenous microbiota, which are mainly related to health conditions (140). 
It has been suggested that the distinctive hallmark of some commensal bacteria is their ability 
to inhibit the growth and the colonization of pathobionts. In homeostasis, beneficial bacteria 
limit the growth of pathobionts. However certain changes in the environmental conditions 
and/or systemic condition of the host can lead to dysbiosis (Figure 5) (108). Although the 
clinical signs that can be linked to dysbiosis, such as bleeding on probing, are relatively well 
known from clinical studies, the mechanisms behind the initiation of dysbiosis are still unclear. 
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                  Figure 5. Polymicrobial synergy and dysbiosis (PSD) model. Figure extracted from (141). 
 
2.2. Role of beneficial bacteria in dysbiosis 
The composition of the indigenous microbiota is related to oral health. There are clear 
differences in the microbial composition of healthy and periodontally diseased patients, with 
the latter being characterized by for instance an increase in pathobionts (e.g. P. gingivalis)  
and a decrease in beneficial bacteria (e.g. S. sanguinis). Several identification techniques have 
been used and are being used to classify oral species in pathogens, beneficial and commensal 
bacteria according to their prevalence in health or disease or according to their effects on 
pathobionts or the host inflammatory response. Although beneficial bacteria are believed to be 
of importance for maintaining a healthy ecosystem, their role in the development and 
prevention of periodontitis is less obvious and far from being elucidated since research in this 
field is only just recently emerging. In general, beneficial bacteria can affect the oral ecology 
by different mechanisms and might therefore modify disease processes by excluding the 
pathogens from the oral niches (142), by reducing the adhesion of the pathogens to hard and 
soft tissue surfaces (143), by inhibiting the growth of oral pathogens (127), by downregulating 
the virulence factors expression from periodontal pathogens (144) and by attenuating the host 
response towards pathogenic species (133). Being part of the 700 oral species that can be 
part of the oral microbiota, streptococci are a predominant population in the oral cavity. They 
have been shown to have an important role in biofilm formation, but also in limiting the growth 
of periodontal pathogens. At the clinical level, it has recently been shown that periodontitis is 
associated with a loss of colonization by certain streptococci (124). Moreover, some of these 
streptococci have been tested clinically as probiotic strains in the treatment of periodontitis 
(145). Although the clinical use of streptococci-containing probiotic lozenges did not result in 
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clinical effects, certain other oral probiotic strains, such as Lactobacillus reuteri, have shown 
clinically beneficial effects (146). For instance, patients with chronic periodontitis treated with 
L. reuteri lozenges as an adjuvant to scaling and root planing treatment for 12 weeks, 
significantly reduced their pocket depth and their amounts of P. gingivalis. Inhibitory effects on 
periodontal pathobionts have already been shown for several commensal species such as S. 
sanguinis, S. gordonii and S. salivarius. The mechanisms behind the inhibition of the 
pathobionts and the influence of the environmental factors on these inhibitory competitions 
have however hardly been studied. An example of such a beneficial-pathobiont interaction is 
the effect of S. sanguinis on A. actinomycetemcomitans. It is known that S. sanguinis produces 
H2O2 and by this can kill A. actinomycetemcomitans (147). Additionally, S. sanguinis can 
interfere with A. actinomycetemcomitans colonization of hard and soft tissues, and can 
attenuate the epithelial cell response (e.g. IL-8 production) towards A. actinomycetemcomitans 
(128, 133). However, the inhibitory properties of beneficial bacteria have only been described 
for a limited number of species primarily towards cariogenic pathogens. Therefore, identifying 
and characterizing the role of beneficial bacteria is of vital importance to further unravel the 
periodontal disease process and to develop new treatment strategies. 
2.3. Antimicrobials produced by beneficial bacteria   
Beneficial bacteria can produce a wide range of antimicrobial substances which are believed 
to kill, suppress or control specific pathogens and pathobionts. The proposed mechanisms 
underlying the health benefits provided by beneficial bacteria include the formation of low 
molecular weight (LMW) compounds (<1,000 Da), such as organic acids and hydrogen 
peroxide, and the production of bacteriocins (>1,000 Da). 
Organic acids such as acetic acid and lactic acid have a strong inhibitory effect against specific 
bacteria and bacterial strains depending on environmental conditions and mode of application. 
They have been considered important antimicrobial compounds responsible for the inhibitory 
activity of beneficial bacteria against pathogens in the GI tract (148). Similarly, lactic acid 
bacteria (Lactobacillus spp.) isolates from healthy individual could inhibit the growth of S. 
mutans and P. gingivalis by the production of organic acids, bacteriocins and H2O2 (149). In 
addition, the growth of P. intermedia, A. actinomycetemcomitans, P. gingivalis and S. mutans 
was decreased by organic acids such as acetic acid and lactic acid produced by oral lactobacilli 
(150). 
 
It has been suggested that many beneficial bacteria produce antibacterial peptides, including 
bacteriocins and small AMPs. Bacteriocins produced by Gram-positive bacteria (usually LAB, 
including lactacin B from L. acidophilus, plantaricin from L. plantarum and nisin from L. lactis) 
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have a narrow activity spectrum and act only against closely related bacteria, but some 
bacteriocins are also active against food-borne pathogens (151). Some specific antibacterial 
compounds have been described for several Bifidobacterium strains, and a unique bacteriocin, 
bifidocin B, which is produced by B. bifidum NCFB 1454 and is active towards Gram-positive 
bacteria, has been described as well (152, 153). Within the oral microbiota, it is known that 
some commensal species, especially S. salivarius strains, can produce bacteriocins to limit 
the growth of oral pathogens. A clinical study demonstrated that the inhibitory effect of two 
lantibiotic bacteriocins (salivaricin A and B) produced by S. salivarius K12 on halitosis 
pathogens and black-pigmented bacteria in patients with malodour (154). 
 
Within the oral cavity, recent studies suggested that hydrogen peroxide production is one of 
the most important inhibitory mechanisms, playing an important role in biofilm formation (155). 
Furthermore, H2O2 can specifically inhibit the growth of certain oral pathogenic species and 
can reduce their virulence (130, 132). However, the effect of H2O2 as competitive factor in 
multi-species communities has hardly been explored. Previous studies suggest that 
environmental factors influence the H2O2 production (156). For instance, the presence of 
oxygen is key factor in the H2O2 production, since the enzymatic activity of the peroxidase 
requires oxygen. In fact, a strong downregulation of H2O2 production is observed during 
anaerobiosis. In dual competitive assays between Streptococcus species and cariogenic 
species, the inhibitory effect of Streptococcus species on cariogenic species was decreased 
in absence of oxygen. Moreover, the prior inoculation of S. sanguinis and S. gordonii inhibited 
the growth of S. mutans by H2O2 production, nevertheless the simultaneous and late 
colonization of both streptococci with respect to S. mutans deceased the inhibitory effect of 
them against S. mutans. In addition, the limitation of nutrients in the medium stimulated the 
inhibition of S. sanguinis against S. mutans by H2O2 (156). Another important factor might be 
the presence of blood components, as some periodontopathogens can produce layers of 
hemin to be protected against the antimicrobial effect of H2O2 (157). Data from these studies 
suggest that the antimicrobial effect of beneficial bacteria are tightly regulated by 
environmental factors. However, the influence of these environmental factors on the inhibitory 
effect of beneficial bacterial towards periodontal pathogens growth is still unknown. 
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2.4. Does inflammation drive dysbiosis? 
Oral biofilms induce an inflammatory response. During the inflammatory process, an exudate 
of serum called gingival crevicular fluid is released from the host tissues. This crevicular fluid 
is composed by inflammatory mediators such as interleukins and other cytokines (135). Some 
molecules of the crevicular fluid, especially metalloproteinases and myeloperoxidase, are used 
as biomarkers to determine the progression and pathogenicity of periodontal diseases (158). 
Additionally, an increase in crevicular fluid is also considered an important factor in the 
microbial shift involved in dysbiosis (159). During periodontal diseases, pathobionts are 
localized in the subgingival crevice in contact to a crevicular fluid enriched in inflammatory and 
antibacterial molecules, which can provide challenges and opportunities to induce periodontal 
diseases (135). In this periodontitis environment, several studies confirmed the prevalence of 
periodontal pathobionts on the crevicular epithelium in spite of the presence of host 
inflammatory and defensive mediators (160, 161). Therefore, this points towards a 
deregulation of the inflammatory response during periodontitis mediated by the dysfunction of 
the inflammatory cells and molecules. For instance, alteration of neutrophil functions in 
crevicular fluid can contribute to dysbiosis, and eventually lead to tooth loss (162). It might be 
that the composition of crevicular fluid (immune cells and/or enzymes) might also influence the 
process of dysbiosis. Several studies reported changes in the composition of oral biofilms after 
being exposed to serum (163). However, the interaction between crevicular fluid and 
antimicrobial compounds produced by beneficial bacteria has never been studied.  
 
Another important factor is the presence of blood in the oral cavity, which is released by 
damaged tissues during inflammation. Clinically, absence of bleeding on probing is directly 
related to periodontal stability (164), and several studies indicated that some blood compounds 
have the capacity to interact with certain antimicrobial compounds (165-167). As an example, 
hemin and hemoglobin have peroxidase activity (168), which can reduce the amount of 
hydrogen peroxide in certain environmental conditions. Periodontal pathogens can even create 
hemin layers with peroxidase activity which can increase their tolerance to hydrogen peroxide 
(157). The neutralization effect of these blood compounds on dysbiosis has never been 
explored.  
 
Saliva can also harbor peroxidases in its composition, which also interact with the hydrogen 
peroxide. The presence of lactoperoxidase neutralized the antimicrobial effect of hydrogen 
peroxide produced by S. sanguinis on S.mutans growth (Figure 6) (169).  
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Figure 6. Effect of the lactoperoxidase reaction (+bLPO) on the competition of S. gordonii (Sg) and 
S. mutans (Sm) on agar plates. The addition of lactoperoxidase alone or in combination with the 
substrate oxidize thiocyanate (SCN−) neutralized the inhibitory effect of hydrogen peroxide produced 
by S. gordonii on S. mutans growth. Figure extracted from (169). 
However, the importance of oral peroxidases in the initiation of dysbiosis needs to be studied. 
Moreover, the dysbiotic effect of molecules with peroxidase activity released during 
inflammation on the microbial shift characteristic of periodontal diseases has to be determined. 
2.5. Host inflammatory response in dysbiosis 
Periodontal health is a clinical condition characterized by the homeostasis (“equilibrium”) 
between the oral microbiota and the host inflammatory response. Homeostasis requires 
continuous physiological adjustments to accommodate the external changes, in order to 
prevent the destructive oral inflammatory reaction (57). This controlled inflammatory 
mechanism can be disrupted either by failures in the host immune response, by an increase 
in host susceptibility or/and environmental changes, leading to dysbiosis (170). Microbial shifts 
can be triggered by host immunodeficiency, the mode of infant delivery, antibiotic treatments, 
neonatal and adult nutrition, stress, hygiene, age, primary or secondary bacterial infections 
and drug tissue damage (170, 171). Recently, potassium was also identified as a triggering 
dysbiotic factor, increasing the virulence of oral microbiota and interfering with the host immune 
response by increasing the TNF-α production and reducing IL-6 and hBD-3 expression (172). 
During dysbiosis, some natural members of the commensal microbiota behave as pathobionts, 
inducing periodontal diseases. These pathobionts were named as keystone-pathogens by 
Hajishengallis, due to their capacity to cause oral diseases without necessarily a predisposing 
host or changes in the environmental conditions (108). The inflammatory response elicited by 
dysbiotic biofilms is mainly depending on a complex interplay between the patterns of pathogen 
receptors (PPRs) and the complement system. This eventually causes the breakdown of oral 
tissues and bone resorption, which releases a degraded proteins and hemin that are utilized 
as a nutritional source by pathobionts, generating a vicious dysbiotic feed-back cycle (108). 
However, the active role of these peptides and enzymes in dysbiosis has been never studied. 
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The presence of peroxidases during the inflammatory response could influence the 
antibacterial activity of commensal bacteria towards pathobionts, contributing to the initiation 
and/or perpetuation of dysbiosis. Since the dysbiotic biofilms are enriched in virulence factors, 
such as gingipains in the case of P. gingivalis (173), differences in virulent potentials between 
dysbiotic biofilms, which can be induced by different specific molecules or environmental 
factors, has never been analysed. Therefore, a direct relationship between an increase in 
virulence factors expression and a higher inflammatory response in dysbiosis has never been 
described. Importantly, differences in inflammatory response between oral biofilms  originating 
from the same baseline community in homeostasis state or after inducing dysbiosis by the 
addition of molecules with peroxidase activity have been never investigated at gene expression 
or protein levels.  
 
3. Treatment of periodontal disease 
3.1. Gold standards in periodontal therapies  
Standard periodontal therapy is focused on the eradication of micro-organisms and the 
dysbiotic biofilm within the subgingival pocket by mechanical subgingival debridement (scaling 
and rooting). This therapy is often supplemented with the use of antiseptics or antibiotics (174). 
The outcome of periodontal therapy depends on the establishment of a non-pathogenic/host-
compatible microbiota or homeostatic biofilm in the subgingival area (175). However, 
periodontal therapy often results in only a temporary microbial shift (176). Pathogenic bacteria 
that survived the therapy and/or translocate from other intra-oral habitats can soon recolonize 
the pockets. Therefore, periodontal therapy is often insufficient to result in the formation of a 
stable non-pathogenic/host-compatible biofilm (177). The patient remains at a continuous 
threat for further periodontal destruction. Additionally, increasing levels of antibiotic and 
antiseptic resistant bacteria favor the development of treatments that do not rely on these 
substances. For instance, a clinical study demonstrated that a high consumption of systemic 
antibiotics in certain countries (Spain) significantly increased the resistance of periodontal 
pathogens compared to other countries (The Netherlands) with a rational use of antibiotics 
(178). Consequently, periodontal pathogens isolated from Spanish patients had higher MIC 
(minimum inhibitory concentration) values of commonly used antibiotics in comparison to 
pathogenic species from Dutch patients (178). Due to these side effects of these traditional 
approaches, alternatives oral treatments are needed. 
3.2. Side effects of current treatments: Necrotrophic growth  
The preventive periodontal therapies are based on the removal and disruption of the oral 
biofilms attached on hard and soft oral tissues. Among all preventive methods, tooth and 
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interdental brushing are the most effective mechanical therapies to control dental plaque (179). 
However, due to motivational matters and/or technical impediments, individuals cannot 
execute a successful mechanical therapy. Hence, partially disrupted oral biofilms are present 
in the oral cavity for a long period. In combination with this mechanical therapy, adjunctive 
chemical compounds like chlorhexidine (CHX), cetylpyridinium chloride (CPC) or triclosan (TC) 
are part of the composition of toothpastes and mouthwashes. They execute an antimicrobial 
effect on oral biofilms, however they are only adjuncts and cannot replace the mechanical 
plaque control by means of brushing (180). Therefore, chemical treatments are also not able 
to remove the oral biofilms completely, because oral bacteria developed surviving strategies 
against these chemical antimicrobials (181). For instance, oral biofilm structures can avoid the 
diffusion of antiseptics and antibiotics, thereby increasing the bacterial survival rates (182). 
Therefore, only the outer layers of bacterial biofilms can be killed by the application of these 
products (183). Due to this inefficient killing effect, few living bacteria can persist and recover 
quickly in the close proximity of many dead bacteria. However, the biological effect of these 
amounts of dead bacteria on the surviving bacteria in oral biofilms is still unknown. Some 
studies described that L. pneumophila can use the dead bodies of different dead bacteria to 
persist in the water piping systems. This behavior was called necrotrophic activity (184). An 
insufficient daily brushing therapy combined with the use of ineffective chemical antimicrobials 
makes that oral bacterial necrotrophy might be relevant in oral ecosystems. Therefore, the 
effect of these massive amounts of dead bacteria on the balance of the oral microbiota needs 
to be clarified. 
4. Aims 
In periodontal health, oral biofilms are in homeostasis with the host tissues, a state 
characterized by the absence of oral pathologies. However, changes in the host at systemic, 
genetic or environmental levels induce dysbiosis, a transitional process that increases the 
number of pathobionts responsible of the oral pathologies. It is already known that certain 
beneficial species are able to limit the growth of pathobiont and consequently recover the 
homeostasis.  Therefore, the overall goal of this PhD project is to identify such beneficial 
bacteria, characterize their modes of action and verify these mechanisms of action in vitro at 
level of multi-species biofilms and at the inflammatory response level. Additionally, new side 
effects of periodontal treatments in term of bacterial antiseptic and antibiotic resistance and 
bacterial virulence will be characterized in order to improve the development of more effective 
and specific periodontal therapies. 
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Aim 1. Identification and characterization of beneficial oral bacteria (Chapter 2): 
The aims of this chapter were to identify commensal bacteria that can inhibit the growth of the 
periodontal pathogens, to determine the main antimicrobial compounds involved in these 
inhibitory effects and to evaluate the possible influence of certain specific environmental 
factors on the outcome of these antagonistic activities. 
Aim 2. Determination of the role of oral peroxidases in the initiation of dysbiosis (Chapter 3): 
The goals of this study were to determine the neutralizing effect of serum, hemoglobin and 
hemin on the inhibitory effect of the commensal bacteria on pathobiont growth and to evaluate 
whether the peroxidase activity of serum and certain blood compounds released during 
inflammation can neutralize the hydrogen peroxide produced by commensal bacteria, leading 
to the initiation of dysbiosis.  
Aim 3. Investigate whether clinical concentrations of peroxidases cause dysbiosis in in vitro 
oral biofilms (Chapter 4):  
The main aims of this chapter were to identify whether the main oral peroxidases present in 
saliva and gingival crevicular fluid could neutralize the suppressive effect of the commensal 
bacteria towards pathobionts and to evaluate the neutralizing effect of clinical concentrations 
of myeloperoxidase, lactoperoxidase and catalase from erythrocytes on the inhibition of 
commensal bacteria by H2O2 on pathobionts growth.  
 
Aim 4. Determine whether in vitro generated dysbiotic biofilms deregulate inflammatory 
response in periodontitis (Chapter 5): 
The major goals of this investigation were to determine the differential virulence gene 
expression of pathobionts in homeostatic and dysbiotic ecologies and to analyse possible 
differences in the expression of the main cellular inflammatory mediators at mRNA and at 
protein level after the exposure of homeostatic or different induced dysbiotic biofilms. 
 
Aim 5. To determine if necrotrophic growth of periodontopathogens can be a novel virulence 
factor in oral biofilms (Chapter 6): 
The principal objective of this research was to study if periodontal pathogens can use dead 
oral bacteria to increase their own growth (necrotrophy), to determine the effect of dead 
bacteria on the bacterial virulence gene expression (necrovirulence) and on the host tissues 
(necrotoxicity). 
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Bacteria images courtesy of Marta Aguirre. 
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Abstract 
Background and objective: Little is known about the initiation of dysbiosis in oral biofilms, which 
is of prime importance for understanding the etiology and preventing periodontitis. The aim of 
this study is to evaluate the role of crevicular and salivary peroxidase and catalase 
concentrations on dysbiosis in in vitro multi-species biofilms. 
Material and Methods: The spotting technique was used to identify the effect of salivary and 
crevicular fluid concentrations of myeloperoxidase, lactoperoxidase, erythrocyte catalase and 
horseradish peroxidase on the inhibitory effect of commensals on pathobiont growth. 
Vitality-qPCR was performed to quantify the dysbiotic effect of the peroxidases adjusted to 
concentrations found in periodontal health, gingivitis and periodontitis on multi-species 
microbial communities.  
Results: Agar plate and multi-species ecology experiments showed that H2O2 production by 
commensal bacteria decreases pathobiont growth and colonization. Peroxidases at 
concentrations found in crevicular fluid and saliva neutralized this inhibitory effect. In multi-
species communities, myeloperoxidase at crevicular fluid concentrations found in periodontitis 
resulted in a 1 to 3 Log increase in pathobionts when compared to crevicular concentrations 
found in periodontal health. The effect of salivary lactoperoxidase and salivary 
myeloperoxidase concentrations was in general similar to the effect of crevicular 
myeloperoxidase concentrations.  
Conclusions: Commensal species suppress pathobionts by H2O2 production. Catalase and 
peroxidases at clinically relevant concentrations, can neutralize this effect and thereby can 
contribute to dysbiosis by allowing the outgrowth of pathobionts. 
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Introduction 
Periodontal diseases are infectious pathologies that originate from oral biofilms and affect the 
tooth-supporting tissues. If left untreated, they can lead to tooth loss (1, 2). Their initiation and 
progression are determined by complex interactions between the microbial community and the 
host (3, 4). Commensal bacteria act with the host to prevent colonization or outgrowth of 
pathobionts that induce inflammation and disrupt the microbial ecology (5, 6, 7). Pathobionts 
are natural members of the human microbiota that under certain perturbations to the host 
and/or microbiota can cause pathology (5, 8). Although pathobionts are thus part of the 
commensal microbiota, commensal bacteria are regarded as bacteria that are normal 
residents of the oral cavity, but that have not been associated with oral pathologies (9). Some 
commensal bacteria can also inhibit pathobionts. Such commensal bacteria can be referred to 
as beneficial bacteria (10).  
It is well known that during the progression from periodontal health to disease, the oral 
microbiota changes (11, 12). These changes, called dysbiosis, are reflected in increased 
numbers of pathobionts, lower proportions of commensal bacteria and/or changes in metabolic 
activity of the oral microbiota (5, 8, 13). They deregulate the host inflammatory response which 
can lead to chronic inflammation (5, 13). Recently it was shown that certain commensal 
bacteria suppress the outgrowth of periodontal pathobionts by H2O2 production (6, 7). 
However, human serum, horseradish peroxidase and blood components could neutralize this 
suppressive effect, leading to dysbiosis (7). The underlying mechanism appeared to be a 
catalytic activity. This is of significance since there are various enzymes within the oral cavity 
with catalytic activity such as catalase and peroxidases. They are generally considered to be 
protective enzymes since they can protect cells from oxidative damage by reactive oxygen 
species (catalase) or produce antibacterial products such as hypothiocyanite (lactoperoxidase) 
or hypochlorous acid (myeloperoxidase) (14, 15, 16). However, several studies have shown a 
positive correlation between myeloperoxidase concentrations in GCF and the progression and 
severity of periodontitis (17-19). Myeloperoxidase was also described as the best 
discriminating biomarker for site-specific diagnosis of periodontitis when compared to 
azurocidin, chemokine ligand 5, TIMP-1 MMP-13, MMP-14 and MMP-8 (17). Additionally, a 
decrease in myeloperoxidase levels in GCF has been observed after periodontal treatment 
(20). Myeloperoxidase in GCF is primarily originating from the azurophilic granules during 
degranulation of neutrophils, which play an important role in the host defense and inflammation 
(21, 22). Even though myeloperoxidase concentrations in GCF have been related to 
periodontal disease severity (17, 19, 23) and myeloperoxidase is also present in saliva, its 
involvement in dysbiosis has never been studied.  
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Saliva also harbors lactoperoxidase which is secreted from the salivary grands (24, 25). 
Although salivary lactoperoxidase concentrations in periodontal health, gingivitis and 
periodontitis have never been compared, it is known that lactoperoxidase can neutralize the 
inhibitory effect of Streptococcus sanguinis and Streptococcus gordonii against Streptococcus 
mutans (26). Therefore the role of salivary peroxidases in dysbiosis should be further 
elucidated. 
For decades, bleeding gums, either spontaneously or provoked by brushing or probing, have 
been related to periodontal diseases. Moreover, absence of bleeding on probing is a good 
indicator of periodontal stability (27). Although bleeding can be merely a consequence of 
inflammation, it might actually contribute to disease progression. Recently, bacterial hemolysis 
was strongly associated with the clinical parameters in periodontitis patients (28). This 
hemolytic activity can release intracellular catalases from erythrocytes (29). This is of 
significance since it has been shown that some blood compounds can initiate dysbiosis in in 
vitro bacterial multi-species ecologies (7). However, the involvement of catalases from 
erythrocytes (30) in dysbiosis has never been explored.  
In summary, it has been shown that commensal bacteria can suppress the overgrowth of 
pathobionts by production of H2O2 (6). High concentrations of catalytic molecules such as 
horseradish peroxidase can neutralize this inhibitory effect and can lead to dysbiosis (7). It is 
however not clear if clinically relevant enzymes with catalytic activity which can be found in the 
oral cavity, such as myeloperoxidase, lactoperoxidase and erythrocyte catalase, have similar 
effects. Additionally, it is unknown if their concentrations in saliva or GCF are sufficiently high 
to remove this H2O2 and contribute to dysbiosis when oral hygiene is restricted in case of 
gingivitis or periodontitis.  
The objective of this study is therefore to determine the neutralizing effect of clinical 
concentrations of myeloperoxidase, lactoperoxidase and catalase from erythrocytes, found in 
health, gingivitis and/or periodontitis, on the inhibitory effect of the commensal bacteria towards 
pathobionts. 
 
Material and Methods 
Bacterial strains and media. All used bacterial species (Streptococcus sanguinis LM14657, 
Streptococcus cristatus ATCC 49999, Streptococcus gordonii ATCC 49818, Streptococcus 
parasanguinis DSM 6778, Streptococcus mitis DSM 12643, Streptococcus oralis DSM 20627, 
Streptococcus salivarius TOVE-R, Streptococcus mutans ATCC 20523, Streptococcus 
sobrinus ATCC 20742, Actinomyces viscosus DSM 43327, Actinomyces naeslundii ATCC 
51655, Prevotella intermedia ATCC 25611, Porphyromonas gingivalis ATCC 33277, 
Fusobacterium nucleatum ATCC 20482, Aggregatibacter actinomycetemcomitans ATCC 
Chapter 4: project 3, paper 3 
60 
43718 and Veillonella parvula DSM 2008) were maintained on blood agar (Oxoid, Basingstoke, 
UK) supplemented with 5 mg/mL hemin (Sigma, St. Louis, USA), 1 mg/mL menadione 
(Calbiochem-Novabiochem, La Jolla, USA) and 5% sterile horse blood (E&O Laboratories, 
Bonnybridge, Scotland). Overnight liquid cultures were prepared in Brain Hearth Infusion (BHI) 
broth (Difco, Detroit, USA). Competitive inhibition experiments were performed in Brain Hearth 
Infusion-2 (BHI-2) broth or agar containing Brain Heart infusion (Difco, Detroit, USA) 
supplemented with 2.5 g/L mucin (Sigma-Aldrich, St. Louis, USA), 1.0 g/L yeast extract (Oxoid, 
Basingstoke, UK), 0.1 g/L cysteine (Calbiochem, San Diego, USA), 2.0 g/L sodium bicarbonate 
and 0.25% (v/v) glutamic acid (Sigma-Aldrich, St Louis, USA). The bacteria were cultured 
under aerobic (5% CO2) or anaerobic (80% N2, 10% H2 and 10% CO2) conditions. Optical 
densities were measured and adjusted using spectrophotometry (OD600, GeneQuant 
Spectrophotometer, Buckinghamshire, UK). 
Peroxidases. Myeloperoxidase from human leukocytes (Sigma-Aldrich, St. Louis, USA) was 
dissolved in BHI-2 at concentrations of 8.91 ng/mL, 53.12 ng/mL and 1.18 µg/mL 
corresponding to clinical concentrations in human gingival crevicular fluid from healthy, 
gingivitis and periodontitis patients (17). Since the original article only mentions the range of 
concentrations, the authors were contacted to obtain the average concentrations. Catalase 
from human erythrocytes and horseradish peroxidase (Sigma-Aldrich, St. Louis, USA) were 
also dissolved in BHI-2 at the same concentrations as myeloperoxidase (17). Lactoperoxidase 
(Sigma-Aldrich, St. Louis, USA) from bovine milk (equal to salivary peroxidase) and 
myeloperoxidase were adjusted to salivary concentrations of 1.90 µg/mL and 3.60 µg/mL in 
BHI-2 respectively (24). 
Antagonistic experiments on agar plates. The spotting technique (6, 7) was used to quantify 
the inhibitory effect of 6 commensal species on 3 pathobionts and to identify neutralization 
effects by crevicular concentrations (1.18 µg/mL) of myeloperoxidase, catalase and 
horseradish peroxidase in periodontitis patients and salivary concentrations of lactoperoxidase 
(1.90 µg/mL) (17, 24). In brief, 7µl of an overnight culture of a commensal species was spotted 
on an agar plate and incubated for 24 hours in aerobic conditions as described by Herrero et 
al. (6, 7). Afterwards, 7µl of the peroxidase solution was spotted next to commensal spots and 
left to dry for 5 minutes at 37°C under aerobic conditions. Afterwards 7 µl of an overnight 
pathobiont cultures was spotted on top of the peroxidase spots and at the opposite side of the 
commensal spot as a control. Afterwards, the agar plates were incubated in anaerobic 
conditions (Supplementary Fig 1). After 48 hours of anaerobic incubation, a calibrated 
photograph was taken from the agar plate. The magnitude of inhibition (AI) was measured from 
the edge of the commensal colony to the border of the inhibited pathogen colony using ImageJ 
(http://rsb.info.nih.gov/ij/download.html) (Supplemental Fig.1) (6, 7). 
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Biofilm experiments. To verify the effect of myeloperoxidase, lactoperoxidase, catalase and 
horseradish peroxidase on the antimicrobial effect of commensal bacteria, the effect of these 
enzymes on the growth of the pathobionts in complex 14-species communities was evaluated. 
Overnight cultures of six H2O2 producing commensal bacteria (S. oralis, S. gordonii, 
S. cristatus, S. parasanguinis, S. mitis and S. sanguinis) (6, 7), were centrifuged and the pellet 
was re-suspended in BHI-2 broth (OD600 0.5  ̴1x108 CFU/mL). Equal volumes (1mL) of these 
solutions were mixed and inoculated in 6 wells of a 24 well-plate and incubated under aerobic 
conditions. After 24 hours, 500 µl of BHI-2, myeloperoxidase, catalase and horseradish 
peroxidase, adjusted to a crevicular fluid concentrations of 8.91 ng/mL (health), 53.12 ng/mL 
(gingivitis) and 1.18 µg/mL (periodontitis), and myeloperoxidase adjusted to a salivary 
concentration of 3.60 µg/mL and lactoperoxidase adjusted to a salivary concentration of 
1.90 µg/mL, were added to the wells. Additionally, 1 mL of a bioreactor (OD600 0.5  ̴ 1x108 
CFU/mL) derived complex multi-species co-culture of 14 species (containing on average 
7.40(±0.61) Log10 Geq/mL A. actinomycetemcomitans, 8.09(±1.47) Log10 Geq/mL 
F. nucleatum, 8.08(±0.26) Log10 Geq/mL P. gingivalis, 7.01(±0.23) Log10 Geq/mL 
P. intermedia, 6.62(±0.92) Log10 Geq/mL S. mutans, 7.21(±0.52) Log10 Geq/mL S. sobrinus, 
6.54(±0.31) Log10 Geq/mL A. naeslundii, 7.45(±0.23) Log10 Geq/mL S. gordonii, 6.43(±0.20) 
Log10 Geq/mL A. viscosus, 5.72(±1.05) Log10 Geq/mL S. salivarius, 5.16(±0.97) Log10 Geq/mL 
S. mitis, 6.80(±0.40) Log10 Geq/mL S. sanguinis, 5.75(±0.45) Log10 Geq/mL S. oralis and 
8.74(±0.49) Log10 Geq/mL V. parvula) was centrifuged (1438 x g, 10 minutes), re-suspended 
in BHI-2 (OD600 0.5  ̴ 1x108 CFU/mL) and added to the wells. After 24 hours of anaerobic 
incubation, 1 mL was taken from each well and analyzed via vitality-qPCR. Afterwards, the 
remaining supernatant was removed and the biofilms at the bottom of the wells were washed 
with phosphate buffered saline (PBS). The biofilms were detached with 500 µL 0,05% Trypsin-
EDTA (Gibco, Paisley, UK) for 15 minutes at 37 °C, transferred to Eppendorf tubes, centrifuged 
(6010 x g, 10 minutes) and after discarding the trypsin, the biofilm pellets were re-suspended 
in 1 mL of PBS and analyzed by vitality-qPCR.  
Bioreactor derived multi-species community. A multi-species community was established 
in a BIOSTAT B TWIN (Sartorius, Germany) bioreactor. 750 mL of BHI-2 broth was added to 
the vessel together with 5.0 mg/mL hemin, 1.0 mg/mL menadione and 200 µl/L Antifoam Y-30 
(Sigma-Aldrich, St. Louis, USA). The medium was pre-reduced over 24 hours at 37°C by 
bubbling 100% N2 and 5% CO2 in the medium under continuous stirring at 300 rpm. pH was 
set at 6.7 +/-0.1. After 24 hours, overnight cultures of S. sanguinis, S. gordonii, S. salivarius, 
S. mitis, S. oralis, S. mutans, S. sobrinus, A. viscosus, A. naeslundii, P. intermedia, 
P. gingivalis, F. nucleatum, A. actinomycetemcomitans and V. parvula were adjusted to an OD 
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of 1.4 and added to the bioreactor. During the first 48 hours, the medium was not replaced. 
After that, the medium was replaced at a rate of 200 mL/24 hours. 
Vitality-qPCR. DNA extraction and vitality-qPCR with propidium monoazide (Biotium Inc, 
Hayward, CA, USA) was performed (31). PMA was dissolved in 20% dimethylsulfoxide to 
produce stock concentrations of 1 mg/mL. These were stored at −20°C in the dark. Ten µL of 
PMA stock solution was added to 90-μl culture aliquots at a final concentration of 100 μg/mL. 
Following a 5-min incubation in the dark, samples were exposed for 10 min to a 650 W halogen 
light source placed 20 cm above the samples. The samples were kept on ice during this period. 
DNA was extracted from bacterial samples using a QIAamp DNA Mini kit (Qiagen Ltd., Hilden, 
Germany) in accordance with the manufacturer’s instructions. A qPCR assay was performed 
with a CFX96 Real-Time System (BioRad, Hercules, CA). The Taqman 5′ nuclease assay PCR 
method was used for detection and quantification of bacterial DNA. Primer and probe 
sequences are described in Supplementary Table 1 (7). Taqman reactions contained 12.5 μl 
Mastermix (Eurogentec, Seraing, Belgium), 4.5 μl sterile H2O, 1 μl of each primer and probe 
and 5 μl template DNA. Primers and probes were used at different concentrations depending 
on the organism. Assay conditions for all primer/probe sets consisted of an initial 2 min at 50°C, 
followed by a denaturation step for 10 min at 95°C, followed by 45 cycles of 95°C for 15 s and 
60°C for 60 s. The bacterial counts are expressed as Genome equivalents per mL (Geq/mL) 
since the concentration was calculated based on plasmid standard curves (31).  
Statistical analysis. The data from agar-plate inhibition experiments were compared for each 
combination of compound, species and pathogen. For each combination of compound, species 
and pathogen, a comparison was made between the inhibition in presence of the compound 
and the inhibition in absence of the compound. As such, the analysis existed each time of a 
comparison between two groups (presence and absence of the compound). Five different 
types of inhibition data existed: (a) one group did not show any growth, the other group did not 
show any inhibition. No analysis was performed for this case. (b) One group did not show any 
growth, the other group did show some growth. A one-sided t-test was applied to test whether 
the group with some growth was significantly different from zero growth. (c) One group showed 
no inhibition at all, the other group showed some growth. A one-sided t-test was applied to test 
whether the group with some growth was significantly lower than the distance for no inhibition 
at all. (d) Both groups had some inhibition. A paired t-test was applied to compare the groups 
and (e) both groups had some inhibition, and at least one observation had no inhibition at all. 
A frailty model with run as random factor was fit to compare the groups and to accommodate 
for the censored character of the data that reflected no inhibition at all. P-values were corrected 
for simultaneous hypothesis testing according to Sidak in order to have a global significance 
level of 95% for all the comparisons made for a specific compound. 
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For every combination of enzyme, sample type and species from planktonic and biofilm data, 
a linear mixed model was fit with compound as fixed factor and the log-transformed CFU-count 
as dependent variable. The run was modeled as a random factor. A weighing inversely 
proportional to the observed variance of each compound was applied. A normal quantile plot 
showed that data were normally distributed. Compounds were compared with the control and 
a correction for simultaneous hypothesis testing was applied according to Dunnett in case one 
control was used, and according to Sidak in case of two controls were used. 
 
Results 
Decrease of the inhibitory effect of commensals on agar plates. 
The inhibitory effect of commensal bacteria on pathobiont growth and the influence of 
crevicular concentrations of myeloperoxidase, catalase and horseradish peroxidase found in 
periodontitis patients and salivary concentrations of lactoperoxidase hereon was examined 
using a qualitative agar-plate method. The addition of myeloperoxidase, catalase and 
horseradish peroxidase (1.18 µg/mL) and lactoperoxidase (1.90 µg/mL) significantly lowered 
the inhibitory effect of commensal bacteria on P. intermedia, P. gingivalis and 
A. actinomycetemcomitans (Supplementary Fig. 1). This lowering effect was observed for all 
commensal species and for all peroxidases on all pathobionts with exception for the inhibitory 
effect of S. mitis on P. intermedia when applying myeloperoxidase (Table 1). Catalase was 
able to completely neutralize the inhibitory effect of all the commensals except for the inhibitory 
effect S. mitis against A. actinomycetemcomitans (Table 1). Lactoperoxidase and horseradish 
peroxidase could also completely neutralize the inhibitory effect of commensals on P. gingivalis 
and P. intermedia, except for the effect of S. mitis and S. gordonii on P. intermedia and 
S. cristatus on P. gingivalis (Table 1). The neutralization of the inhibitory effect by commensals 
was more pronounced on P. intermedia and P. gingivalis than on A. actinomycetemcomitans. 
In general, the effect of myeloperoxidase was lower than the effect of the other peroxidases 
(Table 1). 
Outgrowth of pathobionts in multi-species ecologies exposed to crevicular fluid 
peroxidase concentrations. 
The above observed reduction of the inhibitory effect of commensal bacteria by 
myeloperoxidase, catalase and horseradish peroxidase at concentrations found in crevicular 
fluid of periodontitis patients was verified in complex multi-species ecologies. The 
concentrations of myeloperoxidase, catalase and horseradish peroxidase used in these 
experiments were 8.91 ng/mL, 53.12 ng/mL and 1.18 µg/mL, representing gingival health, 
gingivitis and periodontitis respectively (17).  
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The commensal biofilm significantly inhibited the planktonic and biofilm concentrations of 
P. gingivalis and P. intermedia in a complex multi-species ecology model composed of 14 oral 
species (Fig. 1). The inhibitory effect on A. actinomycetemcomitans and F. nucleatum 
concentrations was limited, without reaching statistical significance (Table 2, Supplementary 
Table 2 and 3). In general, myeloperoxidase, catalase and horse peroxidase lowered the 
inhibitory effect of the commensal biofilm on planktonic and biofilm concentrations of the 
periopathobionts. A positive dose-dependent neutralization effect of myeloperoxidase, 
catalase and horseradish peroxidase on the inhibitory effect of commensal bacteria was 
observed (Fig. 1). The myeloperoxidase, catalase and horseradish peroxidase crevicular 
concentrations found in periodontitis showed the strongest neutralizing effect on the inhibitory 
effect of commensal bacteria. Concentrations found in gingivitis or in periodontal health had 
lower neutralizing effects (Fig. 1, Table 2, Supplementary Table 2 and 3).  
 
Figure 1. Neutralization effect of myeloperoxidase (MPO), catalase (CT) and horseradish peroxidase (HRP) on 
complex multi-species biofilms (mean ± standard deviation, n=3). Control condition refers to a 14 species 
community without the addition of the 6 commensal bacteria and BHI refers a condition without peroxidases. (A) 
and (B) represent the concentration of P. gingivalis (Pg) in presence of myeloperoxidase (MPO), catalase (CT) and 
horseradish peroxidase (HRP) in planktonic and biofilm conditions. (C) and (D) represent the concentration of P. 
intermedia (Pi) in presence of myeloperoxidase (MPO), catalase (CT) and horseradish peroxidase (HRP) in 
planktonic and biofilm conditions. Date are expressed as Log10Geq/ml *designates a statistically significant 
difference of the bacterial concentration in respect to BHI (p<0.05). #designates a statistically significant difference 
of the bacterial concentration in respect to health condition. 
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The crevicular fluid concentrations found in periodontitis patients of myeloperoxidase, catalase 
and horseradish peroxidase resulted respectively in an outgrowth of P. gingivalis of on average 
1.31(±0.28), 3.25(±0.07) and 2.89(±0.43) Log10 Geq/mL in complex planktonic multi-species 
ecologies (Fig. 1A) and of 1.44(±0.02), 2.89(±0.27) and 3.76(±0.01) Log10 Geq/mL in complex 
multi-species biofilms (Fig. 1B). For P. intermedia, the outgrowth was on average 2.84(±0.24), 
2.97(±0.04) and 2.92(±0.01) Log10 Geq/mL in planktonic multi-species ecologies (Fig. 1C) and 
3.16(±0.19), 3.23(±0.05) and 3.14(±0.18) Log10 Geq/mL in complex multi-species biofilms 
(Fig. 1D). The outgrowth was the most pronounced when concentrations found in periodontitis 
were used. However, there was a clear concentration dependent effect observed when using 
concentrations found in periodontal health versus concentrations found in gingivitis or 
concentrations found in periodontitis (Fig. 1). 
The outgrowth of P. gingivalis and P. intermedia was also significantly higher when 
periodontitis concentrations where compared to concentrations found in periodontal health 
(Fig. 1). The difference in myeloperoxidase concentration between periodontal health and 
periodontitis resulted in an outgrowth of P. gingivalis of 1.21(±0.33) Log10 Geq/mL in planktonic 
conditions and of 1.05(±0.09) Log10 Geq/mL in biofilms (Fig. 1A and 1B). The outgrowth of 
P. intermedia was 2.84(±0.24) Log10 Geq/mL in planktonic cultures and 3.16(±0.19) Log10 
Geq/mL in biofilms (Fig. 1C and 1D) when comparing concentrations found in periodontal 
health versus concentrations found in periodontitis. For catalase and horseradish peroxidase, 
no concentration dependent effect was observed. Catalase and horseradish peroxidase 
resulted in a P. gingivalis outgrowth of 2 to 3 Log10 Geq/mL in multi-species biofilms (Fig. 1). 
Myeloperoxidase, catalase and horseradish peroxidase also affected the growth of the other 
species in the community (Table 2, Supplementary Table 2 and 3). The presence of 
myeloperoxidase at a concentration found in gingivitis or periodontitis increased significantly 
the planktonic growth of A. actinomycetemcomitans, A. viscosus, S. sobrinus, S. gordonii, 
S. oralis, S. salivarius or V. parvula when compared to the levels of these species at 
myeloperoxidase levels found in periodontal health. In biofilms, the presence of 
myeloperoxidase at gingivitis or periodontitis concentrations significantly increased the growth 
of V. parvula. Conversely, the presence of catalase and horseradish peroxidase at 
concentrations found in periodontal health reduced significantly the growth of S. mutans, 
S. oralis and S. gordonii compared to the BHI control in planktonic ecologies. At concentrations 
found in gingivitis and periodontitis, catalase decreased the growth of S. mutans, S. sobrinus 
and A. viscosus significantly compared to the BHI control in biofilm ecologies. Similarly, the 
presence of catalase at crevicular fluid concentrations found in in health, gingivitis and 
periodontitis reduced the numbers of S. sobrinus in the biofilms. Additionally, S. mutans was 
reduced when gingivitis and periodontitis concentrations were used and A. viscosus was 
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reduced when concentrations were used found in gingivitis. The presence of horseradish 
peroxidase did not decrease the abundance of any of the species in the biofilm. It increased 
the numbers of S. gordonii at concentrations found in periodontal health and gingivitis and 
A. naeslundii and A. viscosus at concentrations found in periodontitis when compared to the 
BHI control. 
Outgrowth of pathobionts in multi-species ecologies exposed to salivary 
lactoperoxidase and myeloperoxidase concentrations. 
The effect of salivary lactoperoxidase and myeloperoxidase concentrations on 
periopathobionts was investigated in multi-species ecologies (Table 3). They resulted in an 
outgrowth of P. gingivalis of on average 1.00(±0.23) and 1.14(±0.18) Log10 Geq/mL 
respectively in planktonic (Fig. 2A) and of on average 1.29(±0.15) and 1.50(±0.11) Log10 
Geq/mL in biofilms (Fig. 2B). In addition, salivary lactoperoxidase and myeloperoxidase 
concentrations also result in an outgrowth of P. intermedia of 0.95(±0.23) and 1.06(±0.26) 
Log10 Geq/mL respectively in planktonic (Fig. 2A) and of 1.23(±0.23) and 1.28(±0.11) Log10 
Geq/mL in multi-species biofilms (Fig. 2B). In general, the effect of myeloperoxidase was 
slightly more pronounced than the effect of lactoperoxidase. 
The presence of salivary concentrations of lactoperoxidase and myeloperoxidase resulted also 
in an effect on the growth of different species of the community (Table 3). The presence of 
lactoperoxidase reduced significantly the planktonic growth of A. naeslundii and A. viscosus 
and the growth of S. sobrinus and S. oralis in biofilms. The presence of myeloperoxidase 
increased the growth of A. actinomycetemcomitans and S. mutans in biofilms. 
 
 
Figure 2. Neutralization effect of myeloperoxidase (MPO) and lactoperoxidase (LPO) adjusted to salivary 
concentrations on complex multi-species biofilms (mean ± standard deviation, n=3). Control condition refers to a 14 
species community without the addition of the 6 commensal bacteria and BHI refers a condition without peroxidases. 
(A) and (B) represent the concentration of P. gingivalis (Pg) and P. intermedia (Pi) in presence of lactoperoxidase 
(LPO) and myeloperoxidase (MPO) in planktonic and biofilm conditions. Date are expressed as Log10Geq/mL. 
*designates a statistically significant difference of the bacterial concentration in respect to BHI (p<0.05). 
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Discussion 
Little is known about the initiation of dysbiosis in periodontal diseases (5, 13), which is 
obviously of prime importance for understanding the etiology and preventing periodontitis. 
Recently it has been shown that some commensal bacteria inhibit the outgrowth of pathobionts 
by H2O2 production (6, 7). H2O2 production is in essence not restricted to commensal albeit 
beneficial bacteria. For instance, Streptococcus pneumoniae, a common upper respiratory 
pathogen, can inhibit the growth of Haemophilus influenza by H2O2 (32). However, H2O2 
production has never been described in periodontopathogens. Except for the S. oralis, 
S. gordonii, S. cristatus, S. parasanguinis, S. mitis and S. sanguinis species used in this study, 
none of the other species produced H2O2 (6, 7). Serum, high concentrations of horseradish 
peroxidase and certain blood compounds can neutralize this inhibitory effect of H2O2 in multi-
species biofilms, which results in dysbiosis (7). The data from the current study show that, at 
an in vitro level, clinically relevant peroxidases and catalase at clinically relevant 
concentrations can neutralize the inhibitory effect of commensal bacteria on pathobiont growth 
on agar plates, in planktonic cultures and in multi-species biofilms. Moreover, increasing the 
GCF myeloperoxidase concentration found in periodontally healthy patients to concentrations 
found in periodontitis patients resulted in a 1 to 3 Log10 Geq/mL increase in pathobionts. These 
in vitro data might explain the correlation between periodontitis and myeloperoxidase 
concentrations and suggest that GCF myeloperoxidase can contribute to the dysbiosis seen 
in subgingival plaque of periodontally diseased patients. In concordance with these data, 
previous studies showed that the addition of peroxidases could neutralize the inhibitory effect 
of commensal bacteria on agar plates and multi-species communities (6, 7, 26, 33). However, 
the concentrations used in these studies were not clinically relevant. The results indicate that 
an increase in clinically relevant peroxidase concentrations causes the outgrowth of 
pathobionts such as P. gingivalis, A. actinomycetemcomitans, and P. intermedia. The factors 
that influence myeloperoxidase or lactoperoxidase concentrations and activity are not well 
known. However, A. actinomycetemcomitans can increase significantly the release of 
myeloperoxidase by neutrophils (34). This ability could enhance the dysbiosis observed in 
periodontal diseases. For other pathobionts, such effect has not yet been investigated. 
However, in experimental gingivitis studies, myeloperoxidase is shown to increase even after 
4 days (35, 36). Also for smoking, a significant risk factor for periodontitis, elevated salivary 
and serum myeloperoxidase levels have been found, apparently resulting from nicotine 
stimulation of neutrophils (37, 38). Genetic influences can also affect the activity and 
concentration of oral peroxidases. A clinical study showed an association between MPO-463 
gene polymorphisms and aggressive periodontitis (39).  
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The myeloperoxidase activity of MPO-463GG variant individuals has been reported to be 
higher than of MPO-463AA variant individuals. The MPO G/G genotype has been associated 
with coronary artery disease, leukemia, cancer, multiple sclerosis and higher risk for 
periodontal disease (40, 41). Interestingly, myeloperoxidase deficiency, a frequently occurring 
genetic disorder which is related to a reduced quantity or function of myeloperoxidase, is rarely 
associated with clinical symptoms unless the patient also suffers from diabetes mellitus, which 
leads to disseminated candidiasis and other fungal infections (42). Until now there is not even 
a case report published on increased gingivitis or periodontitis levels in patients with 
myeloperoxidase deficiency. In this context, it would be interesting to investigate if patients 
with myeloperoxidase deficiency are more resistant towards gingivitis or periodontitis.   
Bleeding periodontal pockets are an indicator for periodontal diseases (27). Some blood 
compounds have been shown to induce dysbiosis in multi-species ecologies (7). Recently, an 
association between bacterial hemolysis and the clinical parameters of periodontitis has been 
described (28). It can be that the released catalase from erythrocytes, due to the hemolytic 
activity of pathobionts, can attribute to the dysbiotic effect (29, 30). Our results show that 
catalase from erythrocytes decreased the suppressive effect of H2O2 produced by commensal 
bacteria, leading to the outgrowth of pathobionts with 2 to 3 Log10 Geq/mL in oral multi-species 
biofilms. Similar effects have been reported for other blood components with peroxidase 
activity like serum, hemoglobin and hemin (7). The neutralization of H2O2 by serum, 
hemoglobin and hemin also increased the colonization of P. gingivalis with 3 Log10 Geq/mL in 
oral multi-species biofilms. However, it resulted in a higher outgrowth of P. intermedia and 
A. actinomycetemcomitans in multi-species biofilms. These differences in outgrowth can be 
explained by the used concentrations of these blood compounds, which were higher than the 
concentrations of this study. 
Saliva also harbors different peroxidases, mainly lactoperoxidase and myeloperoxidase (24). 
The results of our study showed that salivary concentrations of lactoperoxidase and 
myeloperoxidase increased the growth of pathobionts with 1 to 2 Log10 Geq/mL in multi-
species biofilms. These data are in line with recent clinical studies, which indicated a positive 
correlation between myeloperoxidase concentrations in saliva and clinical signs of gingival or 
periodontal diseases (43, 44). 
Overall, this study suggests that when dental plaque persists over a longer period of time due 
to a poor dental hygiene or/and when the susceptibility of the host changes, peroxidases 
resulting from the inflammatory response can play an important role in the development of 
dysbiosis of oral biofilms by disrupting the pathobionts inhibition provided by the commensal 
bacteria. Additionally, this plaque accumulation progressively creates a more anaerobic 
environment at the base of the sulcus, which limits the oxygen availability, which subsequently 
lowers H2O2 production, and as such can contribute to the dysbiotic effect. Unfortunately, it is 
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not known when dysbiosis becomes irreversible with respect to H2O2 production and no studies 
are available that directly correlate oral peroxidase concentrations with microbiological data.  
The experiments were executed in an in vitro 16-species biofilm model that only partially 
represents the commensals and pathobionts that can be found within the oral cavity. This might 
have an impact on the translation of the data to in vivo conditions. The selection of the 
commensal species used in this study was based on screening the scientific literature for oral 
commensal bacteria with either a high prevalence and association in/to periodontal health, low 
prevalence in periodontal disease and/or with a known inhibitory activity against oral 
pathogens (S. sanguinis, S. cristatus, S. oralis, S. parasanguinis, S. gordonii, S. mitis, 
S. salivarius, A. viscosus, A. naeslundii, and V. parvula) (6, 11, 12). On the other hand, 
F. nucleatum, P. gingivalis, A. actinomycetemcomitans, and P. intermedia are well known for 
their involvement and prevalence in periodontal diseases (6, 11, 12), whereas S. mutans and 
S. sobrinus for their involvement in tooth decay (45, 46). One should consider that the 
16-species biofilm model does not take into account the host-microbiota interactions. This 
might be of importance since myeloperoxidase also promotes Neutrophil Extracellular Traps 
formation, which can enhance its antimicrobial activity through different mechanisms (47). 
Additionally, myeloperoxidase produced by neutrophils can utilize hydrogen peroxide to 
generate hypochlorous acid to kill bacteria (42). The impact of these were not captured in the 
current model and therefore need to be validated in in vivo animal models. 
The chronological steps in the initiation of dysbiosis are far from being elucidated. To date, it 
is not clear if an increase in myeloperoxidase concentrations trigger the shift towards a 
dysbiotic biofilm or if other factors initiate the occurrence of dysbiotic biofilms, which in turn 
induce the release of higher myeloperoxidase concentrations. Other factors might include 
environmental factors like oxygen or pH, although at this point the influence and role of these 
factors in the initiation of dysbiosis remains to be investigated in future studies.   
In conclusion, under the given experimental conditions, clinically relevant peroxidases and 
catalase can contribute to dysbiosis at clinically relevant concentrations in 16-species in vitro 
oral biofilms.  
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Suplemmentary material 
 
 
Supplementary Fig. 1. Spotting technique between commensal bacteria and pathobiont on agar plates. 
Commensal bacteria spot was inoculated 24 hours at 37 °C in aerobic conditions. After 24 hours, one 
spot of peroxidase solutions (myeloperoxidase, lactoperoxidase, catalase or horseradish peroxidase) 
was inoculated only on one side on the commensal spot. After drying for 5 min at 37°C in aerobic 
conditions, spots of pathobionts were inoculated on both sides of the commensal spot and incubated for 
48 hours in anaerobic conditions. Amount of inhibition (AI) was determined by measuring the distance 
between the border of the commensal spot to the border of the inhibited pathobiont spot using ImageJ. 
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Supplementary Table 1. TaqMan primers and probes used for the detection and 
quantification by vitality-qPCR. 
STRAIN  Primer/Probe (5’-3’)/Final concentrations length 
Aggregatibacter 
actinomycetemcomitans 
16S rRNA gen 
Forward 
Reverse 
Probe 
GAA CCT TAC CTA CTC TTG ACA TCC GAA (300 nM) 
TGC AGC ACC TGT CTC AAA GC (300 nM) 
AGA ACT CAG AGA TGG GTT TGT GCC TTA GGG (100 nM) 
80 bp 
Fusobacterium 
nucleatum 
16S rRNA gen 
Forward 
Reverse 
Probe 
GGA TTT ATT GGG CGT AAA GC (300 nM) 
GGC ATT CCT ACA AAT ATC TAC GAA (300 nM) 
CTC TAC ACT TGT AGT TCC G (300 nM) 
162 bp 
Porphyromonas 
gingivalis 
16S rRNA gen 
Forward 
Reverse 
Probe 
GCG CTC AAC GTT CAG CC (300 nM) 
CAC GAA TTC CGC CTG C (300 nM) 
CAC TGA ACT CAA GCC CGG CAG TTT CAA (100 nM) 
68 bp 
Prevotella intermedia 
16S rRNA gen 
Forward 
Reverse 
Probe 
CGG TCT GTT AAG CGT GTT GTG (300 nM) 
CAC CAT GAA TTC CGC ATA CG (900 nM) 
TGG CGG ACT TGA GTG CAC GC (200 nM) 
99 bp 
Streptococcus mutans 
gtfB gen 
Forward 
Reverse 
Probe 
GCC TAC AGC TCA GAG ATG CTA TTC T (900 nM)  
GCC ATA CAC CAC TCA TGA ATT GA (900 nM) 
TGG AAA TGA CGG TCG CCG TTA TGA A (100 nM)  
114 bp 
Streptococcus sobrinus 
gtfT gen 
Forward 
Reverse 
Probe 
TTC AAA GCC AAG ACC AAG CTA GT (200 nM)  
CCA GCC TGA GAT TCA GCT TGT (200 nM)  
CCT GCT CCA GCG ACA AAG GCA GC (250 nM) 
88 bp 
Actinomyces naeslundii 
gen encoding unknown 
protein 
Forward 
Reverse 
Probe 
TCG AAA CTC AGC AAG TAG CCG (200 nM) 
AGA GGA GGG CCA CAA AAG AAA (200 nM) 
GGG TAC TCT AGT CCA AAC TGG CGG ATA GCG (100 nM) 
96 bp 
Streptococcus gordonii 
gtfG gen 
Forward 
Reverse 
Probe 
CGG ATG ATG CTA ATC AAG TGA CC (400 nM) 
GTT AGC TGT TGG ATT GGT TGC C (400 nM) 
AGA ACA GTC CGC TGT TCA GAG CAA (100 nM) 
177 bp 
Actinomyces viscosus 
16S rRNA gen 
Forward 
Reverse 
Probe 
GTG AAG GAG CCA GCT TGC TGG TTC TG (200 nM) 
CGG AAC AAA CCT TTC CCA GGC (200 nM) 
ATG AGT GGC GAA CGG GTG AGT AAC (125 nM) 
155 bp 
Streptococcus salivarius 
Dextranase gene 
Forward 
Reverse 
Probe 
AAC GTT GAC CTT ACG CTA GC (400 nM)   
ACC GTA ACG TGG GAA AAC TG (400 nM)  
GTA GCG TCA GAG TGG TTG AC (100 nM)  
192 bp 
Streptococcus oralis 
gtfR gen 
Forward 
Reverse 
Probe 
ACC AGC AGA TAC GAA AGA AGC AT (400 nM) 
AGG TTC GGG CAA GCG ATC TTT CT (400 nM) 
AAG GCT GCT GTT GCT GAA GAA GT (100 nM) 
229 bp 
Streptococcus mitis 
16S rRNA gen 
Forward 
Reverse 
Probe 
GGC TCG TAG TCT GGA GAT GG (600 nM) 
TAG GTC GTC GTC CCA AGG AA (600 nM)  
CGA AGA GCA CCA ATA GCA CCT CCC (140 nM) 
133 bp 
Streptococcus sanguinis 
gtfP gen 
Forward 
Reverse 
Probe 
CAA AAT TGT TGC AAA TCC AAA GG (600 nM) 
GCT ATC GCT CCC TGT CTT TGA (600 nM) 
AAA GAA AGA TCG CTT GCC AGA ACC GG (100 nM) 
75 bp 
Veillonella parvula 
16S rRNA gen 
Forward 
Reverse 
Probe 
GAC GAA AGT CTG ACG GAG CA (200 nM) 
TGC CAC CTA CGT ATT ACC GC (200 nM) 
AGC TCT GTT AAT CGG GAC GAA AGG C (125 nM) 
171 bp 
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Abstract 
Periodontal diseases originate from a dysbiosis within the oral microbiota which is associated 
with a deregulation of the host immune response. Although little is known about the initiation 
of dysbiosis, it has been shown that H2O2 production is one of the main mechanisms by which 
some commensal bacteria suppress the outgrowth of pathobionts. Current models emphasize 
the critical nature of complex microbial biofilms that form unique microbial ecologies and of 
their change during transition from health (homeostatic) to disease (dysbiotic). However, very 
little is known on how this alters their virulence and host responses. The objective of this study 
was to determine differences in virulence gene expression by pathobionts and the 
inflammatory host response in homeostatic and dysbiotic biofilms originating from the same 
ecology. Quantitative PCR was performed to quantify the pathobiont outgrowth. Expression 
analysis of bacterial virulence and cellular inflammatory genes together with cytokine ELISAs 
were used to detect differences in bacterial virulence and to analyze potential differences in 
inflammatory response. An increase in pathobionts in induced dysbiotic biofilms was observed 
compared to homeostatic biofilms. The main virulence genes of all pathobionts were 
upregulated in dysbiotic biofilms. Exposure of these dysbiotic biofilms to epithelial and 
fibroblast cultures increased the expression of interleukin IL-6, IL-1β, tumor necrosis factor 
TNF-α and matrix metalloprotease MMP-8, but especially the chemokine CXCL8 (IL-8). 
Conversely, homeostatic and beneficial biofilms had a minor immune response at the mRNA 
and protein level. Overall, induced dysbiotic biofilms enriched in pathobionts and virulence 
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factors significantly increased the inflammatory response compared to homeostatic and 
commensal biofilms. 
Introduction  
The initiation and progression of periodontal pathologies is determined by a complex interplay 
between periodontopathobionts and the host inflammatory response (1). Pathobionts are 
natural members of the human microbiota that under certain perturbations to the host and/or 
microbiota can cause pathology (2, 3). The current etiological model for periodontitis proposes 
that changes in the composition of oral biofilms, called dysbiosis, deregulate the host 
inflammatory response, leading to chronic inflammation and consequently periodontitis (4, 5). 
Although little is known about the initiation of dysbiosis in periodontal diseases, it was shown 
that neutralizing H2O2 produced by commensal bacteria in multi-species biofilms results in 
dysbiosis (6). Although several studies have shown differences in the metagenome and 
metatranscriptome of homeostatic and dysbiotic biofilms (7, 8, 9, 10, 11), no studies 
collectively investigate changes in microbiota, virulence gene expression and inflammatory 
mediators when biofilms convert from homeostasis to dysbiosis.  
The expression of virulence factors of oral pathobionts has been extensively investigated, 
primarily in planktonic cultures and biofilms (12, 13, 14). Although it is well accepted that in 
dysbiotic biofilms, virulence gene expression is different (see Table 2 virulence genes in 
chapter 1), it is hardly known how this changes when a biofilm converts from a homeostatic to 
a dysbiotic state (14). Although potassium increases bacterial virulence in dissolved oral 
biofilms (14), the effect of dysbiosis inducing compounds on bacterial virulence in multi-species 
biofilms is unknown.  
Historically, models of the host-microbiota interaction in periodontitis were based on the 
exposure of specific cell lines to planktonic bacteria up to multi-species biofilms containing 
pathobionts (15, 16). Commonly, these studies show a differential inflammatory response 
depending on the species integrated in these biofilms and the challenged cell type (17). 
However, disease associated biofilms were mostly created by selectively including pathobionts 
in a certain biofilm composition (15) without considering their homeostatic and dysbiotic nature 
(16, 18). Surprisingly such biofilms often show no major microbiological differences beyond 
the added pathogenic species (19, 18), whereas a myriad of microbiological changes are 
observed in dysbiosis induced multi-species biofilms (6). The latter is more in line with the in 
vivo reality and let us to conclude that differences in the inflammatory response between 
homeostatic and dysbiotic biofilms, have been never studied.  
Taking all together, although current models emphasize the critical nature of complex microbial 
biofilms that form unique microbial ecologies and their change during transition from health 
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(homeostatic) to disease (dysbiotic), little is known on how this alters their virulence and the 
host responses. Therefore, the objective of this study was to determine differences in virulence 
gene expression by pathobionts and the inflammatory host response in homeostatic and 
dysbiotic biofilms originating from the same ecology.  
Materials and Methods 
Bacterial strains and media. All used bacterial species (Streptococcus sanguinis LM14657, 
Streptococcus cristatus ATCC 49999, Streptococcus gordonii ATCC 49818, Streptococcus 
parasanguinis DSM 6778, Streptoccocus mitis DSM 12643, Streptoccocus oralis DSM 
20627, Streptococcus salivarius TOVE-R, Streptococcus mutans ATCC 20523, 
Streptococcus sobrinus ATCC 20742, Actinomyces viscosus DSM 43327, Actinomyces 
naeslundii ATCC 51655, Prevotella intermedia ATCC 25611, Porphyromonas gingivalis 
ATCC 33277, Fusobacterium nucleatum ATCC 20482, Aggregatibacter 
actinomycetemcomitans ATCC 43718 and Veillonella parvula DSM 2008) were maintained 
on blood agar (Oxoid, Basingstoke, UK) supplemented with 5 mg/mL hemin (Sigma, St. Louis, 
USA), 1 mg/mL menadione (Calbiochem-Novabiochem, La Jolla, USA) and 5% sterile horse 
blood (E&O Laboratories, Bonnybridge, Scotland). Overnight liquid cultures were prepared in 
Brain Hearth Infusion (BHI) broth (Difco, Detroit, USA). Bacteria were cultured under aerobic 
(5% CO2) or anaerobic (80% N2, 10% H2 and 10% CO2) conditions. Optical densities were 
measured and adjusted by spectrophotometry (OD600, Gene Quant Spectrophotometer, 
Buckinghamshire, UK).  
Serum and blood components. Serum, hemin, hemoglobin and peroxidase were used to 
induce dysbiosis in homeostatic biofilms. Solutions were created by dissolving hemin, human 
hemoglobin and horseradish peroxidase (Sigma-Aldrich, St. Louis, USA) in brain heart infusion 
(BHI-2) at concentrations of 5 mg/mL hemin, 0.44 mg/mL hemoglobin or 16 µg/mL peroxidase 
(6). Human serum was obtained by venipuncture of a single, systemically healthy, male 
volunteer with no oral disease and who had not taken any antibiotics for 1 year. Peripheral 
venous blood was immediately centrifuged at 264 x g for 30 min at room temperature. Serum 
was removed, aliquoted and frozen at -20°C.  
Ethics Statement. The use of human serum was approved by the ethical committee of KU 
Leuven (B322201628215).  
Establishment of homeostatic and dysbiotic biofilms. Overnight cultures of six commensal 
bacteria (S. oralis, S. gordonii, S. cristatus, S. parasanguinis, S. mitis and S. sanguinis) with 
inhibitory effects against periodontopathogens (Herrero et al. 2016a) were centrifuged and re-
suspended in BHI-2 broth (OD600 = 0,5 ≈ 1x108 CFU/mL). Equal volumes were mixed and 
transferred to the wells of a 24 well-plate each containing a hydroxyapatite (HA) disc. After 
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24 hours of aerobic incubation, 500 µL of BHI-2 was added to the wells. Homeostatic biofilms 
(HB) were created by adding 500 µL of a bioreactor derived multi-species co-culture of 
14 species to these biofilms. Beneficial biofilms (BB) were created by adding 500 µL of BHI-2. 
Dysbiotic biofilms were created in different ways. Serum-induced dysbiotic biofilms (Se-DB) 
were created by adding 500 µL of serum, hemoglobin-induced dysbiotic biofilms (Hb-DB) by 
adding the hemoglobin solution, hemin-induced dysbiotic biofilms (He-DB) by adding the 
hemin solution and peroxidase-induced dysbiotic biofilms (Pero-DB) by adding the peroxidase 
solution. Additionally, control dysbiotic biofilms (C-DB) were created by adding 500 µL of the 
bioreactor derived multi-species co-culture together with 1000 µL of BHI-2 to the wells of a 
24 well-plate each containing a HA-disc. After 24 hours of anaerobic incubation, the 
supernatant was discarded and biofilms attached to hydroxyapatite (HA) discs were washed 
with phosphate buffered saline. For virulence gene expression analysis, RNA was extracted 
as described below. For quantitative microbial analyses, biofilms were detached with 500 µL 
0,05% Trypsin-EDTA (Gibco, Paisley, UK) for 15 minutes at 37°C, transferred to Eppendorf 
tubes and centrifuged (6010 x g, 5 minutes). After discarding the trypsin, biofilm pellets were 
re-suspended in 500 mL of PBS and analyzed by vitality-qPCR.  
Bioreactor derived multi-species community. A multi-species community was established 
in a BIOSTAT B TWIN (Sartorius, Germany) bioreactor (6). 
Cell cultures. Immortalized human oral keratinocytes (HOK-18A) and human pulp fibroblasts 
(HPFs) were grown as described previously (21, 22).  
Biofilm challenge of cells. Silicon rings (Peleman bvba, Leuven, Belgium) were placed at the 
bottom of 24 well-plates before cell cultures were seeded. The cultures were grown until 
confluence as observed under a microscope. The above-mentioned biofilm-coated HA-discs 
were faced towards the cell monolayer and set on the silicon ring. This ensured a distance of 
1mm between the biofilm and the cell layer. As controls, HA-discs without biofilm were used. 
After 2 hours of contact, HA and silicon rings were removed, the cells were washed with PBS 
and new cell medium plus gentamicin (0.1 mg/mL) was added. After 2, 4, 6, 8 and 24 hours, 
cellular RNA was extracted and cell supernatants was collected to detect CXCL8 by ELISA at 
450 nm using cell medium without serum as a blank according to Moelants et al. 2014 (23). 
Standard curve was performed from an initial value of 10 ng/ml of CXCL8 using a serial dilution 
of 1 in 2 in 12 steps. The limit of detection (LOD) was 1 pg/mL and limit of quantification (LOQ) 
was 5 pg/mL. The coefficient of variation of low and high CXCL8 concentration standards was 
assessed within and between plates to identify intra- (6 replicates) and inter-assay (3 plates) 
precision, and was less than 20%. The recovery value (expressed as the percentage of the 
target concentration) varied between 80-120%. These results are in accordance with the 
guidelines.  
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Gene expression analysis. In brief, RNA from cells was extracted by RNeasy Mini Kit 
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Bacterial RNA was 
extracted by the RNeasy Mini Kit after a mechanical disruption and acid phenol-chloroform 
extraction as described by Vandecasteele et al. 2002 (24). After quality and integrity 
assessment, RNA was converted to cDNA using the PrimeScript 1st strand cDNA Synthesis 
Kit (Takara, Shiga, Japan). Expression of bacterial virulence genes and inflammatory genes 
from cell cultures was analyzed by RT-qPCR in respect to housekeeping genes (16S rRNA 
and β-actin, respectively). A more detailed description and primers can be found in Appendix 
Table 1 and 2. More details about the function and activity of virulence genes in Table 2 in 
chapter 1. 
Vitality qPCR. DNA extraction and vitality-qPCR using propidium monoazide was performed 
according to Loozen et al. 2011 (25). Primers and probe sequences are shown in Appendix 
Table 3. 
Statistical analysis. A linear mixed model with component as fixed factor and run as random 
factor was applied to every study separately. In case a follow up over time was investigated, a 
separate model for each time point was calculated. Differences in variability between the 
components was taken into account by applying a weighing that was inversely proportional to 
the proportion of every component. Comparisons with the control were set up and, for every 
model separately, corrected for simultaneous hypothesis testing according to Dunnett. The 
assumption of normality of residuals was assessed by a normal quantile plot. The residual dot 
plots revealed that the weighing was necessary to take into account unequal variability for 
various components. 
Results 
Effect of blood compounds on bacterial biofilms. In order to evaluate the capacity of blood 
compounds to induce dysbiosis, multi-species biofilms originating from the same baseline 
ecologies were exposed to different blood molecules. The microbial composition of 
homeostatic biofilms (HB) and dysbiotic biofilms is shown in Table 1. Dysbiotic biofilms induced 
by serum (Se-DB), hemoglobin (Hb-DB), hemin (He-DB) or peroxidase (Pero-DB) contained a 
significant higher number of pathobionts compared to homeostatic biofilms (HB). They were 
characterized by a mean outgrowth of A. actinomycetemcomitans, P. gingivalis and P. 
intermedia of 1.38 (± 0.28), 1.15 (± 0.34), and 3.95 (± 0.59) Log10 Geq/mL, respectively 
(p<0.05). The dysbiotic effect of these blood compounds was also examined on the other 14 
bacterial species in the multi-species biofilm communities. When compared to HB, He-DB 
contained significantly higher S. oralis and S. sobrinus counts and significantly lower numbers 
of S. gordonii, S. mitis and A. viscosus (Table 1). Pero-DB contained significantly lower S. 
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gordonii counts. In control dysbiotic biofilms (C-DB), P. gingivalis, A. actinomycetemcomitans, 
P. intermedia and S. mutans counts were significantly higher and S. sanguinis, S. oralis and 
S. mitis counts were significantly lower when compared to the HB. 
Table 1. Log values (Geq/mL) of the different species (mean ± standard deviation, n=3) 
and their percentages that form part of the homeostatic and the different dysbiotic 
biofilms. 
A homeostatic biofilm (HB) refers to a condition without addition of blood compounds. The dysbiotic biofilm (C-DB) 
condition designates the community without the addition of the 6 commensal bacteria. Se-DB, Hb-DB, He-DB and 
Pero-DB designates dysbiotic biofilms induced by serum, hemoglobin, hemin or peroxidase. Bold values with an 
asterisk (*) designates a statistically significant increase of the bacterial numbers in comparison with a HB 
(homeostatic biofilm). (p<0.05). Bold values with a hash (#) designates a statistically significant decrease of the 
bacterial numbers in comparison with a HB (p<0.05). Individual bacterial numbers were determined by qPCR. Total 
numbers were determined by the sum of the numbers of the individual bacteria. The color code represents the log 
values of bacterial numbers (Geq/mL) present in the different biofilms. 
 
 
 Biofilm 
 HB Se-DB Hb-DB He-DB Pero-DB C-DB 
Aa 5,59 ± 0,12 
(0,01%) 
6,97 ± 0,13* 
(0,22%) 
6,87 ± 0,15* 
(0,42%) 
7,25 ± 0,16* 
(0,17%) 
6,81 ± 0,19* 
(0,16%) 
6,91 ± 0,25* 
(0,07%) 
Pi  2,77 ± 0,10 
(0,00001%) 
6,29 ± 0,18* 
(0,04%) 
7,58 ± 0,23* 
(2,01%) 
6,24 ± 0,16* 
(0,01%) 
6,74 ± 0,14* 
(0,10%) 
7,06 ± 0,11* 
(0,09%) 
Pg  5,57 ± 0,06 
(0,004%) 
6,25 ± 0,14* 
(0,05%) 
7,14 ± 0,11* 
(0,48%) 
6,81 ± 0,16* 
(0,05%) 
6,68 ± 0,14* 
(0,09%) 
7,44 ± 0,18* 
(0,22%) 
Fn 8,71 ± 0,10 
(6,1%) 
8,44 ± 0,13 
(6,1%) 
8,42 ± 0,57 
(4,8%) 
8,98 ± 0,31 
(6,0%) 
8,37 ± 0,23 
(4,1%) 
8,91 ± 0,11 
(6,4%) 
S.mutans 6,00 ± 0,19 
(0,01%) 
5,78 ± 0,11 
(0,01%) 
5,77 ± 0,23 
(0,02%) 
6,10 ± 0,19 
(0,01%) 
5,77 ± 0,15 
(0,01%) 
6,39 ± 0,14* 
(0,02%) 
S.sobrinus 5,67 ± 0,36 
(0,01%) 
5,12 ± 0,17 
(0,004%) 
5,24 ± 0,83 
(0,005%) 
7,61 ± 0,08* 
(0,401%) 
5,22 ± 0,54 
(0,004%) 
5,94 ± 0,34 
(0,009%) 
A.naeslundii 7,39 ± 0,19 
(0,29%) 
7,10 ± 0,35 
(0,30%) 
7,12 ± 0,38 
(0,26%) 
7,07 ± 0,12 
(0,10%) 
7,07 ± 0,57 
(0,33%) 
7,58 ± 0,03 
(0,28%) 
A.viscosus 6,96 ± 0,08 
(0,11%) 
6,89 ± 0,15 
(0,17%) 
6,73 ± 0,42 
(0,10%) 
4,65 ± 0,05# 
(0,0004%) 
6,78 ± 0,18 
(0,11%) 
7,06 ± 0,07 
(0,09%) 
S.sanguinis 7,15 ± 0,26 
(0,17%) 
6,97 ± 0,36 
(0,27%) 
6,88 ± 0,80 
(0,13%) 
7,06 ± 0,34 
(0,07%) 
6,97 ± 0,25 
0,17% 
5,15 ± 0,24# 
(0,001%) 
S.gordonii 8,78 ± 0,08 
(7,03%) 
8,26 ± 0,33 
(4,18%) 
8,44 ± 0,64 
(4,49%) 
6,49 ± 0,28# 
(0,02%) 
8,50 ± 0,14# 
(5,64%) 
9,07 ±  0,10 
(9,01%) 
S.oralis 7,18 ±  0,32 
(0,20%) 
7,64 ± 0,24 
(1,38%) 
6,99 ± 0,77 
(0,19%) 
7,88 ± 0,17* 
(0,53%) 
6,89 ± 0,50 
(0,17%) 
5,65 ± 0,15# 
(0,004%) 
S.salivarius 4,29 ± 0,20 
(0,00022%) 
4,21 ± 0,41 
(0,00043%) 
3,88 ± 0,28 
(0,00019%) 
3,76 ± 0,21 
(0,00004%) 
4,20 ± 0,40 
(0,00043%) 
4,41 ± 0,27 
(0,00023%) 
V.parvula 9,88 ± 0,17 
(86,02%) 
9,60 ± 0,20 
(87,29%) 
9,73 ± 0,69 
(87,10%) 
10,17 ± 0,36 
(92,61%) 
9,71 ± 0,21 
(89,15%) 
10,05 ± 0,02 
(83,84%) 
S.mitis 5,95 ± 0,67 
(0,018%) 
5,53 ± 0,75 
(0,016%) 
5,41 ± 0,64 
(0,018%) 
4,77 ± 0,70# 
(0,001%) 
5,70 ± 0,53 
(0,029%) 
3,75 ± 0,16# 
(0,00004%) 
Total 
number 
9,97 ± 0,15 9,70 ± 0,19 10,21 ± 0,67 10,34 ± 0,36 9,81 ± 0,20 10,31 ± 0,02 
 
Bacterial numbers in log values (Geq/mL) 
2 3 4 5 6 7 8 9 10 
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Virulence gene expression. Virulence gene expression of all pathobionts in the different 
multi-species dysbiotic biofilms (Se-DB, He-DB, Hb-DB, Pero-DB and C-DB) was analyzed in 
comparison to their expression in homeostatic biofilms (HB) (Table 2). Differences in virulence 
gene expression were evident depending on the type of biofilm (homeostatic versus dysbiotic) 
but also depending on how dysbiosis was induced (Se-DB, He-DB, Hb-DB, Pero-DB or C-DB).  
In Se-DB, Hb-DB and He-DB, the virulence genes of P. gingivalis (kpg, rgpA, rgpB), P. 
intermedia (phg) and F. nucleatum (hemin transport and hemolysin) were significantly 
upregulated (Table 2). In induced dysbiotic biofilms, the expression of heat shock protein 
genes of P. intermedia was generally more pronounced when compared to C-DB (Table 2). 
Other virulence genes of P. intermedia (adpC, kpsD, ecf), F. nucleatum (transposase), and A. 
actinomycetemcomitans (omp29, cdtB, vapA, pgA, cagE, emaA) were also upregulated 
especially in He-DB and Pero-DB (Table 2). Furthermore, the ABC transporter permease gene 
of F. nucleatum was significantly upregulated in all dysbiotic biofilms (Table 2). 
 
Inflammatory gene expression. A time dependent expression analysis of several 
inflammatory genes in keratinocyte and fibroblast monolayers was performed after exposing 
these cells to HB, Se-DB, Hb-DB, He-DB, Pero-DB, C-DB and BB. The relative change in gene 
expression of CXCL8, IL-6, IL-1β, TNF-α and MMP-8 in biofilm-exposed keratinocytes and 
fibroblasts, compared to non-exposed cells, is shown in Table 3 and Appendix Table 4, 
respectively. HA-discs without biofilms but exposed to serum, hemin, hemoglobin or 
peroxidase did not stimulate inflammatory gene expression significantly in both cell types (data 
not shown). All types of biofilms increased the expression of these inflammatory genes when 
compared to non-exposed cells. However, the magnitude of the increase depended on the 
type of biofilm to which the cells were exposed.  
For keratinocytes in general and at all-time points, the induced inflammatory gene expression 
by dysbiotic biofilms was higher than that by HB (Table 3). In contrast, the induced 
inflammatory gene expression by BB was lower than that induced by HB although this 
difference almost never reached a level of statistical significance. CXCL8, IL-6 and IL-1β 
expression was almost for each time point significantly higher in keratinocytes challenged with 
dysbiotic biofilms when compared to cells exposed to HB. In terms of TNF-α and MMP-8 
expression, the dysbiotic biofilms also induced higher expression when compared to a HB 
although these differences were only occasionally statistically significant. No major differences 
in inflammatory gene expression induction between the different dysbiotic biofilms could be 
detected. For fibroblasts, similar observations could be made although the fibroblasts could 
only be exposed for 4 hours due to significant loss of the monolayer integrity after 4 hours of 
exposure (Appendix Table 4). 
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Table 2. Fold change of virulence gene expression (mean ± standard deviation, n=3) 
from P. gingivalis (Pg), P. intermedia (Pi), A. actinomycetemcomitans (Aa) and F. 
nucleatum (Fn) in different dysbiotic biofilms when compared to homeostatic biofilms. 
A control dysbiotic biofilm (C-DB) condition designates the community without the addition of the 6 commensal 
bacteria. Se-DB, Hb-DB, He-DB and Pero-DB designates dysbiotic biofilms induced by serum, hemoglobin, hemin 
or peroxidase. “A” refers to virulence gene expression of P. gingivalis (Pg), “B” designates virulence gene 
expression of P. intermedia (Pi), “C” designates virulence gene expression of A. actinomycetemcomitans (Aa) and 
“D” designates virulence gene expression of F. nucleatum (Fn). Bold values with an asterisk (*) designates a 
statistically significant upregulation of virulence genes in comparison with HB (homeostatic biofilm) (p<0.05). Bold 
values with a hash (#) designates a statistically significant downregulation of virulence genes in comparison with 
HB (p<0.05). The color code represents the fold change values of virulence genes in dysbiotic biofilms when 
compared with homeostatic biofilms. 
 
Virulence gene expression 
  
Gingipains 
genes 
Genes Se-DB Hb-DB He-DB Pero-DB C-DB 
A 
 
 
Pg 
kgp 5,04 ± 1,53* 22,53 ± 2,56* 32,00 ± 4,78* 3,16 ± 1,28 4,28 ± 1,21* 
rgpB 3,35 ± 0,45* 3,57 ± 0,66* 6,55 ± 2,10* 1,86 ± 0,60 2,09 ± 0,71 
rgpA 2,01 ± 0,25* 1,43 ± 0,18 2,46 ± 0,47* 1,01 ± 0,16 0,69 ± 0,18 
Other 
virulence 
genes 
serB 1,50 ± 0,26 0,88 ± 0,19 1,84 ± 0,49 0,46 ± 0,16# 0,71 ± 0,28 
fimA 0,91 ± 0,16 0,52 ± 0,16 0,63 ± 0,22 0,36 ± 0,16# 0,85 ± 0,20 
prtC 0,47 ± 0,02# 0,59 ± 0,09# 1,26 ± 0,19 0,29 ± 0,10# 0,57 ± 0,21 
B 
 
 
 
 
 
Pi 
 
 
Heat shock 
proteins 
dnaK 1,95 ± 0,31 1,99 ± 0,40 1,79 ± 0,69 4,56 ± 1,16* 3,98 ± 0,60* 
dnaJ 1,38 ± 0,28 2,22 ± 0,95 2,00 ± 0,65 2,73 ± 0,48* 2,13 ± 1,15 
groeL 1,46 ± 0,05* 2,00 ± 0,56 2,40 ± 0,30* 2,30 ± 0,69 0,55 ± 0,05# 
groeS 2,10 ± 0,33* 2,02 ± 0,85 4,67 ± 1,78* 4,28 ± 0,95* 2,27 ± 0,31 
clpB 0,75 ± 0,24 0,43 ± 0,33 3,46 ± 1,50 2,47 ± 0,23* 0,67 ± 0,21 
 htpG 1,36 ± 0,13* 1,60 ± 0,22* 2,17 ± 0,80 1,11 ± 0,18 0,65 ± 0,22 
 
Other 
virulence 
genes 
phg 1,94 ± 0,53* 4,55 ± 1,24* 11,12 ± 3,30* 0,74 ± 0,31 1,44 ± 0,41 
kpsD 1,59 ± 0,36* 0,53 ± 0,06 1,37 ± 0,06 0,88 ± 0,40 0,74 ± 0,24 
adpC 1,94 ± 0,26 1,39 ± 0,30 2,41 ± 0,62* 0,63 ± 0,21# 0,16 ± 0,08# 
inpA 1,38 ± 0,45 0,66 ± 0,13# 1,46 ± 0,38 0,85 ± 0,09 0,75 ± 0,06# 
ecf 1,72 ± 0,51 1,24 ± 0,58 5,56 ± 2,97* 3,48 ± 1,09 1,17 ± 0,09 
C 
 
 
 
 
 
Aa 
 
 
 
 
 
Virulence 
genes 
ltxA 0,37 ± 0,10# 0,87 ± 0,10 1,06 ± 0,17 1,04 ± 0,11 0,65 ± 0,13# 
flp 0,79 ± 0,20 0,81 ± 0,21 1,04 ± 0,06 1,07 ± 0,43 0,39 ± 0,08# 
aae 0,26 ± 0,06# 0,56 ± 0,17# 0,62 ± 0,10# 0,35 ± 0,01# 0,18 ± 0,03# 
apaH 0,88 ± 0,13 0,86 ± 0,18 0,90 ± 0,12 0,64 ± 0,15# 0,68 ± 0,14# 
omp29 1,89 ± 0,22* 2,44 ± 0,43* 2,35 ± 1,15 1,57 ± 0,40 1,89 ± 0,38* 
omp100 0,34 ± 0,09# 1,58 ± 0,62 2,39 ± 0,95 0,86 ± 0,19 1,06 ± 0,36 
cdtB 0,89 ± 0,10 1,03 ± 0,25 2,36 ± 0,77 2,02 ± 0,17* 0,80 ± 0,27 
vapA 0,81 ± 0,26# 1,04 ± 0,16 2,10 ± 0,40* 2,47 ± 0,69 0,93 ± 0,07 
pgA 0,49 ± 0,07# 0,80 ± 0,20 2,25 ± 0,43* 0,75 ± 0,07# 1,23 ± 0,29 
orf859 0,53 ± 0,12# 0,75 ± 0,18 1,36 ± 0,21 1,07 ± 0,08 1,41 ± 0,08* 
vppA 0,91 ± 0,16 0,93 ± 0,28 1,59 ± 0,66 1,48 ± 0,19 0,53 ± 0,13# 
 cagE 0,23 ± 0,08# 0,61 ± 0,10# 2,75 ± 0,75* 1,64 ± 0,30 0,39 ± 0,12# 
 emaA 0,74 ± 0,02# 0,86 ± 0,09 2,11 ± 0,65 2,00 ± 0,25* 1,58 ± 0,13* 
D 
 
 
Fn 
 
 
 
Virulence 
genes 
ABC transp. 2,24 ± 0,50* 3,44 ± 0,65* 7,86 ± 0,66* 4,00 ± 0,68* 2,59 ± 0,61* 
Hemin transp, 4,04 ± 1,35* 2,14 ± 0,75 2,83 ± 0,89* 2,13 ± 0,50 3,85 ± 1,08* 
EF-G 8,09 ± 1,03* 4,61 ± 1,30* 2,22 ±0,45* 2,69 ±0,77* 1,82 ± 0,66 
Hemolysin 1,95 ± 0,15* 3,21 ± 0,73* 2,81 ± 0,20* 2,79 ± 0,25* 6,42 ± 0,52* 
ompA 1,90 ± 0,38 1,13 ± 0,27 1,00 ± 0,23 1,17 ±0,41 0,93 ± 0,12 
Transposase 3,06 ± 0,15* 0,99 ± 0,20 2,00 ± 0,10* 1,80 ± 0,31* 0,88 ± 0,15 
But-CoA 0,45 ± 0,07# 0,95 ± 0,25 0,89 ± 0,33 1,71 ± 0,10* 2,01 ± 0,41* 
                                                     Fold change values 
0 1 2 3 4 ≥5 
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Table 3. Fold change of inflammatory gene expression (mean ± standard deviation, n=3) 
in human oral keratinocytes after being exposed to dysbiotic and homeostatic biofilms. 
FOLD CHANGE EXPRESSION (HOK-18A) 
 TIME 
POINTS 
2 hours 4 hours 6 hours 8 hours 24 hours 
CXCL-8 HB 145,72 ± 12,81 76,80 ± 9,35 52,08 ± 4,41 27,74 ± 3,86 45,28 ± 20,32 
 Se-DB 258,12 ± 33,35* 173,56 ±29,29* 91,91 ± 12,52* 48,48 ± 9,32* 187,09 ± 59,86* 
 Hb-DB 373,44 ± 77,20* 125,04 ± 21,35* 67,45 ± 5,33* 48,22 ± 8,01* 202,33 ± 61,61* 
 He-DB 245,69 ± 41,41* 163,83 ± 41,17 70,19 ± 3,09* 70,82 ± 11,44* 164,18 ± 5,24* 
 Pero-DB 231,47 ± 33,42* 168,79 ± 35,82* 67,51 ± 6,24 56,27 ± 13,28* 179,19 ± 42,35* 
 BB 107,68 ± 12,29# 55,14 ± 5,38 34,13 ± 2,72# 24,77 ± 5,05 14,91 ± 5,92 
 C-DB 435,00 ± 141,40* 194,57 ± 42,15* 77,66 ± 11,44 66,04 ± 18,37* 103,89 ± 9,41* 
IL-6 HB 15,94 ± 3,39 11,79 ± 0,42 11,27 ± 1,27 11,76 ± 2,93 16,05 ± 2,47 
 Se-DB 26,14 ± 0,89* 21,69 ± 2,24* 21,04 ± 3,99* 27,37 ± 7,33* 28,76 ± 5,65 
 Hb-DB 25,51 ± 2,68* 18,50 ± 2,89* 19,13 ± 4,28* 21,24 ± 1,08* 23,34 ± 2,27* 
 He-DB 33,80 ± 3,62* 20,91 ± 4,23* 20,74 ± 3,24* 25,43 ± 1,73* 25,67 ± 2,49* 
 Pero-DB 30,95 ± 3,41* 17,12 ± 0,39 23,00 ± 2,65* 25,37 ± 5,71* 34,47 ± 7,13* 
 BB 13,87 ± 3,47 11,62 ± 1,98 8,28 ± 2,13 9,87 ± 0,84 11,76 ± 5,73 
 C-DB 28,10 ± 3,82* 17,68 ± 2,88* 20,24 ± 3,82* 36,51 ± 11,88* 40,28 ± 12,49 
IL-1β HB 13,77 ± 2,73 8,52 ± 1,92 7,75 ± 1,10 5,72 ±2,61 6,74 ± 0,53 
 Se-DB 31,35 ± 5,00* 18,90 ± 3,60* 18,72 ± 3,50* 7,47 ± 3,24* 13,63 ± 2,84* 
 Hb-DB 34,51 ± 5,33* 18,24 ± 6,56* 14,56 ± 0,76* 7,64 ± 3,04 12,27 ± 2,56 
 He-DB 35,95 ± 4,26* 14,69 ± 2,42* 18,47  ± 2,03* 11,31 ± 2,73* 14,33 ± 0,85* 
 Pero-DB 45,24 ± 13,50* 16,19 ± 3,60* 15,48 ± 3,73 9,80 ± 3,59* 9,78 ± 1,15* 
 BB 15,78 ± 11,67 7,19 ± 3,08 6,84 ±1,55 5,03 ± 2,07 4,21 ±1,56 
 C-DB 44,01 ± 13,56* 16,97 ± 7,63 17,31 ± 6,22 9,53 ± 3,13* 10,21 ± 1,46* 
TNF-α HB 8,14 ± 1,82 3,96 ± 0,97 2,93 ± 0,86 3,42 ± 1,40 3,76 ± 0,64 
 Se-DB 20,50 ± 2,48* 7,56 ± 0,72* 4,38 ± 2,48 4,90 ± 2,12 11,00 ± 3,03* 
 Hb-DB 22,05 ± 7,86 6,26 ± 0,29* 3,88 ± 1,77 5,22 ± 1,83 7,88 ± 1,28 
 He-DB 17,19 ± 1,77* 5,06 ± 1,35 4,68 ± 3,19 5,37 ± 1,47 6,02 ± 1,25 
 Pero-DB 12,78 ± 2,57 5,01 ± 0,68 3,95 ± 2,04 5,30 ± 2,19 7,12 ± 0,45* 
 BB 7,01 ± 1,78 4,60 ± 1,47 2,63 ± 0,79 2,80 ± 0,83 2,95 ± 0,90 
 C-DB 13,29 ± 4,34 5,70 ± 1,25 4,38 ± 1,85 3,57 ± 0,10 8,30 ± 0,78* 
MMP-8 HB 2,69 ± 1,36 3,44 ± 0,43 3,09 ± 1,36 4,01 ± 0,35 3,72 ± 2,01 
 Se-DB 4,57 ± 0,95 5,44 ± 0,91* 4,92 ± 2,18 7,05 ± 0,49* 5,47 ± 1,24 
 Hb-DB 5,58 ± 1,16* 5,36 ± 1,46 4,67 ± 2,67 4,58 ± 0,31 4,95 ±2,43 
 He-DB 6,04 ± 1,68* 3,89 ± 1,21 4,96 ± 1,92* 6,62 ± 0,43* 7,55 ± 3,58* 
 Pero-DB 5,45 ± 1,29* 3,49 ± 2,03 5,45 ± 2,06* 5,47 ± 0,11* 4,91 ± 2,60 
 BB 1,20 ± 0,73 1,59 ± 1,23 3,27 ± 1,18 2,49 ± 0,68 3,78 ± 2,46 
 C-DB 4,53 ± 2,24 5,33 ± 1,15 5,23 ± 2,46 4,83 ± 1,74 9,60 ± 4,56* 
 
A homeostatic biofilm (HB) refers to a condition without addition of blood compounds. Beneficial biofilms (BB) are 
biofilms with 6 commensal species. A control dysbiotic biofilm (C-DB) designates the community without the addition 
of BB. Se-DB, Hb-DB, He-DB and Pero-DB designate dysbiotic biofilms induced by serum, hemoglobin, hemin or 
peroxidase. Bold values with an asterisk (*) designates a significant upregulation of inflammatory genes in 
comparison with HB (p<0.05). Bold values with a hash (#) designates a statistically significant downregulation of 
inflammatory genes in comparison with HB (p<0.05). The β-actin gene was used a reference gene. 
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CXCL8 production by host cells. In order to verify the gene expression data, CXCL8 
production was measured in keratinocyte supernatant after 2, 4, 6, 8 and 24 hours and in 
fibroblast supernatant after 2 and 4 hours of exposure to different types of biofilms (Table 4). 
HA-discs without biofilms and exposed to serum, hemin, hemoglobin or peroxidase did not 
stimulate CXCL8 production significantly in both cell types (data not shown). When exposed 
to biofilms for 2 or 4 hours, CXCL8 production by fibroblasts was higher than by keratinocytes. 
Dysbiotic biofilms increased significantly the CXCL8 production over time when compared to 
HB, irrespectively of the cell type. No major differences in CXCL8 production between the 
different dysbiotic biofilms could be detected. Similar to the gene expression data, CXCL8 
production induced by BB was lower than that induced by HB although was not significantly 
different. As shown in Figure 1, there was a good correlation between CXCL8 gene expression 
and CXCL8 production in the experiments. 
Table 4. CXCL8 concentrations (mean ± standard deviation, n=3) of human oral 
keratinocytes and fibroblast cultures after being exposed to dysbiotic and homeostatic 
biofilms. 
CXCL8 CONCENTRATIONS (pg/mL) 
 Time 
Points 
2 hours 4 hours 6 hours 8 hours 24 hours 
HOKs 
HB <5 9,00 ± 4,90 34,33 ± 2,87 69,00 ± 16,99 183,33 ± 8,26 
Se-DB 6,67 ± 1,25 32,00 ± 8,60* 83,67 ± 5,56* 157,33 ±  29,49* 394,33 ± 46,29* 
Hb-DB <5 57,00 ± 7,79* 77,67 ± 9,84* 159,33 ±  30,73* 210,00 ± 9,20* 
He-DB 12,67 ± 1,70* 25,33 ± 4,03* 88,67 ± 14,06* 153,33 ± 26,40* 395,00 ± 61,60* 
Pero-DB 10,00 ± 2,83* 31,33 ± 9,88* 73,25 ± 13,79* 160,33 ± 40,75* 269,00 ± 23,34* 
BB <5 5,33 ± 1,70 5,00 ± 1,63# 17,00 ± 0,82 118,67 ± 14,08# 
C-DB 38,00 ± 2,16* 42,00 ± 4,08* 69,00 ± 12,03* 194,67 ± 24,78* 295,67 ± 48,88* 
HPFs 
HB 70,65 ± 11,31 294,67 ± 4,78 N.D. N.D. N.D. 
Se-DB 278,43 ± 17,75* 447,33 ± 8,06* N.D. N.D. N.D. 
Hb-DB 137,37 ± 23,55* 386,00 ± 7,87* N.D. N.D. N.D. 
He-DB 125,74 ± 15,13* 336,00 ± 4,08* N.D. N.D. N.D. 
Pero-DB 139,95 ± 11,65* 372,00 ± 5,35* N.D. N.D. N.D. 
BB 38,01 ± 5,59# 217,44 ± 32,94 N.D. N.D. N.D. 
C-DB 96,64 ± 3,56* 484,67 ± 33,23* N.D. N.D. N.D. 
 
A homeostatic biofilm (HB) refers to a condition without addition of blood compounds. A beneficial biofilm (BB) are 
biofilms with 6 commensal species. A control dysbiotic biofilm (C-DB) designates the community without the addition 
of BB. Se-DB, Hb-DB, He-DB and Pero-DB designate dysbiotic biofilms induced by serum, hemoglobin, hemin or 
peroxidase. N.D. means not determined. Bold values with an asterisk (*) designates a significant CXCL8 
concentration compared to HB (p<0.05). Bold values with a hash (#) designates a significant increase of CXCL8 
concentration in comparison with HB (p<0.05). 5 pg/mL was the limit of quantification (LOQ) used in the ELISA test. 
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Figure 1. Fold change and concentrations of CXCL8 (mean ± standard deviation, n=3) after exposure of 
dysbiotic and homeostatic biofilms to keratinocytes after 24h. 
A homeostatic biofilm (HB) refers to a condition without addition of blood compounds. Beneficial biofilms (BB) are 
biofilms contain 6 commensal species. A control dysbiotic biofilm (C-DB) designates the community without the 
addition of BB. Se-DB, Hb-DB, He-DB and Pero-DB designate dysbiotic biofilms induced by serum, hemoglobin, 
hemin or peroxidase. * designates a significant CXCL8 concentration compared to HB (p<0.05). Expression of 
CXCL8 was analyzed by qPCR in respect to the house-keeping gene β-actin, calculated as 2-(CTexp - CTcontrol). 
 
Discussion  
In the current study, homeostatic and dysbiotic biofilms, both originating from the same multi-
species ecology, were created. Although there is no clear definition on what the exact 
composition of homeostatic or dysbiotic biofilms is, we defined BB as biofilms containing only 
bacterial species that can suppress pathobionts by H2O2 production. HB were created by 
adding a 14-species community to BB. This resulted in a biofilm in which the major pathobionts 
were suppressed when compared to a C-DB, except for F. nucleatum that was not inhibited by 
the H2O2 produced by commensal bacteria. When the HB were exposed to peroxidase, serum 
or blood compounds, an outgrowth of pathobionts was induced resulting in biofilms with a 
composition similar to C-DB. The mode of inducing dysbiosis had an impact on the magnitude 
of the dysbiosis. He-DB showed the largest microbial differences with HB whereas Se-DB and 
Hb-DB showed the smallest microbial difference. This might indicate that in vivo different 
dysbiotic factors will result in different dysbiotic biofilms. 
Dysbiosis induction also influenced bacterial virulence gene expression. Virulence gene 
expression analysis was performed for P. gingivalis, P. intermedia, A. actinomycetemcomitans 
and F. nucleatum, since they are considered  as pathobionts (3, 9, 26, 27). In He-DB, Hb-DB, 
Se-DB, virulence genes of P. gingivalis (kpg, rgpA, rgpB), P. intermedia (phg) and F. nucleatum 
(hemin transport and hemolysin) involved in proteolysis, hemagglutination, degradation of 
transferrin and red blood cells and binding of hemoglobin and hemin were increased. This is 
in line with metatranscriptomic studies of dysbiotic biofilms which show increased expression 
of proteases, peptidases, TonB-dependent receptor, hemolysins, iron and haem binding and 
transporter genes (10, 9, 26). Additionally, in these dysbiotic biofilms P. intermedia (adpC, 
kpsD, ecf), A. actinomycetemcomitans (omp29, cdtB, vapA, pgA, cagE, emaA) and F. 
nucleatum (transposase) also increased the expression of genes involved in cell adhesion, 
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host invasion and resistance against the host defense. Furthermore, ABC transporter 
permease gene of F. nucleatum related to multidrug-resistance was significantly upregulated 
in all dysbiotic biofilms. These data are also in concordance with transcriptomic analysis that 
reported an increase in expression of ABC transporters and transposases in dysbiosis (11, 
10). Additionally, in all induced dysbiotic biofilms the expression of P. intermedia heat shock 
protein genes was generally more pronounced than in C-DB. These data indicate that different 
dysbiotic factors differentially contribute to bacterial virulence expression within dysbiotic 
biofilms. 
To verify whether different dysbiotic biofilms increase the inflammatory response more than 
HB and BB, expression analysis of different inflammatory mediators was performed. 
Expression data demonstrated that dysbiotic biofilms induced more expression of CXCL8, IL-
6, IL-1β, TNF-α and MMP-8 than HB and BB. Based on the pronounced CXCL8 expression, 
CXCL8 was selected to corroborate the expression data at protein levels. Similarly, dysbiotic 
biofilms also induced a higher secretion of CXCL8 than HB and BB. These data are in line with 
Ramage and coworkers (2016) (16), who showed differences in CXCL8, IL-6, IL-1β, TNF-α 
expression based on the complexity of the biofilm and the synergistic effect of several 
periodontal pathogens in the activation of these genes. Multi-species biofilms composed of F. 
nucleatum, P. gingivalis, A. actinomycetemcomitans and S. mitis increased the inflammatory 
gene expression more than their respective mono-species biofilms. Similar fold changes of 
CXCL8, IL-6, IL-1β, TNF-α in both studies were observed in epithelial cells, although the 
complexity of the biofilms differed significantly. This underlines the importance of F. nucleatum, 
P. gingivalis and A. actinomycetemcomitans in the activation of these genes. Peyyala and 
coworkers (2013) (17) also showed that the production of IL-1, IL-6 and CXCL8 by epithelial 
cells was influenced by the bacterial composition of the multi-species biofilms. For instance, 3 
species biofilms containing P. gingivalis and/or F. nucleatum increased the secretion of IL-1, 
IL-6 and CXCL8 more than the sum of their respective mono-species biofilms. It would be of 
relevance in future research to also include immune cells such as macrophages. 
The expression and CXCL8 concentration data are in contrast to Belibasakis and coworkers 
(2014) (18), who observed no differences in the transcriptional profile of gingival fibroblasts 
after exposure to either a 10-species biofilm with red complex bacteria or a 7-species biofilm 
without red complex bacteria for 6 hours. Also no differences were observed in the expression 
of CXCL8 and IL-1 after 6 hour challenge of epithelial and fibroblast cell lines. CXCL8 
production was even reduced by biofilms containing the red complex bacteria when compared 
to biofilms without these (15, 19). The differences between these studies and the present data 
can be explained by differences in bacterial composition and biofilm complexity. Whereas in 
the latter studies different biofilms were created by adding extra pathogens, in the current study 
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biofilms were created by interacting with the same starter inoculum. Additionally, the used 
bacterial species might be of importance since only P. gingivalis, F. nucleatum and P. 
intermedia were used in both studies. In essence, when compared to HB and BB, dysbiotic 
biofilms stimulated the expression of cytokines, CXCL8 and MMP8 and increased the secretion 
of CXCL8 in keratinocytes and fibroblasts which can activate chemotaxis and an acute 
inflammatory response during bacterial infections.  
Overall, it could be shown that the induction of dysbiosis results in an outgrowth of pathobionts 
and an increase in their virulence gene expression. The dysbiosis inducing factor differentially 
influences dysbiotic biofilm composition and virulence gene expression. Dysbiotic biofilms 
significantly increased the inflammatory response compared to HB and BB.  
Author Contributions 
Herrero ER contributed to conception, design, data acquisition, analysis, interpretation, drafted 
and critically revised the manuscript; Fernandes S contributed to acquisition and analysis of 
data and drafted the manuscript; Verspecht T contributed to data interpretation and drafted the 
manuscript; Ugarte-Berzal E contributed to experimental design, analysis and interpretation of 
data and critically revised manuscript; Boon N contributed to experimental design, data 
interpretation and critically revised manuscript; Proost P contributed to experimental design 
and conception, analysis and interpretation of data and critically revised manuscript; Bernaerts 
K contributed to data interpretation and critically revised manuscript; M. Quirynen contributed 
to data interpretation and critically revised manuscript and W. Teughels contributed to 
conception, design, data analysis, interpretation and critically revised the manuscript. All 
authors gave final approval and agree to be accountable for all aspects of the work. 
Acknowledgements 
This study was supported by grants of the KU Leuven (OT/12/101), of the Belgian Science 
Policy Office Interuniversity Attraction Poles Programme (I.A.P. Project 7/40), and the Fund 
for Research Foundation-Flanders Belgium (FWO G.0584.13). EUB is a post-doctoral 
researcher for Research Foundation-Flanders Belgium. All authors declare to have no conflict 
of interest. 
References 
1. Kinane DF, Preshaw PM, Loos BG. (2011). Host-response: understanding the cellular and 
molecular mechanisms of host-microbial interactions--consensus of the Seventh European 
Workshop on Periodontology. J Clin Periodontol. 38 (11):44-48. 
2. Chow J, Tang H, Mazmanian SK. 2011. Pathobionts of the gastrointestinal microbiota and 
inflammatory disease. Curr Opin Immunol 23(4):473-480. 
Chapter 5: project 4, paper 4 
94 
3. Cugini C, Klepac-Ceraj V, Rackaityte E, Riggs JE, Davey ME. 2013. Porphyromonas 
gingivalis: keeping the pathos out of the biont. J Oral Microbiol. 5. 
4. Wang GP. 2015. Defining functional signatures of dysbiosis in periodontitis progression. 
Genome Med. 7(1):40. 
5. Hajishengallis G, Lamont RJ. 2012. Beyond the red complex and into more complexity: the 
polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral 
Microbiol. 27(6):409-419. 
6. Herrero ER, Slomka V, Boon N, Bernaerts K, Hernandez-Sanabria E, Quirynen M, Teughels 
W. 2016. Dysbiosis by neutralizing commensal mediated inhibition of pathobionts. Sci Rep. 
6:38179. 
7. Jorth P, Turner KH, Gumus P, Nizam N, Buduneli N, Whiteley M. 2014. Metatranscriptomics 
of the human oral microbiome during health and disease. MBio. 5(2):e01012-01014. 
8. Benitez-Paez A, Belda-Ferre P, Simon-Soro A, Mira A. 2014. Microbiota diversity and gene 
expression dynamics in human oral biofilms. BMC Genomics. 15:311. 
9. Szafranski SP, Deng ZL, Tomasch J, Jarek M, Bhuju S, Meisinger C et al. (2015). Functional 
biomarkers for chronic periodontitis and insights into the roles of Prevotella nigrescens and 
Fusobacterium nucleatum; a metatranscriptome analysis. NPJ Biofilms Microbiomes. 1:15017. 
10. Duran-Pinedo AE, Yost S, Frias-Lopez J. 2015. Small RNA Transcriptome of the Oral 
Microbiome during Periodontitis Progression. Appl Environ Microbiol. 81(19):6688-6699. 
11. Frias-Lopez J, Duran-Pinedo A. 2012. Effect of periodontal pathogens on the 
metatranscriptome of a healthy multispecies biofilm model. J Bacteriol. 194(8):2082-2095. 
12. Wen ZT, Yates D, Ahn SJ, Burne RA. 2010. Biofilm formation and virulence expression by 
Streptococcus mutans are altered when grown in dual-species model. BMC Microbiol. 10:111. 
13. Pecharki D, Petersen FC, Scheie AA. 2008. LuxS and expression of virulence factors in 
Streptococcus intermedius. Oral microbiol Immun. 23(1):79-83. 
14. Yost S, Duran-Pinedo AE, Krishnan K, Frias-Lopez J. 2017. Potassium is a key signal in 
host-microbiome dysbiosis in periodontitis. PLoS Pathog. 13(6):e1006457. 
15. Belibasakis GN, Guggenheim B, Bostanci N. 2013. Down-regulation of NLRP3 
inflammasome in gingival fibroblasts by subgingival biofilms: involvement of Porphyromonas 
gingivalis. Innate Immun. 19(1):3-9. 
16. Ramage G, Lappin DF, Millhouse E, Malcolm J, Jose A, Yang J,  Bradshaw DJ, Pratten 
JR, Culshaw S. 2016. The epithelial cell response to health and disease associated oral biofilm 
models. J  Periodontal Res. 52(3):325-333. 
17. Peyyala R, Kirakodu SS, Novak KF, Ebersole JL. 2013. Oral epithelial cell responses to 
multi-species microbial biofilms. J Dent Res. 92(3):235-240. 
18. Belibasakis GN, Bao K, Bostanci N. 2014. Transcriptional profiling of human gingival 
fibroblasts in response to multi-species in vitro subgingival biofilms. Mol Oral Microbiol. 
29(4):174-183. 
19. Belibasakis GN, Thurnheer T, Bostanci N. 2013. Interleukin-8 responses of multi-layer 
gingival epithelia to subgingival biofilms: role of the "red complex" species. PloS One. 
8(12):e81581. 
20. Herrero ER, Slomka V, Bernaerts K, Boon N, Hernandez-Sanabria E, Passoni 
BB,  Quirynen M, Teughels W. 2016. Antimicrobial effects of commensal oral species are 
regulated by environmental factors. J Dent. 47:23-33. 
Chapter 5: project 4, paper 4 
95 
21. Sliepen I, Van Damme J, Van Essche M, Loozen G, Quirynen M, Teughels W. 2009. 
Microbial interactions influence inflammatory host cell responses. J Dent Res. 88(11):1026-
1030. 
22. Li X, Yoshihara K, De Munck J, Cokic S, Pongprueksa P, Putzeys E  Pedano M, Chen 
Z, Van Landuyt K, Van Meerbeek B. 2016. Modified tricalcium silicate cement formulations 
with added zirconium oxide. Clin Oral Investig. 21(3):895-905. 
23. Moelants EA, Loozen G, Mortier A, Martens E, Opdenakker G, Mizgalska D  Szmigielski 
B, Potempa J, Van Damme J, Teughels W. 2014. Citrullination and proteolytic processing of 
chemokines by Porphyromonas gingivalis. Infect Immun. 82(6):2511-2519. 
24. Vandecasteele SJ, Peetermans WE, Merckx R, Van Ranst M, Van Eldere J. 2002. Use of 
gDNA as internal standard for gene expression in staphylococci in vitro and in vivo. Biochem 
Biophys Res Commun. 291(3):528-534. 
25. Loozen G, Boon N, Pauwels M, Quirynen M, Teughels W. 2011. Live/dead real-time 
polymerase chain reaction to assess new therapies against dental plaque-related pathologies. 
Mol Oral Microbiol. 26(4):253-261. 
26. Yost S, Duran-Pinedo AE, Teles R, Krishnan K, Frias-Lopez J .2015. Functional signatures 
of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome 
analysis. Genome Med. 7(1):27. 
27. Wang J, Qi J, Zhao H, He S, Zhang Y, Wei S, Zhao F. 2013. Metagenomic sequencing 
reveals microbiota and its functional potential associated with periodontal disease. Sci Rep. 
3:1843. 
28. Rodriguez Herrero E, Boon N, Pauwels M, Bernaerts K, Slomka V, Quirynen M, Teughels 
W. 2017. Necrotrophic growth of periodontopathogens is a novel virulence factor in oral 
biofilms. Sci Rep. 7(1):1107. 
29. Umeda JE, Longo PL, Simionato MR, Mayer MP. 2013. Differential transcription of 
virulence genes in Aggregatibacter actinomycetemcomitans serotypes. J Oral Microbiol. 5: 
21473. 
30. Tardif F, Ross G, Rouabhia M. 2004. Gingival and dermal fibroblasts produce interleukin-
1 beta converting enzyme and interleukin-1 beta but not interleukin-18 even after stimulation 
with lipopolysaccharide. J Cell Physiol. 198(1):125-132. 
31. Luo W, Wang CY, Jin L. 2012. Baicalin downregulates Porphyromonas gingivalis 
lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by 
negative regulation of TLR signaling. PloS One. 7(12):e51008. 
32. Herath TD, Wang Y, Seneviratne CJ, Lu Q, Darveau RP, Wang C, Jin L. 2011. 
Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity differentially modulates the 
expression of IL-6 and IL-8 in human gingival fibroblasts. J Clin Periodontol. 38(8):694-701. 
33. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh 
VW, Helaakoski T, Kainulainen T, Rönkä H, et al. (1997). Matrix metalloproteinase-8 is 
expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor 
necrosis factor-alpha and doxycycline. J Biol Chem. 272(50):31504-31509. 
 
 
 
 
 
Chapter 5: project 4, paper 4 
96 
Appendix Table 1. Primers for virulence and housekeeping genes from P. gingivalis (Pg) 
P. intermedia (Pi), A. actinomycetemcomitans (Aa) and F. nucleatum (Fn). 
Gene Sequence 5’-3’ Length 
16S rRNA (Pi) 
 
housekeeping gene 
F: CGGTCTGTTAAGCGTGTTGTG 
R: CACCATGAATTCCGCATACG 
99 pb 
Rodriguez Herrero et al. 2017 
Hemagglutinin gene 
 
phg (Pi) 
F: TTGCAAGTATTGGTTCGGC 
R:TCAGGCTGTAAGCGTAGACG 
438 pb 
gb|AF017417.1|:154-1083 
GenBank: AF017417.1 
protein_id="AAB70257.1" 
Rodriguez Herrero et al. 2017 
Heat shock protein 90 
 
htpG  gene (Pi) 
F: TGAACGTAAGCCGCAGTTAC 
R: TTGTTCTTGGCGCAAAGCAG 
860 pb 
gi|965694490:724387-726444 
GenBank: AP014598.1 
protein_id="BAU19169.1" 
Rodriguez Herrero et al. 2017 
Chaperone dnaK 
 
gene (Pi) 
F: ACGGTGTTGAGGTTGTTGGT 
R: CTCCGCTGACACTCGGTATC 
598 pb 
gi|965692493:1150302-1152203 
GenBank: AP014597.1 
protein_id="BAU17563.1" 
Rodriguez Herrero et al. 2017 
Chaperone dnaJ 
 
gene (Pi) 
F: CGAACATTGTCACGGAACAG 
R: GCAGGAAGTCCTTTGCCTCT 
519 pb 
gi|965692493:412565-413722 
GenBank: AP014597.1 
protein_id="BAU16891.1" 
Rodriguez Herrero et al. 2017 
Chaperone groeL 
 
gene (Pi) 
F: TGAAGATTTGCGCTGTCAAG 
R: TAGCTGGAGTTTCTTCAGGT 
780 pb 
gi|965692493:260345-261970 
GenBank: AP014597.1 
protein_id="BAU16749.1" 
Rodriguez Herrero et al. 2017 
Chaperone 
 
groeS gene (Pi) 
F: AGCGGAGCAGAAAGTAGGTG 
 
R: CAACAGCAAGAACGTCGCTT 
215 pb 
gi|965692493:259953-260222 
GenBank: AP014597.1 
protein_id="BAU16748.1" 
Rodriguez Herrero et al. 2017 
Chaperone 
 
clpB gene (Pi) 
F: CGCTCCATACGAAGCTTTGC 
R: ATTATCCGTGGCGACGTACC 
548 pb 
gi|965692493:10024-12612 
GenBank:AP014597.1 
protein_id="BAU16518.1" 
Rodriguez Herrero et al. 2017 
Polysialic acid transport 
kpsD gene (Pi) 
F: CGGCAGCTTTAAGTTGTGCC 
R: GGGTATGACCGATACGCAGG 
422 pb 
gi|877799833:1064644-1065294 
GenBank: AP014925.1 
protein_id="BAR95643.1" 
Rodriguez Herrero et al. 2017 
RNA polymerase ECF-type 
sigma factor 
 
ecf  gene (Pi) 
F: ATGGAAGCCTCGCAATTCAA 
R: TCCGTAAGTCCTGTTTCGGC 
428 pb 
gi|965692493:1634435-1634935 
GenBank: AP014597.1 
protein_id="BAU17984.1" 
Rodriguez Herrero et al. 2017 
Interpain A 
 
inpA gene (Pi) 
F: GAAGGACAACTACAGCGGAAA 
R: TCCTTTCGTTAGTTCGCTGA 
250 pb 
 
Rodriguez Herrero et al. 2017 
Invasin adpC 
 
gene (Pi) 
F: CTGTGTTCTTCAGTTGCACGC 
R: TATTGCGCCCGCCTTCACCTC 
900 pb 
 
Rodriguez Herrero et al. 2017 
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16S rRNA (Pg) 
 
housekeeping gene 
F: GCGCTCAACGTTCAGCC 
R: CACGAATTCCGCCTGC 
68 pb 
Rodriguez Herrero et al. 2017 
Collagenase prtC 
 
gene (Pg) 
F: TTCTTTGTAGCAGCGGCAGA 
R: CGTATGCCAACGAGATCGGA 
506 pb 
gi|333802964:798156-799409 
GenBank: AP012203.1 
protein_id="BAK24920.1" 
Rodriguez Herrero et al. 2017 
Arginine-specific cysteine 
proteinase 
 
rgpA gene (Pg) 
F: CACAACCTTGGCTTCGTTGG 
R: CAATGGCGCCAAACCTCAAA 
508 pb 
gi|333802964:315477-320528 
GenBank: AP012203.1  
protein_id="BAK24470.1" 
Rodriguez Herrero et al. 2017 
Arginine-specific cysteine 
proteinase 
rgpB (Pg) 
F: GGAGGAATCTCGTTGGCCAA 
R: TGCCGACCATATCACCATCG 
571 pb 
gi|333802964:1685747-1687957 
GenBank: AP012203.1 
protein_id="BAK25772.1 
Rodriguez Herrero et al. 2017" 
Lysine specific cysteine 
protease 
 
kgp (Pg) 
F: TGGCTTTGGTTGGTGACACT 
R: AGCCCCTTTCTCCTTAACGC 
581 pb 
gb|AF017059.1|:738-5936 
GenBank: AF017059.1 
protein_id="AAC26523.1" 
Rodriguez Herrero et al. 2017 
FimA type II fimbrilin 
 
fimA gene (Pg) 
F: TTGCAGGGGTATAAGCACCG 
R: TTGGAGTTGGCGATGACGAA 
567 pb 
gi|333802964:1331121-1332290 
GenBank: AP012203.1 
protein_id="BAK25445.1" 
Rodriguez Herrero et al. 2017 
16S rRNA (Aa) 
housekeeping gene 
F: GAACCTTACCTACTCTTGACATCCGAA 
R: TGCAGACCTGTCTCAAAGC 
80 pb 
Rodriguez Herrero et al. 2017 
Leukotoxin 
 
ltxA gene (Aa) 
F: TTGTCGCAAGTGCCATAGTTATCCAC 
R: TAGCCCCATGGCAACGGTAGAA 
193 pb 
Umeda et al. 2013 
Fimbriae subunit 
 
flp gene (Aa) 
F: TCAAAGCAATCGAAGCAATC 
R: GCAATAGCGATCAAACCGTA 
82 pb 
Umeda et al. 2013 
Autotransporter protein 
 
aae gene (Aa) 
F: GGTTTTAGGCGGCACATTTA 
R: TGCTTGACCAACCATAACCA 
152 pb 
Umeda et al. 2013 
Tetraphosphatase 
 
apaH gene (Aa) 
F: CACCTTGGTTTGCCTTGGATA 
R: TGTCTTCCCAACGTAGCATG 
159 pb 
Umeda et al. 2013 
Outer membrane protein 
 
omp29 gene (Aa) 
F: TCTCAACAAGCCATCTCTGC 
R: CGACCTTTAACTACGTCGCA 
80 pb 
Umeda et al. 2013 
Autotransporter protein 
 
omp100 gene (Aa) 
F: ATCTTCAAGCCAAAACATC 
R: AAGGCTGCCGACATTAT 
169 pb 
Umeda et al. 2013 
Cytolethal distending toxin 
 
cdtB gene (Aa) 
F: CAACAACACAATTCCAACCC 
R: GGCGATACCTGTCCATTCTT 
94 pb 
Umeda et al. 2013 
Virulence associated protein 
 
F: CGAAATTATGGCTGGGTATGC 60 pb 
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vapA gene (Aa) R: AATGGTTGGATGTTGAATACGG Umeda et al. 2013 
Associated with intracellular 
survival 
 
orf859 gene (Aa) 
F: CAATCTCACCCAAGCCCTAC 
R: GCGGCGGAAATATAGAAACTG 
83 pb 
 
Umeda et al. 2013 
 
Virulence plasmid protein 
 
vppA gene (Aa) 
F: GGTTACCGGTGGAGTTCG 
R: CGGGTCGTAATCGTTTGA 
190 pb 
 
Umeda et al. 2013 
Apoptotic protein 
cagE gene (Aa) 
F: TGGATTGGGACAAGTGAACA 
R: TACAAAGCCATAAGAGAAAT 
190 pb 
 
Umeda et al. 2013 
Autotransporter protein 
 
emaA gene (Aa) 
F: CTGCAGCAACCGGGGATTAT 
R: AATGGATTGGTTGCCTTTAG 
110 pb 
 
Umeda et al. 2013 
Extracellular polysaccharide 
synthesis 
 
pgA gene (Aa) 
F: GACGGTGATGCGGTATTGG 
F: GACCGATGATGGAGCTGAA 
160 pb 
 
Umeda et al. 2013 
16S rRNA (Fn) 
 
housekeeping gene 
F: GGATTTATTGGGCGTAAAGC 
R:GGCATTCCTACAAATATCTACGAA 
162 bp 
 
Rodriguez Herrero et al. 2017 
ABC transporter 
 
permease gene (Fn) 
F:AGCAGCTATCGTGCCACTTT 
R: TGTTGAATTGCTAGCTCCCA 
127pb 
Gene ID: FN0659 
Hemin receptor gene (Fn) 
F: AGAGGACAAGGGGAAGGAAG 
R: GAACCACCACCAGGAATGAC 
155 pb 
 
Gene ID: FN0831 
Elongation factor-G 
 
EF-G gene (Fn) 
F: TGGTGTTCATGCTGAATTGG 
R: TCCTTTTTCAACAGCAGGAA 
220 pb 
Gene ID: FN1546 
Hemolysin gene (Fn) 
F: GGAATGCCATCAGGAAGTGC 
R: TGTTCCTATCGCTCCTGCTG 
141 pb 
 
Gene ID: FN0132 
Outer membrane protein A 
 
ompA gene (Fn) 
F: AGCAATGGGAGAAGAACAACCA 
R: TGCTTTCAGTAGGCATTGGT 
119 pb 
 
Gene ID: FN2059 
Transposase gene (Fn) 
F: TTACTTGCATTTGCCGGTCT 
R: TGCAACATGACCAAGAGCAT 
216 pb 
 
Gene ID: FN1676 
Butyrate-acetoacetate 
CoA-transferase subunit B 
(Fn) 
F: AGGACACGTTGACGCTACTG 
R: ATTGCTCCACCCATTCCAGG 
108pb 
 
Gene ID: FN1856 
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Appendix Table 2. Primer sequences of inflammatory and housekeeping genes. 
Gene  Forward 5’-3’ Reverse 5’-3’ Lenght Ref 
IL-1β AGTACCTGAGCTCGCCAGTG CTGCTTGAGAGGTGCTGATG 850pb 
NCBI ref seq: 
NP_000567.1 
Tardif et 
al. 2000 
IL-6 AATCATCACTGGTCTTTTGGAG GCATTTGTGGTTGGGTCA 177pb 
GenBank: 
CAG29292.1 
Lue et al. 
2012 
CXCL8 GAACCATCTCACTGTGTGTAAA CACTCCTTGGCAAAACTG 108pb 
NCBI ref seq: 
NM_000584.3 
Herath et 
al. 2011 
TNF-α TCTTCTCCTTCCTGATCGTG GAAGATGATCTGACTGCCTG 139pb 
NCBI ref seq: 
NM_000594.3 
Herath et 
al. 2011 
MMP-8 AAGGCAACCAATACTGGG ATTTTCACGGAGGACAGG 522pb 
NCBI ref seq: 
XM_017017771.1 
Hanema
aijer et al. 
1997 
β-actin 
(House- 
Keeping) 
TTGGCAATGAGCGGTT AGTTGAAGGTAGTTTCGTGGAT 93pb 
NCBI ref seq: 
NM_001101.4 
Herath et 
al. 2011 
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Appendix Table 3. TaqMan primers and probes used for the detection and quantification by 
vitality-qPCR. 
STRAIN  Primer/Probe (5’-3’)/Final concentrations length 
Aggregatibacter 
actinomycetemcomitans 
16S rRNA gen 
Forward 
Reverse 
Probe 
GAA CCT TAC CTA CTC TTG ACA TCC GAA (300 nM) 
TGC AGC ACC TGT CTC AAA GC (300 nM) 
AGA ACT CAG AGA TGG GTT TGT GCC TTA GGG (100 nM) 
80 bp 
Fusobacterium 
nucleatum 
16S rRNA gen 
Forward 
Reverse 
Probe 
GGA TTT ATT GGG CGT AAA GC (300 nM) 
GGC ATT CCT ACA AAT ATC TAC GAA (300 nM) 
CTC TAC ACT TGT AGT TCC G (300 nM) 
162 bp 
Porphyromonas 
gingivalis 
16S rRNA gen 
Forward 
Reverse 
Probe 
GCG CTC AAC GTT CAG CC (300 nM) 
CAC GAA TTC CGC CTG C (300 nM) 
CAC TGA ACT CAA GCC CGG CAG TTT CAA (100 nM) 
68 bp 
Prevotella intermedia 
16S rRNA gen 
Forward 
Reverse 
Probe 
CGG TCT GTT AAG CGT GTT GTG (300 nM) 
CAC CAT GAA TTC CGC ATA CG (900 nM) 
TGG CGG ACT TGA GTG CAC GC (200 nM) 
99 bp 
Streptococcus mutans 
gtfB gen 
Forward 
Reverse 
Probe 
GCC TAC AGC TCA GAG ATG CTA TTC T (900 nM)  
GCC ATA CAC CAC TCA TGA ATT GA (900 nM) 
TGG AAA TGA CGG TCG CCG TTA TGA A (100 nM)  
114 bp 
Streptococcus sobrinus 
gtfT gen 
Forward 
Reverse 
Probe 
TTC AAA GCC AAG ACC AAG CTA GT (200 nM)  
CCA GCC TGA GAT TCA GCT TGT (200 nM)  
CCT GCT CCA GCG ACA AAG GCA GC (250 nM) 
88 bp 
Actinomyces naeslundii 
gen encoding unknown 
protein 
Forward 
Reverse 
Probe 
TCG AAA CTC AGC AAG TAG CCG (200 nM) 
AGA GGA GGG CCA CAA AAG AAA (200 nM) 
GGG TAC TCT AGT CCA AAC TGG CGG ATA GCG (100 nM) 
96 bp 
Streptococcus gordonii 
gtfG gen 
Forward 
Reverse 
Probe 
CGG ATG ATG CTA ATC AAG TGA CC (400 nM) 
GTT AGC TGT TGG ATT GGT TGC C (400 nM) 
AGA ACA GTC CGC TGT TCA GAG CAA (100 nM) 
177 bp 
Actinomyces viscosus 
16S rRNA gen 
Forward 
Reverse 
Probe 
GTG AAG GAG CCA GCT TGC TGG TTC TG (200 nM) 
CGG AAC AAA CCT TTC CCA GGC (200 nM) 
ATG AGT GGC GAA CGG GTG AGT AAC (125 nM) 
155 bp 
Streptococcus salivarius 
Dextranase gene 
Forward 
Reverse 
Probe 
AAC GTT GAC CTT ACG CTA GC (400 nM)   
ACC GTA ACG TGG GAA AAC TG (400 nM)  
GTA GCG TCA GAG TGG TTG AC (100 nM)  
192 bp 
Streptococcus oralis 
gtfR gen 
Forward 
Reverse 
Probe 
ACC AGC AGA TAC GAA AGA AGC AT (400 nM) 
AGG TTC GGG CAA GCG ATC TTT CT (400 nM) 
AAG GCT GCT GTT GCT GAA GAA GT (100 nM) 
229 bp 
Streptococcus mitis 
16S rRNA gen 
Forward 
Reverse 
Probe 
GGC TCG TAG TCT GGA GAT GG (600 nM) 
TAG GTC GTC GTC CCA AGG AA (600 nM)  
CGA AGA GCA CCA ATA GCA CCT CCC (140 nM) 
133 bp 
Streptococcus sanguinis 
gtfP gen 
Forward 
Reverse 
Probe 
CAA AAT TGT TGC AAA TCC AAA GG (600 nM) 
GCT ATC GCT CCC TGT CTT TGA (600 nM) 
AAA GAA AGA TCG CTT GCC AGA ACC GG (100 nM) 
75 bp 
Veillonella parvula 
16S rRNA gen 
Forward 
Reverse 
Probe 
GAC GAA AGT CTG ACG GAG CA (200 nM) 
TGC CAC CTA CGT ATT ACC GC (200 nM) 
AGC TCT GTT AAT CGG GAC GAA AGG C (125 nM) 
171 bp 
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Appendix Table 4. Fold change of inflammatory gene expression (mean ± standard 
deviation, n=3) in human pulp fibroblasts (HPF) after being exposed to dysbiotic and 
homeostatic biofilms. 
FOLD CHANGE EXPRESSION (HPF) 
 TIME 
POINTS 
2 hours 4 hours 
CXCL-8 HB 2,21 ± 0,32 22,36 ± 3,08 
 Se-DB 7,78 ± 2,24* 37,39 ± 4,25* 
 Hb-DB 3,70 ± 1,26 40,49 ± 6,05* 
 He-DB 5,58 ± 1,46* 36,84 ± 8,54 
 Pero-DB 7,94 ± 2,50 32,24 ± 3,10* 
 BB 2,07 ± 1,02 17,77 ± 7,27 
 C-DB 3,05 ± 0,64 44,10 ± 9,92 
IL-6 HB 1,21 ± 0,27 11,76 ± 1,91 
 Se-DB 3,77 ± 1,10* 18,80 ± 2,45* 
 Hb-DB 3,27 ± 0,56* 23,06 ± 4,56* 
 He-DB 3,36 ± 0,90* 22,72 ± 3,64* 
 Pero-DB 3,51 ± 0,74* 26,13 ± 1,51* 
 BB 1,87 ± 0,74# 11,86 ± 2,05 
 C-DB 5,82 ± 0,57* 19,21 ± 1,42* 
IL-1β HB 1,80 ± 0,51 3,77 ± 1,26 
 Se-DB 2,97 ± 1,47 6,90 ± 0,21* 
 Hb-DB 3,04 ± 0,42* 7,20 ± 1,22* 
 He-DB 3,44 ± 1,10 7,42 ± 1,36* 
 Pero-DB 3,34 ± 0,71* 8,73 ± 1,64* 
 BB 2,21 ± 1,18 4,10 ± 0,87 
 C-DB 2,94 ± 0,19 6,85 ± 0,78* 
TNF-α HB 4,63 ± 0,83 6,11 ± 0,82 
 Se-DB 7,54 ± 1,88 9,30 ± 1,59 
 Hb-DB 6,37 ± 0,62 10,72 ± 2,13 
 He-DB 8,21 ± 3,28 12,36 ± 1,90 
 Pero-DB 8,83 ± 1,84 8,91 ± 3,22 
 BB 5,12 ± 2,26 5,45 ± 2,27 
 C-DB 8,23 ± 0,81 10,48 ± 2,73 
MMP-8 HB 3,15 ± 0,45 1,39 ± 0,48 
 Se-DB 5,17 ± 3,20 2,53 ± 0,86 
 Hb-DB 6,14 ± 0,91* 3,38 ± 1,13* 
 He-DB 8,81 ± 2,71 3,16 ± 0,45* 
 Pero-DB 5,52 ± 2,36 2,08 ± 0,72 
 BB 4,77 ± 1,55 1,33 ± 0,26 
 C-DB 5,85 ± 1,41 2,05 ± 0,34 
 
A homeostatic biofilm (HB) refers to a condition without addition of blood compounds. Beneficial biofilms (BB) are 
biofilms containing 6 commensal species. A control dysbiotic biofilm (C-DB) designates the community without the 
addition of BB. Se-DB, Hb-DB, He-DB and Pero-DB designate dysbiotic biofilms induced by serum, hemoglobin, 
hemin or peroxidase. N.D. means not determined. Bold values with an asterisk (*) designates a significant 
upregulation of inflammatory genes compared to HB (p<0.05). Bold values with a hash (#) designates a statistically 
significant downregulation of inflammatory genes in comparison with HB (p<0.05).The β-actin gene was used a 
reference gene. 
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General discussion and future perspectives 
a. Are beneficial bacteria a microbial management tool in periodontal therapy? 
 
Since the current mechanical and chemical oral treatments are not effective enough and not 
sufficiently target-pathogen specific, other oral therapies need to be explored (175). This PhD 
explored the possibility to use oral beneficial bacteria in order to improve oral health by re-
establishing the homeostasis within oral biofilms. Several clinical trials observed positive 
outcomes when probiotics (in these cases specific beneficial oral bacteria) were included in 
non-surgical periodontal therapy (146, 185). The probiotic effect seemed to be limited mainly 
because of 1) the use of non-indigenous bacterial species such as lactic acid bacteria and 
bifidobacteria with reduced integration in oral biofilms (186, 187), 2) the bacterial doses 
(specific concentration of beneficial bacteria which needs to be determined for each 
bacterium), 3) treatment time (dependent on different factors such as bacterial species, 
disease status,…) and 4) vehicle used (generally as lozenge, toothpaste or mouthwash) during 
clinical trials (188). To overcome previous limitations, chapter 2 focused on the identification 
of beneficial species that are indigenous in oral biofilms and explored their inhibitory effect in 
different in vitro conditions. The selection of the beneficial strains was basically done based on 
their prevalence in periodontal health and by their capacity to inhibit the main periodontal 
pathogens. Although 14 species were screened, only six streptococcal species could inhibit 
the growth of the three main periodontopathogens. Since streptococcal species are well-
described dominant species in periodontal health and their absence is related to oral disease 
development (116), the identification of six streptococcal species could be promising to 
possible future clinical studies. Therefore, the characterization of their inhibitory mechanism 
and the influencing factors, which regulate the production of the antimicrobial substances is 
essential in order to design future in vitro and in vivo studies. Based on the results from Chapter 
2, H2O2 production turned out to be the main inhibitory mechanism by which the 6 identified 
beneficial bacteria can compete with the pathogens. This might indicate a much bigger role for 
hydrogen peroxide, not only during biofilm formation but also in the maintenance of 
homeostasis, than anticipated by previous publications in which it was only one of the multiple 
mechanisms of inhibition described in beneficial bacteria (189). However, hydrogen peroxide 
production is not always constitutive under different conditions, since this production is tightly 
regulated by several factors. Among the factors, absence of oxygen, timing of colonization, 
bacterial concentration and distance between beneficial and pathogenic bacteria were shown 
to determine the magnitude of inhibition during bacterial competition. The consideration of 
these factors in future clinical probiotic studies could possibly improve or change the outcome 
of probiotic treatments. Therefore, future clinical trials should take into account the use of an 
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optimal concentration of beneficial bacteria, the timing of inoculation of the beneficial bacteria 
and the oxygenation of the oral pockets by mechanical removal of oral biofilms in order to 
facilitate the beneficial bacteria colonization and to improve the effect of the beneficial bacteria 
during the periodontal treatment. However, the main limitation of the use of beneficial bacteria 
resides in the fact that uncontrolled inoculation of these bacteria can result in serious 
secondary infections or complications due to the translocation of these bacteria to other host 
systems, for instance to the bloodstream (bacteremia) subsequently leading to so-called 
‘probiotic sepsis’ (190). To avoid these possible side effects, our research group recently 
proposed a new periodontal therapy based on specific growth stimulation of the indigenous 
beneficial bacteria by certain innocuous substrates such as N-acetyl-D-mannosamine or β-
methyl-D-galactoside called prebiotics, to recover the homeostasis (134). The combination of 
probiotics (application of external beneficial bacteria) plus prebiotics (stimulation of indigenous 
beneficial bacteria) could improve the effectiveness of both therapies and reduce the required 
concentrations of the beneficial bacterial inoculum and of the prebiotic substrates. Another 
important limitation of the experimental set-up described in chapter 2 was that competition 
experiments were only performed which 2 species on agar-plate conditions. Since oral bacteria 
are grouped in biofilms, chapter 3 explored the beneficial effects of the identified beneficial 
bacteria on dual and multi-species biofilms.  
 
b. Does the neutralization of peroxide lead to dysbiosis? 
 
The data of chapter 3 demonstrated that hydrogen peroxide produced by the 6 beneficial 
bacteria can inhibit the growth of the 3 main periodontal pathogens P. gingivalis, P. intermedia 
and A. actinomycetemcomitans in dual and multi-species biofilms. These results confirmed 
that H2O2 might be a key factor in the formation of biofilms and consequently in the 
maintenance of homeostasis. To assess the anti-dysbiotic effect of hydrogen peroxide by 
limiting the growth of periodontal pathogens, a peroxidase was added in order to neutralize the 
inhibitory effect of the H2O2. The result of this neutralization was the outgrowth of these three 
periodontal pathogens in dual and multi-species biofilms, leading to dysbiosis. Since in vivo 
dysbiosis is characterized by an increase in pathobionts that are able to induce the host 
inflammatory response (56, 141), the possible implication of oral peroxidases in dysbiosis 
needs to be investigated. The selection of oral peroxidases was based on their presence in 
the oral cavity, especially during oral diseases, and on their peroxidase capacity. Since 
increases in gingival crevicular fluid (GCF) flow and gingival bleeding are two hallmarks of 
periodontal diseases (164, 191), serum (~GCF) and several blood compounds (hemin, 
hemoglobin and heme) with known peroxidase activity were selected as possible inducers of 
dysbiosis. The result of the addition of these compounds was an outgrowth of the pathobionts, 
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leading to dysbiosis. These results allowed us to propose a new theoretical dysbiosis model 
based on the neutralization of the commensal inhibitory effect on pathobionts growth by blood 
molecules with peroxidase activity. Briefly, the model describes that when plaque accumulation 
occurs over time and/or when the host susceptibility increases, the host inflammatory response 
is activated. This immune activation causes a release of serum and blood compounds which 
in turn neutralize the hydrogen peroxide produced by beneficial oral bacteria, finally allowing 
outgrowth of the pathobionts (Figure 7A). The neutralization effect of hydrogen peroxide by the 
blood compounds and serum has a positive feedback on itself. However, this in vitro model 
could be improved by increasing the number of bacterial species and the complexity, for 
instance by evaluating whether this dysbiotic effect can be further increased by the presence 
of H2O2-resistant and/or catalase-positive bacteria (i.e. F. alocis). Furthermore, a bacterial 
ecology originating from periodontitis and gingivitis patients could be established in order to 
contrast these results in more complex and clinically relevant in vitro multi-species biofilms. 
Since all experiments were performed under in vitro conditions without considering the 
influence of the interaction between host and microbiota, these data should be confirmed in in 
vivo models. Since the addition of these molecules with peroxidase activity could induce 
periodontal disease, no clinical trials in humans could be carried out. However, an in vivo 
animal model can be proposed, for instance based on the addition of these blood compounds 
and oral peroxidases in the drinking water, after which a possible dysbiotic effect on the oral 
microbiota could be investigated. 
 
c. Are clinical concentrations of oral peroxidases triggering dysbiosis? 
 
In chapter 4, the same dysbiotic effect as the one observed in chapter 3 was achieved by using 
clinical concentrations of specific molecules with peroxidase activity found in periodontitis. 
Since the results of chapter 3 showed that serum (~GCF) induced dysbiosis, possible 
molecules with peroxidase activity in its composition might be responsible for this effect. Since 
the composition of GCF is currently being investigated to identify possible diagnostic markers 
for periodontal diseases (159, 191), it can be hypothesized that some of these markers, 
especially those that appeared in significantly higher concentrations in periodontitis, could play 
a role in dysbiosis. Surprisingly, myeloperoxidase was found to be one of best biomarkers 
since its levels dramatically increase during progression periodontitis and severe periodontitis 
(158, 192). In addition, lower myeloperoxidase concentrations were detected after periodontal 
treatment (193). Therefore, clinical concentrations of myeloperoxidase found in health, 
gingivitis and periodontitis were selected to induce dysbiosis in our model (Figure 7A). The 
addition of myeloperoxidase in clinical periodontitis concentration induced significantly more 
dysbiosis compared with myeloperoxidase concentrations found in gingivitis and health. Since 
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myeloperoxidase can also be found in saliva together with salivary peroxidase 
(~lactoperoxidase), salivary concentrations of both enzymes were applied as well. The addition 
of salivary myeloperoxidases and lactoperoxidases also induced dysbiosis. Moreover, 
catalase originating from red blood cells could be found in the oral cavity as a consequence of 
bacterial hemolysis (194, 195) , so this molecule was also adjusted to clinical myeloperoxidase 
concentrations and subsequently applied. Erythrocyte catalase also exhibited a dysbiotic effect 
in our multi-species biofilms. Hence, clinical concentrations of oral peroxidases, especially 
myeloperoxidase, were shown to induce dysbiosis in in vitro biofilms. These data are in line 
with chapter 3, where serum and several catalytic blood compounds also induced dysbiosis by 
the neutralization of H2O2, but without being adjusted to clinical concentrations (Figure 7A). 
However, these results did not address the influencing factors behind the increase in 
myeloperoxidase concentrations observed in periodontitis. Most of the studies pointed towards 
general plaque accumulation as an important factor behind myeloperoxidase increase. For 
instance, some experimental gingivitis model studies reported a peak of myeloperoxidase after 
4 days of plaque accumulation (196). However, some studies showed that certain oral 
pathobionts such as A. actinomycetemcomitans can specifically trigger myeloperoxidase 
release from neutrophils (197). Additionally, behavioural and genetic host factors such as 
smoking or myeloperoxidase polymorphisms and deficiency could also elevate the 
myeloperoxidase concentrations in these patients (198-200). Intriguingly, the deficiency or 
dysfunction of myeloperoxidase, which is a host defensive enzyme with antimicrobial activity 
by causing the production of hypochlorous acid (201), has never been directly related to a 
higher risk for developing periodontitis (202). To correlate myeloperoxidase with the 
development of periodontal diseases, periodontitis could be induced in an in vivo model using 
myeloperoxidase knockout mice. If myeloperoxidase knockout mice present more resistance 
to periodontitis, a direct link between myeloperoxidase and periodontal diseases can be 
established. To demonstrate this relation in humans, an epidemiological study could be 
performed in order to investigate whether patients with myeloperoxidase deficiency and/or 
dysfunctions in myeloperoxidase activity could be more resistant to periodontal diseases. 
 
d. Immune balance between host-bacteria is deregulated by virulent dysbiotic biofilms 
 
In the previous chapters, dysbiotic biofilms were created through the addition of serum and 
blood compounds, which was characterized by an increase in pathobionts (Figure 7A). 
However, the effect of these dysbiosis inducers was only verified by changes at the microbial 
composition level. It is well-accepted that during dysbiosis changes at the microbial 
composition and virulence level unbalance the inflammatory response, thereby leading to 
periodontal diseases (141, 203). However, little is known about the initiation and progression 
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of dysbiosis. Most of the published studies on natural periodontitis or in vitro models are mainly 
focused on one of the main aspects involved in dysbiosis (204), whereas our new model 
described in chapter 5 studied dysbiosis in multi-species biofilms at microbial, virulence and 
inflammatory response levels. Chapter 5 showed that dysbiotic biofilms induced by serum, 
hemin and hemoglobin increased their bacterial virulence gene expression and caused a 
significant increase in the cellular inflammatory response. The virulence gene expression of all 
pathobionts in induced dysbiotic biofilms was increased depending on the dysbiosis inducer 
that was applied, especially for genes related to bacterial proteolysis and iron transport. These 
results are in line with several metatranscriptomic studies which also showed an upregulation 
of protein catabolism- and iron acquisition-related-genes during periodontitis progression and 
in severe periodontitis patients (205, 206). The expression of these virulence genes in 
dysbiosis could only be explained by nutritional aspects, since serum is a protein-rich fluid and 
iron forms part of the hemoglobin and heme structures. However, our results demonstrated 
that these transcriptomic analyses could never predict the dysbiotic effect resulting from 
neutralization of the H2O2 produced by beneficial bacteria. Moreover, induced dysbiotic 
biofilms also significantly upregulated the expression of the main inflammatory mediators (IL-
8, IL-1β, IL-6 and TNF-α) compared to homeostatic biofilms. Therefore, the secretion of IL-8 
was also significantly higher when induced dysbiotic biofilms were exposed to epithelial and 
fibroblast cell cultures. The results in chapter 5 showed that the induced dysbiotic effect does 
not only causes an increase in the concentrations of pathogenic species, it also increases 
bacterial virulence and the cellular inflammatory response. Moreover, characteristic and 
specific dysbiotic profiles were observed depending on the specific dysbiosis inducer, in terms 
of pathobiont concentrations, bacterial virulence gene expression and cellular inflammatory 
response. Therefore, this model qualitatively improved most of the inflammatory in vitro 
models, which were basically focused on differential secretion of inflammatory molecules after 
biofilms exposure, and which differed only in the inclusion of different numbers of pathogenic 
species without taking into account the nature of the bacterial community in terms of 
homeostasis or dysbiosis. Recently, in the same line of our study, Yost and colleagues 
identified potassium as a new key factor in dysbiosis based on a previous metatranscriptomic 
analysis which showed an upregulation of the potassium transport in progressive periodontitis 
patients (172). The addition of potassium to healthy dental plaque increased the expression of 
virulence genes and the activity of virulence factors, especially of those related to hemolytic 
activity and intriguingly also to iron transport. Specific potassium levels also alter the 
inflammatory response, inducing secretion of TNF-α and reducing the expression of IL-6 and 
the antimicrobial peptide human β-defensin 3 (hBD-3) (172). The approach used in this study 
is completely different to ours, since Yost and colleagues analysed the metagenome and 
transcriptome in in vivo dental plaque to elucidate the mechanisms involved in dysbiosis. The 
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demonstration of the important role of potassium in dybiosis was again performed in an in vitro 
model, even without using biofilms but only with re-suspended dental plaque. Additionally, our 
in vitro model demonstrated the involvement of several blood compounds in in vitro dysbiosis 
at virulence levels, which perfectly correlates with the gene expression profiles found in a 
metatrancriptomic analysis in progressive and severe periodontitis. Although our model lacked 
a transcriptomical analysis, the final corroboration of a dysbiotic role has to be done in 
simplified models where the conditions of the experiment can be regulated and controlled to a 
certain extent. This does not mean that our model cannot be improved by including -omics 
techniques to explore the global effect of our findings in the metabolism, metagenome and 
transcriptome of the whole community. Therefore, future experiments should incorporate a 
global transcriptomics and metabolomics analysis from whole dysbiotic biofilms induced by 
using hemin, hemoglobin and serum. These analyses will allow us to identify the metabolomic 
and transcriptomic networks that are activated when dysbiosis was induced and therefore to 
relate the effect of our dysbiosis-inducing factors with other new dysbiosis inducers like 
potassium. Lastly, this model should be improved by the use of dental plaque from individuals 
with periodontal health and patients suffering from progressive periodontitis and severe 
periodontitis in order to confirm all results obtained using our simplified in vitro model. 
 
 
Figure 7. Dysbiotic oral models. A. Dysbiosis caused by peroxidase activities. B. Dysbiosis caused by 
presence of dead bacteria.  
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e. Limitations and side effects of the current standards treatments 
 
The ineffective outcome of the current therapies based on mechanical treatments 
supplemented with antimicrobial compounds (chlorhexidine (CHX), cetylpyridinium chloride 
(CPC) or triclosan (TC)), resides in the stability of oral biofilms structures, which provides 
resistance to periodontal treatment. For instance, microbial biofilms can be up to 1000 times 
more resistant to antimicrobial agents than planktonic bacteria. In addition, a reduced host oral 
hygiene, for instance due to a physical incapacity or a lack of motivation for certain individuals, 
can also contribute to the persistence of oral biofilms. The result of this incomplete and 
unspecific periodontal treatment is the presence of a cloud of dead bacterial biomass 
composed by different bacterial structures (cell wall, DNA...) to which the living bacterial 
survivors are directly exposed. Chapter 6 was focused on investigating the impact of the dead 
biomass on the growth, virulence and toxicity status of living periodontal pathogens in 
planktonic and multi-species biofilms. The data shown in chapter 6 demonstrated that living 
bacteria can feed from the dead bacterial biomass and thereby increase their growth (Figure 
7B), depending on the amounts of dead bacteria, the dead bacterial species and the structure 
of the cell wall. Previous publications observed the same behaviour in Legionella pneumophila 
in water pipe lines, but only in planktonic conditions (184). These data confirmed for the first 
time the necrotrophic activity of the main periodontal pathogens could occur in the oral cavity. 
This suggests that the bacterial necrotrophic effect could be extrapolated to other human 
mucosal surfaces. Additionally, the results showed that dead bacteria could induce the 
virulence gene expression of two main periodontal pathogens. In order to verify that this new, 
more virulent bacterial phenotype is also translated to a higher toxicity towards the host tissues, 
a cell toxicity test was performed. The combination of dead bacteria plus living bacteria resulted 
in the lowest cell viability. Taking all together, an “at first sight” innocuous dead population 
induced new pathogenic phenotypes characterized by a higher nutritional flexibility 
(necrotrophy), an increased virulence (necrovirulence) and with more toxicity towards the host 
tissues (necrotoxicity) (Figure 7B). Although the results presented in chapter 6 seemed to 
answer some questions, many still remain to be answered in order to characterize this necro-
effect on bacterial behaviour in detail. Since the dead bacterial biomass can be as 
consequence of an incomplete biofilm disruption by using antiseptic or antibiotics, this new 
bacterial phenotype could be resistant to antiseptics or antibiotics after being exposed to dead 
bacteria. A brief future experiment could consist of the determination of antiseptics and 
antibiotics MICs of planktonic bacteria and biofilms which were previously exposed to dead 
bacteria. On the other hand, this necrotrophic behaviour could also be related to dysbiosis, 
since the bacterial necrotrophic activity induced an increase in pathogenic species in oral 
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biofilms. Therefore, multi-species biofilms could for instance be treated with dead bacteria and 
subsequently be analysed by -omics techniques (metagenomics, metatranscriptomics and 
metabolomics). The resulting necrotrophic biofilms could be subsequently exposed to cell 
cultures in order to determine their ability to deregulate the inflammatory response, which is a 
hallmark of dysbiosis, compared to a biofilm that was never exposed to dead bacteria.  
Additionally, future studies on the mechanism of interaction between dead bacteria, or dead 
bacteria combined with living bacteria, respectively, and the cell cultures could provide more 
information on the metabolic cell death pathways involved in the necro-toxic effect that was 
previously observed with the XTT technique. For instance, the use of flow cytometry will allow 
us to evaluate cell apoptosis and necrosis. Apoptosis will be determined by measuring the 
externalization of phosphatidylserine on the plasma membrane using flurorescent-tagged 
annexin V. However, necrosis will be detected by the permeability of the plasma membrane to 
a normally impermeable fluorescent dye, such as the DNA-binding dye propidium iodide. 
Furthermore, the nuclear morphology and integrity would be assessed by fluorescent 
microscopy. This new information could point towards new metabolic therapeutic targets for 
future treatment. 
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Summary 
Periodontitis is an oral infectious pathology which affects the surrounding and supporting 
tissues of the teeth, leading to permanent loss of the teeth. In terms of prevalence, about 50 
percent of the population suffers from periodontitis and around 15 percent of them from 
periodontitis in its more severe form. In addition, periodontitis is also associated with a large 
number of systemic disorders.  
In healthy persons, the oral microbiota and host are in equilibrium (homeostasis). However, 
genetic, systemic and environmental changes can disrupt the equilibrium and cause the 
overgrowth of periodontal pathogens. In this pathological condition, the periodontal pathogens 
can directly inflict damage to the host tissues and subsequently provoke a strong activation of 
the inflammatory host response. The combination of the bacterial infection and the subsequent 
immune response causes the progressive destruction of host tissues. The current standard 
treatments are primarily based on the eradication of pathogenic micro-organisms by means of 
mechanical subgingival debridement, often supplemented with the use of antiseptics or 
antibiotics. The outcome of these therapies strongly depends on the establishment of a non-
pathogenic/host-compatible microbiota in the subgingival area. However, they often only result 
in a temporary microbial shift. The pathogenic bacteria that either survived the therapies or 
that translocated from other intra-oral habitats, are soon recolonizing the pockets. Therefore, 
these traditional periodontal therapies are often insufficient to result in the formation of stable, 
non-pathogenic/host-compatible biofilms. Additionally, increasing levels of antibiotic-resistant 
bacteria requires the development of treatments that do not rely on antibiotics. Therefore, 
alternative and/or complementary therapies are needed to replace and/or complement the 
inefficient conventional treatments. 
As part of the indigenous oral microbiota, the beneficial bacteria play an important role in the 
limitation of the periodontal pathogens. They can produce a wide spectrum of antimicrobial 
substances to antagonize the growth of the oral pathogens. The application of beneficial oral 
species, that are able to produce specific antimicrobial substances effective against the 
periodontal pathogens, could be an alternative or complementary treatment in periodontitis 
therapy. Based on this, the objective of the first study was to identify commensal bacteria with 
inhibitory activity against the main periodontopathogens, to determine the antimicrobial 
substances responsible for these inhibitory activities and to study the influence of the 
experimental and environmental conditions on the magnitudes of inhibition. The Streptococcus 
species S. sanguinis, S. cristatus, S.gordonii, S. parasanguinis, S.mitis and S. oralis were 
classified as beneficial bacteria because of their inhibitory properties against Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia. Hydrogen 
peroxide (H2O2) production by the commensals was found to be the main mechanism of 
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inhibition and the bacterial antagonism was shown to be species-specific and dependent on 
as well experimental as environmental conditions. These results indicate that these bacterial 
species could possibly be applied as new probiotics in a potential future treatment. 
Furthermore, they also provide new insights into the important role of H2O2 in the formation 
and composition of oral biofilms and into the major influence that several environmental 
conditions can have on the magnitudes of inhibition.  
Concerning the influence of these environmental factors, the interfering effect of blood 
compounds with the inhibitory mechanisms was investigated. The addition of blood in the agar 
plates completely blocked the inhibitory effect of the beneficial streptococcal species identified 
in the first experiment. Based on these results, we hypothesized that some blood components 
could interfere with H2O2 and neutralize its antimicrobial effect. Serum, hemin and hemoglobin 
from the blood were selected based on their capacity to react with H2O2. The application of 
these blood compounds on oral biofilms subsequently caused dysbiosis, blocking the 
antimicrobial effect of H2O2 and stimulating the growth of A. actinomycetemcomitans, 
P. gingivalis and P. intermedia. This study brings new knowledge on the process of dysbiosis 
and leads to a new understanding of the compounds involved in the microbial shift that 
accompanies the transition from health to disease.  
The next studies addressed which kind of compounds present in the gingival crevicular fluid 
(GCF) are also able to interfere with H2O2 and to neutralize the inhibitory effect of H2O2 
produced by the beneficial bacteria. It is known that GCF emerges from the host tissues to 
control the microbial challenge posed by the periodontal pathogens. Several studies analyzed 
the composition of GCF both in healthy individuals and in periodontitis patients, and showed 
that myeloperoxidase (MPO) concentrations are significantly higher in periodontitis patients. 
The concentration of MPO found in the GCF of healthy individuals and periodontitis patients 
was subsequently used in the in vitro experiments to test the capacity of MPO to produce 
dysbiosis in complex oral biofilms. In the same way, the neutralization capacity of other 
enzymes (lactoperoxidase and catalase) was also tested using their salivary concentrations. 
Both the peroxidases originating from the GCF and from saliva showed a significant 
neutralization of the inhibitory effect of H2O2. The results obtained during this study allow us to 
make a correlation between the concentrations of peroxidases found in GCF and saliva on the 
one hand and the dysbiosis process that occurs in oral biofilms on the other hand. 
The objective of the next study was to demonstrate that the microbial shift of the oral biofilms 
caused by exposition to serum, hemoglobin, hemin and peroxidase could produce an increase 
in the host inflammatory response due to the outgrowth of periodontal pathogens. The possible 
overexpression of several inflammatory mediators (IL-8, IL-6, TNF-α...) was evaluated. 
Furthermore, the expression of virulence genes from the periodontal pathogens was also 
Summary 
 
135 
analyzed. This research showed that the presence of dysbiosis-inducing compounds can 
cause the outgrowth of the periodontal pathogens and increase their virulence. These dysbiotic 
biofilms also increased the inflammatory response from the host tissues.  
The last study focused on an important side effect of the traditional but unspecific and 
ineffective treatments in periodontitis. It is already known that oral bacteria developed different 
strategies to overcome the effects of these standard treatments. Necrotrophic growth could be 
one of these strategies, since it was already demonstrated that Legionella pneumophila 
bacteria were able to survive in refrigeration pipes by using dead bacteria as nutritional source. 
The experiments conducted during this study showed that the main periodontal pathogens 
indeed could feed from parts of dead oral bacteria, thereby increasing their own growth and 
virulence. The presence of dead bacteria plus living bacteria also caused an increase in 
mortality of cell cultures. This study demonstrated that necrotrophy is an important side effect 
of the current periodontitis treatments and that new, more specific therapies are highly 
necessary for an efficient treatment of periodontitis. 
All together, the obtained results offer a new insight into the development of periodontitis. 
These insights were obtained by means of characterization of the important role beneficial oral 
bacteria play in the maintenance of homeostasis. The most important function of H2O2 was 
demonstrated, namely limiting the growth of periodontal pathogens in oral biofilms. The 
initiation of dysbiosis is related to the neutralization of the inhibitory effect of H2O2 produced by 
beneficial bacteria during inflammation, and more specifically to myeloperoxidase in gingival 
crevicular fluid that is responsible for this neutralization. Furthermore, the dysbiotic biofilms 
could also induce an increased inflammatory response. Standard treatments supplemented 
with the use of antimicrobials can thus enhance the pathogens growth and increase their 
virulence. A next generation of oral treatments of periodontitis should be based on the 
stimulation of the advantageous properties of the beneficial bacteria by using prebiotics and 
leave behind the unspecific killing procedures. 
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Samenvatting 
Parodontitis is een orale infectieuze pathologie die de omliggende en ondersteunende 
weefsels van de tanden aantast, hetgeen kan leiden tot permanent verlies van de tanden. Wat 
de prevalentie betreft, lijdt ongeveer 50 procent van de wereldbevolking aan parodontitis, 
waarvan 15 procent aan de meest ernstige vorm. Parodontitis is eveneens geassocieerd met 
een groot aantal systemische aandoeningen. 
In gezonde individuen zijn de orale bacteriële flora en de gastheer met elkaar in evenwicht 
(homeostase). Desalniettemin kunnen genetische, systemische en omgevingsfactoren deze 
balans verstoren, hetgeen een overgroei aan parodontale pathogenen tot gevolg heeft. In deze 
pathologische situatie kunnen de parodontale pathogenen rechtstreeks schade berokkenen 
aan de gastheerweefsels en een sterke ontstekingsreactie uitlokken. De combinatie van de 
bacteriële infectie met de daaropvolgende immuunrespons is vervolgens verantwoordelijk voor 
de progressieve destructie van de gastheerweefsels. De huidige standaardbehandelingen zijn 
voornamelijk gericht op het uitroeien van de pathogene micro-organismen door middel van 
mechanisch subgingivaal debridement, vaak aangevuld met het gebruik van antiseptica en/of 
antibiotica. De uitkomst van deze therapieën hangt sterk af van het al dan niet tot stand komen 
van een niet-pathogene/gastheer-compatibele microbiota in het subgingivale gebied. Helaas 
treedt er vaak slechts een tijdelijke verschuiving op in de microbiële samenstelling. Pathogene 
bacteriën die de behandelingen overleefd hebben of vanuit andere intra-orale habitats 
afkomstig zijn, kunnen de tandvleespockets spoedig rekoloniseren. Hierdoor schieten deze 
traditionele parodontitisbehandelingen vaak te kort om te kunnen resulteren in stabiele, niet-
pathogene/gastheer-compatibele biofilmen. Daarenboven is er vanwege een toename in 
antibiotica-resistentie een hoge nood aan de ontwikkeling van behandelingen die niet 
gebaseerd zijn op het gebruik van antibiotica. Dit alles maakt dat er dringend alternatieve en/of 
complementaire behandelingen nodig zijn om de inefficiënte conventionele therapieën te 
vervangen en/of aan te vullen. 
Als belangrijk onderdeel van de inwendige microbiota spelen zogenaamde goedaardige 
bacteriën een belangrijke rol in de groeilimitatie van de parodontale pathogenen. Een brede 
waaier aan antimicrobiële substanties geproduceerd door deze goedaardige bacteriën is 
verantwoordelijk voor de groeiremming van de paropathogenen. Dit maakt dat de toediening 
van uitwendige goedaardige orale bacteriën, die in staat zijn om specifieke antimicrobiële 
substanties te produceren, een goede alternatieve en/of complementaire behandeling voor 
parodontitis zou kunnen betekenen. Uitgaande van deze hypothese was het doel van de 
eerste studie om commensale, goedaardige bacteriën met een remmende activiteit op de 
belangrijkste paropathogenen te identificeren, te bepalen welke antimicrobiële substanties 
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hierbij betrokken zijn en om de invloed van verschillende experimentele condities en 
omgevingsfactoren op de sterkte van deze remming na te gaan. De Streptococcus-soorten S. 
sanguinis, S. cristatus, S. gordonii, S. parasanguinis, S. mitis en S. oralis konden 
geclassificeerd worden als zulke goedaardige bacteriën omwille van hun remmende 
eigenschappen ten opzichte van Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis en Prevotella intermedia. De productie van waterstofperoxide (H2O2) door deze 
commensalen bleek het belangrijkste remmingsmechanisme te vertegenwoordigen. 
Daarenboven bleek het bacteriële antagonisme soort-specifiek te zijn, alsook afhankelijk van 
zowel experimentele condities als van omgevingsfactoren. Deze resultaten tonen aan dat deze 
bacteriën mogelijk aangewend kunnen worden als nieuwe probiotica tijdens toekomstige 
behandelingen. Bovendien verlenen deze resultaten ook nieuwe inzichten in de belangrijke rol 
van H2O2 in de vorming en samenstelling van orale biofilmen en in de grote invloed die 
verschillende omgevingsfactoren kunnen hebben op de sterkte van de remming.  
Wat betreft de invloed van deze omgevingsfactoren, werd onder meer de mogelijke 
interferentie van bloedcomponenten met het remmend mechanisme nagegaan. De toevoeging 
van bloed aan de voedingsbodems deed het remmend effect van de eerder geïdentificeerde 
goedaardige bacteriën volledig teniet. Op basis van deze resultaten werd verondersteld dat 
sommige bloedcomponenten mogelijks interfereren met H2O2 en het antimicrobieel effect 
ervan neutraliseren. Serum, hemine en hemoglobine afkomstig uit het bloed werden 
vervolgens geselecteerd op basis van hun vermogen tot reactie met H2O2. Het toedienen van 
deze bloedcomponenten aan orale biofilmen veroorzaakte vervolgens dysbiose omwille van 
het blokkeren van het antimicrobiële effect van H2O2 en het stimuleren van de groei van A. 
actinomycetemcomitans, P. gingivalis, en P. intermedia. Deze studie hielp bij het verwerven 
van nieuwe kennis over het dysbiose proces en werpt een nieuw licht op welke componenten 
mogelijks betrokken zijn bij de verschuiving in microbiële samenstelling die gepaard gaat met 
de overgang van gezondheid naar ziekte.  
Tijdens de daaropvolgende studies werd vervolgens nagegaan welke componenten uit 
gingivaal creviculair vocht (GCV) eveneens kunnen interfereren met het remmend effect van 
H2O2 geproduceerd door de goedaardige bacteriën. Het is algemeen geweten dat GCV 
afgescheiden wordt door de gastheerweefsels om zo de microbiële uitdaging die de 
paropathogenen vormen het hoofd te bieden. Tijdens verscheidene studies werd de 
samenstelling van GCV afkomstig van gezonde individuen en parodontitispatiënten nagegaan, 
waarbij men tot de vaststelling kwam dat de myeloperoxidase (MPO) concentraties in 
patiënten die aan parodontitis lijden significant hoger zijn dan deze in gezonde individuen. 
Dezelfde MPO-concentraties als deze die werden teruggevonden in het GCV van gezonde 
individuen en parodontitispatiënten werden vervolgens gebruikt in de in vitro experimenten die 
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werden opgezet om de MPO-capaciteit tot inductie van dysbiose in complexe orale biofilmen 
na te gaan. De neutralisatiecapaciteit van andere enzymen (namelijk lactoperoxidase en 
katalase) werd op éénzelfde manier nagegaan. Hiervoor werd gebruik gemaakt van hun 
respectievelijke speekselconcentraties. Zowel de peroxidases afkomstig uit GCV als deze 
afkomstig uit speeksel vertoonden een significante neutralisatie van het remmend effect van 
H2O2. De resultaten bekomen in deze studie laten toe om een correlatie te maken tussen de 
peroxidaseconcentraties in GCV en speeksel enerzijds en het dysbioseproces dat plaatsvindt 
in orale biofilmen anderzijds. 
Het doel van de volgende studie was aantonen dat de verschuiving in microbiële samenstelling 
van de orale biofilmen veroorzaakt door blootstelling aan serum, hemoglobine, hemine en 
peroxidase een toename in inflammatoire respons kan veroorzaken, en dit vanwege een 
overgroei aan paropathogenen. De mogelijke overexpressie van verschillende inflammatoire 
mediatoren (IL-8, IL-6, TNF-α, …) werd nagegaan, alsook de expressie van virulentiegenen in 
de paropathogenen. Dit onderzoek toonde aan dat de aanwezigheid van dysbiose-
inducerende componenten een overgroei aan paropathogenen kan veroorzaken alsook hun 
virulentie kan doen toenemen. Daarenboven zorgden deze dysbiotische biofilmen ook voor 
een toegenomen inflammatoire respons. 
De laatste studie focuste op een belangrijk neveneffect van de traditionele maar weliswaar 
aspecifieke en ineffectieve parodontitisbehandelingen. Het is algemeen geweten dat orale 
bacteriën verschillende strategieën ontwikkeld hebben om het beoogde effect van deze 
behandelingen te omzeilen. Necrotrofische groei is hier mogelijk één van, zoals reeds werd 
aangetoond voor Legionella pneumophila bacteriën in koelingsleidingen, die wisten te 
overleven door dode bacteriën aan te wenden als voedingsbron. De experimenten uitgevoerd 
tijdens deze studie toonden aan dat de belangrijkste paropathogenen inderdaad in staat waren 
om zich te voeden met dode orale bacteriën en op deze manier hun eigen groei en virulentie 
konden doen toenemen. De aanwezigheid van dode bacteriën in combinatie met levende 
bacteriën veroorzaakte eveneens een toename in mortaliteit van celculturen. Deze studie 
toonde aan dat necrotrofie een belangrijk neveneffect is van de huidige 
parodontitisbehandelingen en dat nieuwe, meer specifieke therapieën hoognodig zijn om 
parodontitis efficiënt te kunnen behandelen. 
Samengevat bieden de bekomen resultaten nieuwe inzichten in de ontwikkeling van 
parodontitis. Deze inzichten werden verworven door middel van de karakterisering van de 
belangrijke rol die goedaardige orale bacteriën spelen in het onderhouden van de 
homeostatische balans. De belangrijke functie van H2O2 werd aangetoond, namelijk de limitatie 
van de groei van paropathogenen in orale biofilmen. De initiatie van dysbiose blijkt gerelateerd 
te zijn aan de neutralisatie van het remmend effect van H2O2 geproduceerd door goedaardige 
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bacteriën tijdens inflammatie, en meer bepaald aan myeloperoxidase uit het GCV dat hiervoor 
verantwoordelijk is. Daarenboven lokten de dysbiotische biofilmen ook een sterkere 
inflammatoire respons uit. Standaardbehandelingen aangevuld met het gebruik van 
antimicrobiële middelen kunnen dus een toename in de groei en virulentie van de 
paropathogenen veroorzaken. Een volgende generatie van orale behandelingen voor 
parodontitis zou dus gericht moeten zijn op het stimuleren van de voordelige eigenschappen 
van de goedaardige bacteriën door middel van gebruik van prebiotica en de aspecifieke 
dodingsmechanismen achterwege laten. 
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